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Medication management is a complex and expensive multistage process that covers the 
prescribing and ordering, order communication, dispensing, administering, and monitoring and 
use of prescription medications. While challenges in medication management are ubiquitous 
across all settings, they can be particularly exacerbated in a free clinic that serves a medically 
vulnerable population. These patients suffer from financial constraints, poor health literacy, 
multiple chronic conditions, and medication non-adherence. Clinical pharmacists play an integral 
role in the provision of healthcare services to these patients and could benefit from the use of 
medication management information technology (MMIT) to provide efficiencies in the tracking, 
provision, and use of medications. While MMITs exist, they are not designed to support the 
unique needs of pharmacists in these settings.  
To address challenges related to medication management in this setting, and the inability 
of existing technologies to alleviate them, we developed a system for Prescription Management 
And General Inventory Control, or RxMAGIC, in collaboration with the Birmingham Free Clinic 
(BFC) in Pittsburgh, PA. RxMAGIC is an interoperable, web-based dispensary management 
information system designed to streamline the dispensing process and improve inventory control 
in a free clinic dispensary. This research describes the process employed to create, deploy, and 
evaluate RxMAGIC in the BFC. We used a range of evaluation studies and methods to 
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understand challenging aspects of the pharmaceutical workflow, design a system that alleviates 
those challenges, and evaluate it to ensure that it does.  
We assert that this research is significant in several ways. First, we developed a 
medication management tool for free clinic dispensaries that pharmacists in this setting do not 
currently have. Second, we demonstrated the importance of various levels of evaluation 
throughout the system development process to ensure successful adoption. Third, we utilized 
health data standards to achieve functional and semantic interoperability with an electronic 
health record. Lastly, RxMAGIC is freely available and amenable to customization, which 
makes it an attractive solution for low-resource settings.  
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1.0  INTRODUCTION 
Medication management is a complex and expensive continuum that covers all aspects of 
prescription medications. Bell et al. model this continuum in five main phases: prescribing and 
ordering, order communication, dispensing, administering, and monitoring [1]. Each phase has 
high potential for both benefit and harm. While prescription drugs can improve patients’ health 
and well-being, their rising significance in healthcare systems has come with access, safety, and 
cost challenges [2,3]. Many of these challenges are exacerbated in medically vulnerable 
populations such as low-income individuals, uninsured persons, immigrants, racial and ethnic 
minorities, and the elderly. These patients often suffer from multiple chronic conditions, the need 
for several medications, poor health literacy, and medication non-adherence; they also have 
difficulty accessing appropriate healthcare services altogether [2,4,5].  
The availability of healthcare services by safety net providers is essential to improve our 
nation’s health. Many underpinnings of patient-centered care models – individualized planning 
and delivery of pharmaceutical services, monitoring medication use, and interdisciplinary team 
care – are often absent in safety net care [6]. Free and charitable clinics strive to provide a 
medical home for the underserved in a setting that enables the establishment of a respectful 
relationship between patient and provider. However, these clinics face severe challenges due to a 
lack of resources, such as essential medicines, medical equipment, and available providers [7]. 
These challenges, coupled with poor medication-use in underserved populations [8], may 
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contribute to medication utilization errors and ultimately less than optimal patient outcomes 
[5,7]. Health information technology (health IT), particularly medication management 
information technology (MMIT), holds great potential to improve care associated with 
medication management and provide efficiencies for the tracking, provision, and use of 
medications in free clinic settings [2].  
The use of MMIT applications to support the medication management continuum is not a 
new concept. Pharmacists have a history of early information system adoption, with the first 
MMIT application published in 1979 as a decision support system to help in prescribing 
appropriate antibiotics [9]. However, pharmacists are often left out of the discussion when it 
comes to informatics research, design, and decision-making [9]. Further, while many groups 
have studied the effects of new and old MMIT applications on components of the medication 
management process, their role in free and charitable clinics remains understudied and 
underutilized. MMIT can play a critical information support role in these unique healthcare 
environments if they are designed to meet pharmacists’ workflow and information needs. 
1.1 DESCRIPTION OF THE PROBLEM 
Few tools currently exist for pharmacists, and those that do are primarily designed for use in 
hospital and/or retail community pharmacies [9]. Most of these systems are offered as integrated 
modules within electronic health records (EHRs)1 or are stand-alone systems capable of 
                                                
1 Electronic medical record (EMR) and EHR are used somewhat interchangeably in the 
literature, although differences between the two are recently being defined. For the purposes of 
this research, EMR and EHR may be used interchangeably throughout this document. 
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receiving prescription data from EHRs [10]. While homegrown options may exist, they may not 
be generalizable and are typically unable to connect with other systems in an enterprise. As there 
is a need for accurate and timely health information exchange (HIE) between disparate systems 
(i.e. EHRs) within an enterprise [11], a system’s inability to share data with an EHR is a recipe 
for redundancy and implementation failure [9]. 
Although EHRs have made their way into several free clinics due to donations by larger 
hospital systems [12,13], many clinics cannot afford the additional modules and/or product suites 
needed to support their dispensing processes. Further, EHR pharmacy modules may only provide 
support for preparing and dispensing medications [9], as those are the primary responsibilities of 
a pharmacy department in a hospital setting. Medication administration and monitoring activities 
are responsibilities of nurses and physicians, and pharmaceutical purchasing may be handled by 
an entirely separate department altogether [14]. Thus, pharmacy modules within an EHR may 
not accommodate the multiple workflows of a clinical pharmacist in a free clinic setting who is 
involved in all stages of the medication management continuum, from medication procurement 
to monitoring activities. 
Most retail community pharmacies purchase stand-alone MMIT applications from 
technology companies like McKesson or Surescripts or, in the case of large pharmacy chains, 
they utilize homegrown software [15]. These systems are designed to support the business of 
pharmacy rather than a clinical practice. Although they can receive electronic prescription data, 
the exchange is not seamless and typically requires manual data entry from one system to 
another, a process that is redundant and labor-intensive for pharmacists [16]. Further, these 
systems are transactional and include billing frameworks and forms to submit claims for 
reimbursements to third party payers [15]. These features are not needed in a MMIT for free 
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clinics because medications are provided to uninsured patients for free. Unnecessary 
functionality would burden the user experience in a free clinic setting.  
1.2 SIGNIFICANCE OF THIS RESEARCH 
Overall, existing MMIT applications may not be viable implementation strategies for free clinics 
due to several challenges [13], such as cost, poor integration with existing systems, unnecessary 
functionality (i.e. insurance/billing screens, additional data entry), and their inability to 
accommodate multiple workflows (i.e. dispensing, inventorying, etc.). Clinical pharmacists are 
an integral part of the healthcare team, especially in free clinics, and could benefit from a user-
centered MMIT effectively designed to alleviate challenges associated with all stages of 
medication management in these settings. The success of this system relies on a sophisticated 
understanding of the problems it is designed to address, its ability to support multiple workflows 
and processes, a low-cost implementation that is amenable to customization, and its ability to 
receive electronic prescription data from an EHR. I call this system RxMAGIC, or a system for 
Prescription (Rx) Management And General Inventory Control. This dissertation describes the 
process used to design, develop, and evaluate RxMAGIC, as guided by Friedman and Wyatt’s 
evaluation framework [17], from needs assessment to problem impact, culminating in its 
deployment in a local free clinic. 
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2.0  BACKGROUND 
In this section I discuss relevant topics that pertain to this research. These topics include free and 
charitable clinics and the role of clinical pharmacists in the medication management continuum; 
existing MMIT applications in several healthcare settings; the importance of standards to achieve 
interoperability; systems thinking and lean management principles; and lastly, usability and user-
centered design in health informatics, in the context of the fundamental theorem of biomedical 
informatics. 
2.1 FREE AND CHARITABLE CLINICS 
Implementation of the Affordable Care Act (ACA) has transformed the American healthcare 
landscape. However, this landmark law does not provide universal access to healthcare, and 
numerous barriers to health care access continue to exist for many [6]. The non-partisan 
Congressional Budget Office estimates that 29-31 million Americans will remain uninsured 
following the full implementation of the ACA [6]. However, at the time of this writing, there is 
much uncertainty regarding the future of the ACA as the new administration attempts to reform 
the health law. While we are unsure of the implications of a potential repeal of the ACA, 
researchers are certain there will be a significant increase in the number of uninsured citizens in 
the coming years [18,19]. 
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Despite the reforms made by the ACA, significant health disparities persist in vulnerable 
populations due to a variety of intersecting economic, social, and geographical factors [6]. For 
many Americans, a lack of health literacy and proper education has comprised their healthcare 
[4]. Further, many low- and moderate-income families report that, even if they have health 
insurance, out of pocket health costs remain a significant barrier to receiving medical care and 
purchasing prescription drugs [20,21]. Perhaps one of the largest contributing factors to health 
disparities in these populations is their inability to access healthcare services [22]. This is 
particularly true for patients living in rural areas, and the 11 million undocumented immigrants 
who are legally prohibited from participating on the healthcare exchanges created under the 
ACA [6]. 
The provision of healthcare services by safety net providers is essential to improve our 
nation’s health. Free and charitable clinics remain the only healthcare providers to provide 
services regardless of the patient’s ability to pay, filling the gaps in the US healthcare system. 
Sometimes that gap is urgent care, sometimes bridge care, and sometimes it is primary care; all 
free clinics are different [23]. Free clinics provide comprehensive services that may include 
medical, dental, pharmacy, vision, mental health, substance abuse treatment, and even health 
education [24]. Most free clinics provide treatment for routine illnesses or injuries, such as strep 
throat or the flu, in addition to managing long-term chronic conditions like diabetes and 
hypertension in the adult population. In addition to these services, clinics regularly serve as 
advocates for their patients, playing a major role in helping individuals and families secure 
affordable healthcare [24].  
There are currently more than 1,200 clinics within the United States conducting an 
estimated 5 million patient visits each year [6]. These non-profit organizations receive little-to-
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no state or federal funding and rely heavily on the generosity of individual donors, foundations 
and grants to acquire medications and medical supplies [6]. While demand for their services has 
increased in the last two years, donations to free and charitable clinics have fallen by 20% [6]. 
Further, a growing shortage of physicians is likely to impact disadvantaged communities and the 
clinics that serve them due to a lack of compensation. Providers receive greater incentives when 
practicing within higher-income populations. [7].  
Most challenges in a free clinic can be attributed to a lack of resources, and meeting the 
pharmaceutical needs of patients is often one of the most prominent [8,22,24]. The rising cost of 
prescription drugs has been causing pain and hardships for millions of Americans, especially 
lower income residents lacking drug coverage [22,25]. Uninsured Americans are more likely 
than their insured counterparts to go without prescription medications or skip doses because of 
cost [20,21]. Providing prescription drugs to patients who cannot afford them is perhaps one of 
the most important services a free clinic can offer. Most free clinics obtain drugs through a 
variety of channels, including the donation of drug samples from licensed practitioners (from 
pharmaceutical companies, physician practices, and partnering hospitals), discounted bulk 
purchases, state prescription drug return, reuse, and recycling laws, and, especially, private drug 
companies’ Patient Assistance Programs (PAPs) [19,24]. 
2.1.1 Patient assistance programs 
Some pharmaceutical companies offer PAPs. These programs provide prescription medications 
for free or at a greatly reduced cost to those who cannot afford them [20,24]. Many free clinics 
work to qualify patients on behalf of these programs and greatly assist them in the application 
process, which often requires one full-time, non-pharmacy staff person. Navigating the different 
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and often variable eligibility requirements and application procedures for PAPs is time-
consuming and labor-intensive [26]. However, these programs fill a major gap in health 
insurance coverage and are necessary to enhance access to cost-effective medicines for patients 
meeting certain eligibility criteria [24,26,27]. Further, research shows improved medication 
compliance and significant cost savings for clinics and patients when PAPs are employed 
systematically [24]. In many cases, this means that the clinic is responsible for receiving and 
dispensing the medications to qualifying patients on-site. 
2.2 THE ROLE OF CLINICAL PHARMACISTS 
Pharmacists are in expanded clinical roles of direct patient care in many clinical settings, 
practicing independently or in collaboration with other healthcare professionals [9]. Clinical 
pharmacy is defined as providing patient care to optimize medication therapy and promote 
health, wellness, patient safety, and disease prevention [28]. Within the system of healthcare, 
clinical pharmacists are experts in the therapeutic use of medications and invaluable in the 
provision of team-based healthcare [29]. The role of a clinical pharmacist extends far beyond the 
traditional dispensing role, a task that can be done by a pharmacy technician, to include regular 
consultations with patients and healthcare professionals regarding medication therapy 
evaluations and recommendations [9,29,30]. These services are typically referred to as 
medication therapy management (MTM), where the focus is more patient-centered as opposed to 
individual product-centered. The MTM service model includes five core elements: medication 
therapy review, personal medication record (i.e. access and review of the patient’s health record), 
medication-related action plan, intervention and/or referral to other services, and documentation 
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and follow-up [31]. These services are dependent upon pharmacists working collaboratively with 
physicians and other healthcare professionals to optimize medication use.  
Integrating these services into interdisciplinary patient care at free and charitable clinics 
is particularly effective in improving access to prescription drugs and resolving medication 
related problems [29,30]. Challenges with medication adherence are especially pronounced in 
vulnerable populations due to cost and poor health literacy [5,32]. Clinical pharmacists are in an 
optimal position to directly educate patients on the importance of appropriate medication use, 
monitoring one’s disease state, and improved lifestyle recommendations. Research also shows 
that clinical pharmacy services can support improvement in clinical indicators such as blood 
pressure, A1C and LDL-C readings [24,30,33]. Further, the environment of a free clinic enables 
pharmacists to develop a trustful relationship with patients and increased communication with 
prescribers, both of which are typically absent in community pharmacies. These patient-
pharmacist relationships allow pharmacists to carefully observe medication utilization and 
patient behavior over time, which is critical in preventing prescription drug abuse [34]. Similarly, 
the enhanced prescriber-pharmacist relationship is beneficial to patient care, particularly in a free 
clinic setting [35]. 
Free clinics provide pharmacists and student pharmacists with a unique opportunity to 
expand their clinical role and utilize their expertise in all stages of the drug management 
continuum [23]. This role can be different from clinic to clinic. Clinical pharmacists can 
establish a medication dispensary within a free clinic under the auspices of a physician’s license 
[36]. They are responsible for developing a site-specific medication formulary and an 
appropriate payment structure, in addition to determining how pharmaceuticals will be stored, 
inventoried, and dispensed [19]. Ensuring an uninterrupted drug supply to their patients is often 
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the sole mission of free clinics [6,19,24], and pharmacists must be prepared to identify 
inexpensive medication alternatives to optimize medication therapy. This relies on their 
specialized therapeutic knowledge, knowledge of the patient population, and ability to determine 
appropriate stock levels and average consumption rates to avoid stockouts [9,37].  
Appropriate management support technologies can reinforce clinical pharmacists at each 
stage of the drug management continuum, especially in a free clinic setting. However, few tools 
exist for pharmacists, and many of them fail to support a clinical pharmacists’ cognitive needs 
and workflow [9,38]. Moreover, pharmacists are not currently considered eligible providers by 
the Centers for Medicare and Medicaid Services (CMS), and do not receive incentive funds 
through Meaningful Use [9,39]. There is a critical need for pharmacists in informatics and 
informatics in clinical pharmacy, so that better tools can be developed to support a 
multidisciplinary health care team. The pharmacy profession needs to articulate requirements for 
tools that will meet their cognitive needs, and informaticists must study and understand the 
realities of the pharmacy workflow to design tools that support the entire clinical practice, not 
just electronic prescribing. 
2.3 EXAMPLES OF PHARMACY INFORMATICS 
Pharmacists have a history of early information system adoption; the use of technology and 
automation to support pharmacy practice predates back to the 1970s [9]. While there is an 
increasing demand for accuracy, safety, and efficiency in medication use, the pace of 
medication-use-supporting technologies adoption remains slow, understudied, and underutilized 
[9,10]. These technologies are often described within the framework of an EHR and include, as 
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envisioned by the Institute of Medicine: Computerized Provider Order Entry (CPOE) and clinical 
decision support systems, pharmacy systems, medication reconciliation systems, and medication 
administration systems [10,40]. These technologies have been tailored to support specific roles 
and responsibilities, as healthcare professionals have traditionally practiced within their 
functional silos. 
This mindset has created fragmented solutions that focus on departmental tasks rather 
than the comprehensive process of healthcare delivery [10]. This is even more problematic if 
only some of the listed core medication-use systems are implemented (i.e. just CPOE), or the 
technologies are unable to interoperate within the framework of an EHR and/or communicate to 
other MMITs. Standalone medication management solutions that are unable to communicate 
with disparate systems are not realistic implementation strategies in a time where accurate and 
timely health information exchange is necessary to improve medication safety. These strategic 
and technical challenges are just a few examples of fragmentation and poor system integration 
[41].  
This notion of MMIT can differ depending on the implementation setting, i.e. community 
pharmacy or hospital pharmacy, because the medication management process is very different 
between the two sites. In hospitals, prescriptions are entered into systems at the same place they 
are filled, whereas in ambulatory care, the information is fragmented across several sites [42]. 
Perhaps one of the most significant differences between these two settings is the pharmacist’s 
involvement in EHR use [9]. Although some community pharmacies (i.e. Walgreens) are 
beginning to integrate EHRs into their practice [16,43], they are predominately absent in these 
settings. Contrary to community pharmacies, pharmacists in a hospital setting are active users of 
the EHR. They are involved in processes such as medication reconciliation, CPOE, clinical 
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decision support, immunizations, and patient evaluation and monitoring [9]. Differences in EHR 
access and use between these two settings has a large impact on the design and utility of 
pharmacy information systems in practice.  
I discuss these differences and how they contribute to the application of pharmacy 
information systems in US hospital pharmacies, community retail pharmacies, and free clinics. 
Further, I discuss examples of medication-use-supporting technologies in low-income countries, 
as the literature describing pharmacy informatics in these settings is more dense and descriptive. 
Free clinics represent an interesting environment in US healthcare as they share similarities with 
all three settings, especially if they utilize an EHR: prescriptions are entered into systems at the 
same place they are filled, yet they are technically an outpatient facility. Thus, lessons can be 
learned from the implementation of pharmacy information systems in all settings, which I 
discuss at the end of this section. 
2.3.1 US hospital pharmacies 
A national survey done by the American Society of Health-System Pharmacists (ASHP) in 2013 
assessed the use of pharmacy informatics in US hospitals, which includes the use of information, 
information technology, and automation in the medication-use practice. The ASHP focuses on 
the use of technology in the following processes related to medication-use: prescribing, 
transcribing, dispensing, administration, monitoring and follow-up, and MTM [44]. In 2013, 
80% of hospitals with an EHR (partial or complete) that allowed pharmacists to view some 
component of the record also allowed pharmacists to document and make recommendations in 
the EHR [44]. The number of hospitals allowing pharmacists to document in the EHR has 
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increased from 56.7% in 2007 [41], which may be attributed to the documented benefits that 
pharmacist-prescriber communication has on patient care [16]. 
The survey concluded that 75% of hospitals reported having a CPOE system, and 61.4% 
of these hospitals used concurrent clinical decision support for inpatient orders [44]. Nearly 60% 
of survey respondents reported that their hospital used electronic prescribing (e-prescribing) to 
communicate outpatient medication orders to community pharmacies [44]. Further, fewer than 
15% of respondents reported a purely electronic medication reconciliation process, with most 
respondents using a paper-based method or a hybrid paper and electronic method [44]. Thus, in 
2013, most hospitals were only ‘partially implemented’ sites in terms of core medication-use 
technologies [44].  
Most relevant to this research, however, is the use of transcribing and dispensing 
technology in US hospitals (i.e. pharmacy computer systems). Transcribing typically refers to the 
use of medication ordering and receiving technology (i.e. for procurement and inventorying) and 
dispensing includes medication dispensing, distribution, and storage technology. Fox et al. found 
that US hospitals’ pharmacy computer systems are primarily purchased and integrated as a suite 
of products from a single vendor (56%) or are interfaced with other systems but not necessarily 
components of a suite (28.3%) [44]. Approximately 10% of systems are homegrown or 
standalone systems that may only support information transfer with other applications within 
their institution; this is particularly true in specialty hospitals and all Veterans Affairs hospitals 
[44]. While nearly all hospitals reported ordering medication products online from their primary 
wholesalers, only 39% of them used barcoding for inventory control [44]. This response 
surprised the researchers as they consider barcoding a critical technology that has a positive 
impact on the medication-use process [44]. There are a variety of technologies that exist to 
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support dispensing, such as dispensing robots, carousels, and automated dispensing cabinets 
[44]. Amongst these, automated dispensing cabinets were the most common and found in 80% of 
US hospitals [44].  
Most hospitals utilize technology for medication administration, as it is a primary focus 
area for safe medication use in hospitals. A variety of technologies were found among all 
hospitals to address medication safety during medication administration, such as barcode-
assisted medication administration (75%) and smart pumps (75%) [44]. In regard to MTM 
services, the survey does not discuss any form of technology to support these processes in an 
outpatient setting. As MTM services have become an important aspect of pharmacists’ activities, 
the ASHP makes recommendations for an ideal MTM documentation system that includes 
features to support workflow, regulatory compliance, and patient care activities.  
Overall, the results from this survey demonstrate the variability in the use of tools to 
support pharmacists’ activities toward safe, effective, and efficient medication-related care. 
Further, as there are so many individual technologies that comprise the medication-use process, 
these results emphasize the importance of sharing structured data across disparate systems [40]. 
While much of pharmacy informatics is focused on prescribing and administration, as driven by 
government initiatives like Meaningful Use, it is important that all aspects of the medication-use 
process are considered. MMIT could be better utilized in areas of extended-duration medication 
counseling, such as MTM and disease state management, which are primarily done in 
community pharmacy settings [16].  
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2.3.2 Community pharmacies 
Compared to US hospital settings, the use of pharmacy informatics in community pharmacies is 
both limited and understudied. While software programs have been in wide use in community 
pharmacies, the literature revealed few publications regarding the experience of community 
pharmacies and medication-use technologies. Several technology companies have created 
products or systems for use in pharmacies, such as Computer Rx, McKesson and Surescripts, 
which manage the business and clinical workings of a pharmacy [15]. What product, or portions 
of a product, that a community pharmacy purchases varies greatly depending on its needs; there 
may not be a one-size-fits-all system. In addition to these vendors, many large chain pharmacies 
have created their own pharmacy management systems that are customized for certain locations 
[15].  
While functionality varies between different installations, these systems are mostly 
capable of receiving and verifying e-prescriptions, managing inventory and ordering, and 
facilitating the dispensing workflow (i.e. tracking which employee completed which steps and 
when and when prescriptions have been picked up and paid for) [15,45]. They can also be used 
to review and submit claims for reimbursement to third-party payers. More sophisticated systems 
may help manage clinical tasks, such as MTM interactions, and track adherence data.  
Apart from electronically receiving e-prescriptions, there is little connectedness between 
pharmacy dispensing information systems and the EHR [16]. Further, although pharmacy 
systems are ‘interoperable,’ the exchange of information is not seamless and requires manual 
entry of data from one system to another; pharmacists typically print the e-prescription before 
entering it into their dispensing system [16,46]. In some cases where pharmacies do have shared 
EHR access with a physician practice, they still have to print out the information they need from 
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the EHR and manually enter it into the pharmacy’s own system by hand (i.e. medication order, 
billing codes, etc.) [15]. This is essentially an error detection process because the dispensing and 
prescribing are done at two different sites, and because approximately 9% of e-prescriptions have 
medication errors [46]. Many pharmacists report that this detection process is time-intensive and 
disruptive, especially when they have to call the prescriber to verify the prescription [16]. The 
American Medical Association (AMA) has stated that inquiries related to prescription 
verification are disruptive to the practice of medicine in general, however many of these 
inquiries may be required for billing [16]. Moving forward, shared EHR access and bidirectional 
systems are necessary to enable the seamless sharing of information between prescriber and 
pharmacist [16,40]. 
2.3.3 Free and charitable clinics 
A literature search revealed few MMIT solutions for free clinic dispensaries. A research group at 
Vanderbilt University has developed a pharmaceutical tracking system for a local free clinic that 
facilitates the acquisition and efficient management of medications [47]. While this system 
facilitates the restocking of medications and inventory management, it is not capable of 
interoperating with a prescribing system. Thus, manual data entry is required to dispense 
medications. 
Similarly, AmeriCares, a non-profit disaster relief and global health organization, has 
recently piloted an inventory management program for selected free and charitable clinics in the 
US [48]. The proposed software does offer integrated functionality and support for the 
pharmaceutical workflow, but is incapable of interoperability, does not adhere to standard 
prescribing vocabularies, and will require an implementation fee. 
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2.3.4 Low income countries 
Much of the research regarding medication-use-supporting technologies in low-income countries 
has focused on the development of electronic medical records to support drug management for 
specific treatments, such as HIV and Tuberculosis (TB), pharmacy dispensing systems, inventory 
control applications, or quantification tools [49]. Levison et al. reviews available computer-
assisted technologies for pharmacies in developing countries and concludes that many 
applications operate primarily as independent systems. I discuss some of these applications 
below, and Table 1 (adapted from Levison et al.) provides an overview of existing software and 
their functionality as it relates to the four medication-use-supporting technologies: EMR, 
inventory control, dispensing, and quantification. 
Table 1: Overview of sampled software and their functionality for developing countries adopted from Levison et al. 
[49]. Pluses indicate partial functionality or functionality in development. 
Software package EMR Inventory Dispensing Quantification 
PIH-EMR ✔  ✔ ✔ 
HIV-EMR ✔   ✔ 
FUCHIA ✔   MSFH Order Tool 
MMRS ✔    
BART ✔  ✔  
CAREWare ✔  ✔  
OpenMRS ✔   ✔ 
mSupply (Dispensing)  ✔ ✔  
iDart ➕ ✔ ✔  
RxSolution ➕ ✔ ✔ ✔ 
ADT   ✔  
SIGMED  ✔  FoCaMed 
ORION  ✔   
mSupply (Warehouse)  ✔   
HIV-EMR Pharmacy system  ✔   
Navision  ✔   
Syspro  ✔   
ePICS  ✔ ➕  
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Douglas et al. in collaboration with Baobab Health demonstrate the effective use of 
touchscreen, point-of-care EMR system to support and monitor antiretroviral therapy and TB in 
Malawi, and how this platform can be expanded to support other chronic diseases (e.g. 
hypertension and diabetes). The Baobab Anti-Retroviral Therapy (BART) system is open-source 
and runs on rugged, low-power appliance hardware [49,50]. To effectively engineer this solution, 
Douglas et al. first developed a system to issue unique patient identifiers to manage continuity of 
care within the country. This patient management information system has expanded its 
functionality to support order entry for medications, laboratory and radiology tests [51]. 
Fraser et al., a research team at Partners In Health (http://www.pih.org/), has developed a 
web based EMR to support a treatment programme for drug resistant tuberculosis in Peru (PIH-
EMR) [52], and an HIV-EMR to support HIV treatment in rural Haiti [53]. Both of these 
applications are open source, web-based systems that focus on drug supply management to 
ensure uninterrupted drug supplies to specific patient populations in these two countries. The 
HIV-EMR supports two methods of determining medication use: 1) manual calculation of total 
requirements for a patient group for a specified period based on their prescribed regimen; 2) 
calculating the amount of drugs that enter and leave the warehouse each month [53]. While these 
methods may be effective at avoiding most stockouts, they do not support dispensing 
functionality at the health center level and thus cannot accurately quantify consumption data.  
Building on the experiences of the EMR team at Partners In Health, OpenMRS was 
developed as a robust open-source EMR platform intended to be adopted and modified by 
different organizations, and is used in over forty countries across every continent [54,55]. 
OpenMRS is a platform for the creation of medical record systems in developing countries that 
consists of an open source data model, a set of core application functions, and a default 
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implementation [56]. Implementation sites are given the opportunity to implement additional 
modules to support functions that may be unique to their organization. For example, a simple 
inventory module was developed to manage and track items in a stockroom [57]. An order entry 
module is currently under development to support simple outpatient orders, focusing on 
medication orders and laboratory tests [58]. While this module is designed to support medication 
ordering, the fulfillment of these orders will be managed by applications external to the EMR 
(e.g. prescriptions dispensed by a pharmacy system interacting with an inventory system) [58]. 
Thus, OpenMRS provides modules to support inventory management and order entry, but fails to 
integrate the actual dispensation process, which is necessary for effective medication 
management.  
Levison et al. describe several pharmacy dispensing systems, such as mSupply, iDart, and 
RxSolution, which have been developed for use in developing countries [49]. These systems, all 
developed by different groups, enable pharmacists to enter medication orders from paper 
prescriptions, dispense appropriate regimens, and deduct this dispensed quantity from the stock 
levels [49]. mSupply was primarily designed for use in a warehouse but has a ‘dispensing mode’ 
that allows pharmacists to dispense medication if desired; although it may have been open-
source at one point, mSupply is no longer free to download [49,59]. Although iDart is open-
source and able to print multilingual barcode labels which has significantly improved pharmacist 
efficiency, it is designed to only support the dispensing of antiretroviral therapy (ARV) drugs 
and does not interface with a medication ordering system [49,60]. RxSolution offers additional 
functionality, such as inventory control, consumption-based ordering, and recording patient 
regimen information, but is close-sourced which makes customization and technical support 
difficult and costly [49,61]. While each of the dispensing systems described by Levison et al. are 
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problem-driven and appropriate for their implementation setting, an integrated system that 
receives prescription orders from an EHR, facilitates the dispensing process, uses a standard 
vocabulary, and manages inventory levels would provide the most accurate stock levels and 
greatest workflow enhancements in a low-resource setting.  
A literature search uncovered only two relevant articles describing possible stand-alone 
inventory programs to support procurement of essential medicines in a third world country. 
Berger et al. developed a web based stock tracking system that is intended to provide a 
communications link between pharmacies as well as recording local stock levels [62]. Pharmacy 
staffs at nine clinics in rural Haiti are able to enter stock levels, request drugs, and track 
shipments from a central warehouse. Pharmacists are reminded to request drugs when their stock 
balances fall below predetermined minimum stock alert levels. These levels are based on 
consumption data that is manually calculated by the pharmacists. The researchers conclude that 
stockouts have decreased from 2.6% to 1.1%, and that they plan to implement the same software 
in Rwanda, Malawi, and Lesotho [62]. However, to the best of our knowledge, there is no 
additional research regarding implementation of this specific pharmacy stock tracking system in 
other countries.  
Holm et al. developed a similar system for medication supply chain management in a 
Haitian hospital pharmacy [63]. This pharmacy computerized information program (PCIP) is a 
web-based system that enables nursing staff to view how frequently certain medications are 
requested (from the central warehouse) and how much the pharmacy currently has on hand of 
certain medications. If a nurse wants to place a request for a drug order, it is electronically sent to 
the pharmacy and the pharmacist must verify the current stock count and approve or deny the 
drug request. The authors conclude that this system allows real-time knowledge of inventory 
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status as well as forecasting, increases availability of medications at the point of care, reduces 
waste and shortages, and provides a deterrent to drug diversion. While results from system 
implementation are optimistic, this system only provides support for inventory management and 
fails to integrate drug dispensing and order entry, which may lead to inaccurate stock counts in 
the future. 
2.3.5 Lessons learned 
These examples demonstrate the variability of pharmacy informatics in different settings. While 
the settings described here each share similarities with a free clinic, the tools utilized to support 
the medication-use process are not designed to effectively meet the needs of free clinic 
pharmacist for several reasons. First, many of the pharmacy informatics interventions in US 
hospitals are expensive and fragmented, which are not viable implementation strategies for free 
clinics with financial and strategic challenges. Second, the software used in community 
pharmacies is designed to support the business of pharmacy, and not pharmacists who are active 
users of the EHR, which may be the case at a free clinic. Further, the transactional framework 
and billing screens are not necessary in a free clinic setting and would burden the user 
experience. Lastly, while medication-use-supporting technologies for low-income countries have 
proven to be helpful, most have been developed in isolation and do not effectively make use of 
data standards to enable the sharing of health information between disparate systems.  
While helpful in their own context, the MMITs described in this section may not be 
suitable implementation strategies for free clinics. However, due to their relative success, certain 
attributes of these MMITs should be considered in the development of a similar system for a free 
clinic setting. Some of these attributes may include:  
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• A minimalistic design that is easily implemented (i.e. web-based) and adapted to user 
needs and workflow in a specific setting;  
• A system design that is focused on improving health worker efficiency and patient 
outcomes;  
• Identification of the value proposition for the user to achieve sustainability;  
• A system that supports the entire medication management cycle, i.e. integration of 
different clinical processes such as order entry, dispensing, and inventory control, which 
improve real-time overview of stock counts;  
• The use of health data standards and open-source software to achieve data sharing 
between independent systems. 
2.4 HEALTH DATA STANDARDS IN PHARMACY INFORMATICS 
Health data standards are required to enable interoperability, which is the extent to which 
disparate systems can exchange, interpret, and display data in a way that makes sense to human 
users [64]. Generally, this data must be built upon data elements and terminology, structures, and 
organizations to make it usable and shareable within and across hospitals, pharmacies, 
laboratories, outpatient clinics, patients, etc. There are many types of standards that can be used 
to support interoperability in health information management. Functional interoperability is the 
capability to reliability exchange information without error, and semantic interoperability refers 
to the ability to interpret and make effective use of the exchanged information. In this research, 
we achieved functional and semantic interoperability using Health Level-7 (v 2.3) and RxNorm.  
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Health Level Seven International is one of the leading organizations for standards 
development in the healthcare arena. Health Level-7 (HL7) provides a framework (and related 
standards) for the exchange, integration, sharing, and retrieval of electronic health information 
[65]. To define how information is packaged and communicated from one party to another, HL7 
standards define the language, structure, and data types required for integration between systems. 
While other alternatives exist, HL7 standards are recognized as the most commonly used in the 
world to support clinical practice and the management, delivery, and evaluation of health 
services [65]. Its messaging standard has been widely used to support the exchange of clinical 
and administrative data enabling departmental hospital systems to communicate with one 
another.  
2.4.1 RxNorm in ambulatory e-prescribing  
Ambulatory e-prescribing requires the use of reliable standards to represent drug names in 
prescriptions. In the domain of pharmacy informatics, drugs in e-prescriptions are identified 
using the Food and Drug Administration’s (FDA) National Drug Code (NDC) Directory, which 
enumerates prescription drug products at the level of distinct manufacturers and packaging [66]. 
Despite its overwhelming use, NDC Identifiers have been criticized for several shortcomings 
relative to their application in e-prescribing as these granular distinctions have little clinical 
meaning [67]. A single e-prescription drug concept (i.e. drug name, strength, and dosage form) 
can have multiple assigned NDC identifiers, which can be restrictive and problematic if the 
receiving dispensing system does not contain a particular NDC identifier in its database [68]. 
Further, the NDC Directory has been shown to be unreliable and poorly maintained [66]. One 
study found that 27% of the 123,856 codes in the Directory were erroneous, and an additional 
 24 
14,337 prescription drug products were missing codes [69]. Although there are documented 
challenges with using NDC identifiers, it continues to be used as the primary nomenclature in 
most vendor e-prescribing systems.  
RxNorm, developed and maintained by the US National Library of Medicine (NLM), is 
the first publically available standardized nomenclature of prescribable clinical drugs in the US 
[70]. Early work that led to the development of RxNorm was motivated by efforts of the HL7 
vocabulary technical committee to facilitate the semantic interoperation between various systems 
that use different drug vocabularies [71–73]. RxNorm includes multiple components – 
medication names (generic and non-proprietary brands), dosages, forms, ingredients, and 
packaging - that are linked together through a relational file structure that is easily portable into a 
database format [72,73]. These components are structured to represent prescribable concepts as 
unique triples {drug, strength, dose form}, i.e. Fluoxetine 10 mg Oral Tablets, that are 
independent of non-clinical elements such as inert ingredients [70].  
The RxNorm data model is organized by concepts to provide a set of clinically relevant 
drug names and relationships based on 11 different external source vocabularies [70]. Each 
concept, or clinically distinct drug, is assigned a unique and permanent Rx concept unique 
identifier (RXCUI) and a normalized name (i.e. Normalized name = Azithromycin 250 mg Oral 
Capsule, RXCUI = 141962). These concepts most closely resemble the drug products that are 
familiar to clinicians and pharmacists [67]. Drugs that map to the same RXCUI are synonyms 
that are each assigned an RXAUI, or atom unique identifier [70]. Each RXCUI is linked to at 
least one, but potentially many, RXAUIs, however each RXAUI is only linked to one RXCUI 
[70]. Table 2 shows sample data from an RxNorm file that represents synonymous drug names of 
the same concept. Only a portion of the total fields in this RxNorm file (RXNCONSO.RRF) are 
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shown in this table for simplicity. By providing links to the source vocabularies, RxNorm can 
mediate messages between systems using different vocabularies.  
Table 2: Synonymous drug names from the same concept. The RxNorm normal form is indicated in bold. 
RXCUI RXAUI Source Name 
141962 2407920 FDB MedKnowledge AZITHROMYCIN@250mg@ORAL@Capsule (HARD, SOFT, ETC.) 
141962 944489 RXNORM Azithromycin 250 MG Oral Capsule 
141962 944502 SNOMED CT Azithromycin 250mg capsule (product) 
141962 944496 VANDF AZITHROMYCIN 250mg CAP 
 
Each of the sources used to create the RxNorm vocabulary (i.e. SNOWMED CT, FDB 
MedKnowledge, etc.) provide NDC codes in a different format, which makes it difficult to assess 
consistency in NDCs across sources. RxNorm normalizes all received NDC data into the 11 
digit, no dashes HIPAA NDC format [70]. When the data is available, RxNorm assigns “correct” 
NDC identifiers as attributes to clinical drug concepts in its data model. “Correctness” of a NDC 
assignment essentially means that there is consistency among the various sources in the 
association of a clinical drug concept with a particular NDC [70]. Similar to RXAUIs, a RXCUI 
may have several NDCs assigned as attributes, however a single NDC is expected to be assigned 
to only one RXCUI [73].  
RxNorm has been recommended as the preferred alternative to the NDC identifier 
scheme for use as a standardized nomenclature in e-Prescribing applications, as it more closely 
approximates an “ideal” system of drug identifiers [68,74]. Bell et al. describe an “ideal” system 
of drug identifiers as one where clinically distinct drugs each have their own unique identifier 
[67]. Clinically distinct refers to differences that matter when a drug is administered to a patient, 
as opposed to differences that matter in production or distribution (i.e. NDCs) [67]. Several 
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different RxNorm applications have been documented. It has been found to be a suitable 
terminology for capturing medication history in live EHRs, supporting its use in the medication 
reconciliation process [72], and its identifiers have been used as a mediation between the 
disparate drug vocabularies of the U.S Department of Veterans Affairs and the Department of 
Defense [73].  
Several groups have evaluated RxNorm’s completeness in ambulatory e-prescribing. 
RxNorm was demonstrated to have a 99.995% coverage rate for nearly 20,000 prescribed 
clinical drugs in a real-world sample of e-prescriptions [69]. In this sample, NDC identifiers 
automatically mapped to 98.8% of RXCUIs in RxNorm, and 1.2% were manually mapped [69]. 
However, when using the vendor’s proprietary nomenclature instead of RxNorm, 0.5% of 
identifiers failed to automatically translate from the NDC to the vendor’s proprietary, non-
RxNorm prescribable concept [69]. These ‘missing concepts’ prevent pharmacists from relying 
on representative NDC identifiers to auto-populate their dispensing systems, which creates extra 
work for the pharmacists. This further supports claims that the NDC Directory is unreliable in 
ambulatory e-prescribing [66]. 
Although RxNorm has been found to be highly-complete in representing prescribable 
concepts, researchers have identified some areas of caution [69]. For example, in 3.4% of the e-
prescriptions described above, two non-identical CUIs were mapped to distinct NDCs; only one 
unique CUI should be mapped to distinct NDCs [69]. This implies that there are errors in some 
NDC-to-CUI mappings in RxNorm due to the existence of two concepts having the same 
meaning. Although these mismatches were of low clinical significance (i.e. involving minor 
differences in dose forms, salts, or inhaler canister sizes), it is important to maintain the 
completeness and accuracy of mapping NDC-to-CUIs [67,69]. Eliminating nonspecific terms 
 27 
from RxNorm may reduce ambiguity and facilitate more complete mappings. Further, drug 
manufacturers could contribute to this maintenance process by ensuring that the FDA has 
complete and accurate information for each drug they make available on the market [69].   
The RxNorm distribution is updated monthly with new RXCUIs, some of which replace 
existing concepts [68,70]. Although RxNorm maintains documentation of old RXCUIs, they are 
essentially retired and not included in the primary prescribable dataset. An evaluation of the 
RxNorm concept replacement rate found that 8.1% of RXCUIs used in April 2009 were replaced 
with new CUIs six months later, however researchers were able to forward-map 100% of these 
replaced CUIs to their current representation using RxNorm’s archival table for retired concepts 
[69]. While this forward-mapping rate is optimistic, retired CUIs could be problematic in 
practice depending on the implementation of RxNorm [68].  
Although several challenges remain unresolved, as evidenced by several evaluation 
studies, RxNorm has demonstrated its potential to improve drug identification in ambulatory e-
prescribing [67–69,73]. Compared with the current use of representative NDCs, RxNorm could 
improve the ability of e-prescribing systems to accurately and unambiguously represent the 
clinical drug intended by physicians, which will also be beneficial for pharmacists [69]. 
However, much of this research is focused on the application of RxNorm in e-prescribing, and its 
use in electronic dispensing (e-dispensing) is understudied. Further, the e-prescriptions sampled 
in these evaluation studies demonstrate high-coverage in a primary care setting, but how will it 
perform in other settings with different prescribing patterns? The RxNorm documentation states 
that it contains the names of many over-the-counter (OTC) drugs available in the US, however it 
has not been evaluated in a setting, i.e. a free clinic, that frequently prescribes these products.  
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While RxNorm is described as a terminology for use in e-prescribing, its application in e-
dispensing is inherently related, yet there are limited studies investigating this relationship. If 
RxNorm improves the ability to identify prescribable clinical concepts in e-prescriptions, how 
will this translate to a pharmacy information system using a local medication terminology? As 
vendor EHR systems move toward using RxNorm as the standardized vocabulary in their own 
systems [73], it is important that departmental systems, specifically in pharmacy, utilize RxNorm 
similarly to support semantic interoperability. Thus, for the many reasons described here, 
RxNorm was chosen as the standardized nomenclature for use in RxMAGIC. Although there are 
uncertainties around the use of RxNorm in an e-dispensing system in a free clinic setting, as it 
has not been discussed in the literature, it should be effective at supporting semantic 
interoperability if implemented appropriately. The implementation described in this research 
provides potential avenues for evaluation of RxNorm in this setting, which would be a 
significant contribution to the field of pharmacy informatics. 
2.5 LEAN HEALTHCARE AND SYSTEMS THINKING 
The US healthcare system is discussed as having gaps in quality, safety, equity, and access [75]. 
Moreover, rising healthcare costs impact all members of a healthcare organization, including 
employers, payers, and patients. Changing the way healthcare is delivered requires process 
redesigns that improve quality and reduce cost growth at the same time, thereby making 
healthcare more efficient. To address this, some healthcare institutions have adopted lean 
management, a quality improvement philosophy and set of principles originated by the Toyota 
Car Company [76]. Lean is an approach to process improvement and organizational excellence 
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focused on eliminating waste and redundancy and providing value for customers, and has been 
adopted by many organizations across service industries (e.g. automobile and airplane 
manufacturing) [77]. Waste can be defined as anything that does not add value in the eyes of the 
customer [78]. 
The key elements of lean involve determining the value of any given process as identified 
by the customer, distinguishing value-added steps from non-value-added steps (a process called 
“value stream mapping”), and eliminating waste so that every step ultimately adds value to the 
process [76,78]. Lean describes primary and internal processes. Primary processes serve the 
external customer, such as patients and their families, while internal processes serve healthcare 
staff and other internal customers, such as hospitals and insurers, in support of the primary 
processes. Primary processes are typically easier to see, particularly in healthcare, however 
internal processes are necessary to create value in the primary process [79].   
The ultimate goal of lean is to transform the behavior and culture of an organization over 
time through employee empowerment, standardized work, and incremental improvement, all 
with use of efficient resources [78], which is particularly important in an under-resourced 
environment. Healthcare organizations in several continents have demonstrated their use of lean 
principles to design effective interventions (not necessarily technological) that improve process 
efficiency and better utilization of health worker time, reduce costs, patient outcomes, and the 
overall financial health of the organization. These four metrics — time, satisfaction, quality, and 
financial — represent the lean value diamond (Figure 1). Each metric should experience 
improvement through reduction of waste in individual processes [78,80]. 
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Figure 1: Lean value diamond. Adapted from [80]. 
 
The literature discusses several examples of process improvement with use of the lean 
value diamond metrics as outcome measures. A case study conducted in East Africa describes 
many examples of simple process improvements as a result of lean implementation [77]. For 
example, researchers decreased the internal time to procure goods in Rwanda from 27 days to 14 
days by eliminating redundant reviews and approvals. Likewise, the annual costs of goods (e.g. 
mosquito nets, office supplies) in Burundi was decreased by 30% by changing the procurement 
planning and sourcing tasks. Similar studies in the literature summarized improvements in 
operational costs, organizational efficiencies, and employee satisfaction in the US [78,81,82]. 
Lean methodology was effectively used to improve operating room efficiency in 12 
hospitals across Saudi Arabia [83]. The Saudi Ministry of Health (MoH) developed the Surgical 
Pathway Improvement (SPI) initiative to improve patient flow through the surgical pathway, 
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increased patient and staff satisfaction. External consultants trained local healthcare 
professionals and hospital staff members on the principles of lean methodology to design the SPI 
initiative, which evaluated the current surgical pathway in each hospital using value-stream 
mapping. In summary, the SPI initiative was developed using existing resources, including: 1) 
the creation of visual dashboards that facilitate case start times; 2) computerized surgical list 
management to optimize use of the OR; 3) optimization of time allocation to enhance OR 
productivity; and 4) creation of pamphlets and other documents summarizing hospital procedures 
to reduce cancellations. Implementation of the SPI initiative resulted in hospital improvements, 
such as on-time start time for cases, decreased OR turnover times, and improvements in OR time 
utilization to reduce overrun cases [83]. 
A research group in Seattle applied lean methods to improve the quality and safety of 
surgical sterile instrument processing at Virginia Mason Medical Center. Errors in the processing 
of these instruments can lead to increased operative time and costs in addition to detrimental 
patient outcomes [84]. Blackmore et al. employed lean to identify and categorize errors in sterile 
instrument processing, which were used as outcome measures in their study. The intervention 
consisted of several components that utilized checklists to monitor packaging of surgical 
instruments, redefinition of roles and standard work, staff training toward formal sterile process 
certification, physically changed space, and continuous feedback through weekly team 
discussions. As a result of the intervention, errors in instrument processing decreased by half in 
surgical cases, and improvements were measured in the rate of assembly errors and presence of 
foreign objects in packaging [84]. 
These examples demonstrate successful use of lean methods to improve various 
processes in hospital and public health settings. The heterogeneity of lean is also evident from 
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these studies in which a variety of implementation methods, research designs, and outcome 
measures are used. This further demonstrates that lean is not a strict methodology, but rather a 
set of operating philosophies and principles that can be employed to maximize value for a variety 
of customers, whether it is the patient or the healthcare worker. 
2.5.1 Systems thinking 
Many quality improvement specialists draw similarities between lean principles and systems 
thinking. Particularly in healthcare, systems thinking provides a framework to which we can 
approach problems and design solutions, which focuses on the integrated nature of health 
systems [85]. This approach is opposite to that of ‘silo thinking,’ which currently drives the 
design of most health IT, as evident in the interventions described previously in the medication-
use process (Section 2.3.1). Many technological solutions in healthcare are developed and 
deployed vertically, in that they do not consider synergistic aspects of a health system [86,87]. 
For example, deploying an e-prescribing system in a health practice without deploying a 
pharmacy system to receive the information and dispense medication does not consider all 
processes comprising the therapeutics value stream in system design. This type of vertical, 
simplistic culture can breed isolationism, redundancy, and error [87]. 
A systems thinking approach considers the multifaceted and interconnected relationships 
among health system components, such as order entry and dispensing, and how they all affect the 
same goal of safe healthcare delivery [85,88]. Health IT interventions must consider the complex 
dynamics of a clinical event so that they optimize the performance of individual components to 
maximize the overall output. There are an extensive number of theories, methods, and tools that 
explain the utility of systems thinking and how it can be used to design and implement cross-
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cutting interventions [85]. Moreover, there are a number of different terms used to describe these 
theories, and their means of implementation and use can be variable.  
2.5.1.1 The sociotechnical model     
One framework that is relevant to this research is the sociotechnical model for studying health IT 
proposed by Sittig and Singh [89]. This 8-dimensional model is specifically designed to address 
the socio-technical challenges involved in the design, development, implementation, use, and 
evaluation of health IT. While many conceptual models of user interaction, acceptance, and 
evaluation exist [90,91], they are relatively limited in scope which limits their utility to address 
the full range of factors that should be considered at all stages of the system development life 
cycle [89]. The model proposed by Sittig and Singh has eight interdependent, interrelated 
concepts that span the socio-technical spectrum, including: hardware and software computing 
infrastructure; clinical content; human computer interface; people; workflow and 
communication; internal organizational policies, procedures, and culture; external rules, 
regulations, and pressures; and system measurement and monitoring. 
This model is comprehensive in that it provides a framework to address challenges that 
exist in complex relationships between the intervention itself, its information content, its human-
computer interface, and its users. Similar to the systems thinking approach, these dimensions 
must be studied in relationship to one another, as they are not independent, sequential steps. As 
such, several of the model’s components are more tightly coupled than others. For example, the 
‘technology’ components, which include the hardware, software, content, and user interface are 
all dependent on one another. However, this model specifically represents these items 
independently to enable researchers to dissect out the causes of particular implementation 
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problems [89]. While challenges may not occur in all 8 dimensions of the model, its segmented 
framework encourages researchers to carefully monitor the impact, effectiveness, and unintended 
consequences of an intervention.   
The sociotechnical model motivated components of this research to understand 
challenges and facilitators for successful adoption and use of RxMAGIC. Its multi-dimensional 
approach was appropriate because it considers several user interactions, workflows, 
organizational policies, and external pressures - all of which are relevant in a free clinic setting. 
From our experience, we found that problems could, and often do, occur in most dimensions of 
the model. To address these problems, it is important their solutions are interrelated as well. 
Solution creation and implementation is not explicitly discussed by Sittig and Singh, however the 
language they use to describe various solutions is similar to the language used in change 
management techniques.  
Change management is the process by which an organization moves toward its future 
state by empowering its individuals to champion organizational change [92]. Change 
management specialists emphasize that, just as we manage technological change, it is also 
important to understand peoples’ needs and manage the natural resistance to change. Health IT 
should not disrupt workflow, but rather enhance the quality of work life and increase 
responsibility, empowerment, and motivation so that users feel empowered to think creatively 
and solve problems. These principles are the foundation of many change management techniques 
that we found to be useful in this research. Further, these techniques share many similarities to 
lean healthcare principles, as they both focus on staff empowerment and incremental 
improvement. Many of the models and principles described in this section are complementary 
 35 
(i.e. lean healthcare, the sociotechnical model, and change management), thus we have used 
aspects of all of them in this research. 
2.6 EVALUATION METHODS IN BIOMEDICAL INFORMATICS 
In this section I focus on the importance of evaluation in informatics, with many references to 
the book Evaluation Methods in Biomedical Informatics by Friedman and Wyatt [17]. I 
specifically focus on the usability of health IT, which measures how well a resource performs the 
function for which it was designed [93]. Nielsen identified five facets of usability that include: 
learnability, efficiency, memorability, errors, and satisfaction [93]. A new user of an informatics 
resource should learn how to use it quickly, be highly productive using the resource quickly, 
remember how to use the resource early, not experience many errors in using the resource, 
quickly recover from errors that do occur, and be subjectively pleased with the experience. 
Particularly in the design of health IT, it is necessary to optimize these usability factors to ensure 
the system effectively meets the needs of the user that the developers sought to address.  
Research has demonstrated the importance of displaying unambiguous and actionable 
information in the right way at the right time, particularly in the design of clinical information 
systems [94]. The benefits of health IT are not often recognized by clinicians due to poor system 
design, incorrect implementation, and its inability to integrate into the cognitive and clinical 
workflow [95]. This is particularly true in the design of drug alerting systems. Usability flaws in 
these systems typically include poor information presentation, quality and content, information 
density, lack of consistency between disparate systems, and a lack of flexibility to support a 
range of user types (i.e. physicians, pharmacists, nurses, etc.) [94–96]. These challenges are just 
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an example of the types of interaction problems users encounter when navigating a new system, 
and it is essential that they are understood and addressed through careful evaluation at all stages 
of system development.  
As health IT takes on an increasingly central role in healthcare, reliable methods for 
evaluation are more and more imperative [17]. Methods for evaluation are important to 
understand user requirements, system usability, and the impact or side effects of health IT in 
both laboratory and field settings. There are a range of techniques, methods, study designs, and 
analysis methods that can be applied across a range of evaluation problems. Friedman and Wyatt 
describe different types of evaluation problems as they pertain to five major aspects of an 
information resource that can be studied, which include: the need for the resource, the design and 
development process, resource static structure, resource usability and dynamic functions, and 
resource effect and impact [17]. The authors further expand these five areas into nine important 
evaluation study types that are described in the table below (Table 3). These study types help 
researchers determine “what” should be studied, and although these nine study types comprise a 
theoretically “complete” evaluation, it is rarely necessary to be so comprehensive in the ‘real 
world’ [17]. We used several of the nine study types in this research, which are indicated in bold 
in Table 3, and described below. We selected these study types to ensure that they span the five 





Table 3: Classification of nine generic evaluation study types by broad study question and version of resource 
studied. The items in bold indicate the studies used in this research. The numbers in ‘Aspect studied’ refer to: 1) 
Need for resource; 2) Design and development process; 3) Resource static structure; 4) Resource dynamic usability 
and function; 5) Resource effect and impact. Adapted from [17]. 





What are the problems? None (or one that 
will be replaced) 
Design validation 2 





Is the resource appropriately designed 
to function as intended? 
Prototype or 
released version 
Usability test 4 
Can intended users navigate the 











Does the resource have the potential to be 
beneficial in situ? 
Prototype or 
released version  
Lab user effect 
study 5 






Does the resource change actual user 
behavior in ways that are positive?  
Released version  
Problem impact 
study 5 
Does the resource have a positive impact 
in the original problems (uncovered in 
the needs assessment)? 
Released version  
 
User-centered design principles are rooted in ethnographic and cognitive science, which 
focuses on the need to gather evidence for system design by observing healthcare workers in 
their automatic environment rather than purely laboratory-based design ideas that are removed 
from daily practice [94,97,98]. Thus, to understand the nature of the problems the resource is 
intended to address, a needs assessment study that utilizes a subjectivist approach is helpful. 
These methods include passive observation, key-informant interviews, informal discussion, and 
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workflow modeling to understand user information needs, abilities, expectations, and workflows 
[17,99]. During the design and implementation stages, it is important that the intervention is 
thoroughly evaluated in the laboratory to ensure it is functioning as designed and not violating 
any usability requirements. Once the system is in use, the focus switches from the resource itself 
to its effects on users and the healthcare organization. It is important to understand how the 
resource impacts the behaviors and actions of its users to facilitate a seamless integration and 
adoption; this is the field-user effect study. Lastly, to understand if the resource has a positive 
impact on the initial problems uncovered in the needs assessment studies, a problem impact 
study is critical.    
2.6.1 The “fundamental theorem” of biomedical informatics  
Further emphasizing the importance of evaluation methods in biomedical informatics, we discuss 
a “Fundamental Theorem” of informatics as proposed by Charles Friedman [100]. The 
fundamental theorem of biomedical informatics states that “a person working in partnership with 
an information resource is ‘better’ than that same person unassisted.” A resource, for example, 
can be an information system, an algorithm, a dataset, or even a new method of standardized 
work; in this research, RxMAGIC represents the ‘resource.’ This theorem is illustrated in Figure 
2 and referenced several times throughout this research. Friedman describes three important 
corollaries to the theorem that offer a finer depiction of what informatics is and is not. We found 
these corollaries to hold mostly true as this research progressed, with some exception to the 




Figure 2: The 'fundamental theorem' of biomedical informatics proposed by [100]. 
 
Corollary 1: Informatics is more about people than technology. This corollary 
reminds us that, as informaticians, we are developing resources for the benefit of the users. This 
was particularly important in this research as it is grounded in user-centered design principles. 
Users were engaged at every stage of the design and development process to ensure that the 
resource effectively meets the pharmacists’ needs. Further, this corollary emphasizes the 
importance of what informatics is not: automation. The goal of this research was to deliver a 
resource that augments the pharmacy workflow and requires user intervention to be successful, 
rather than something that replaces the user altogether. While automation certainly plays a role in 
health IT, it is important that resources do not compete with their users.  
Corollary 2: In order for the theorem to hold, the resource must offer something 
that the person does not already know. It is important that an information resource is 
informative and capable of incrementing the knowledge of the user in some way. While we 
believe this to be true, it is not the only indicator of success. It is possible that an information 
resource does something that can already be done, but does it better. The resource should offer 
users information and assistance they did not previously have in a way that adds value to the 
process.  
Corollary 3: Whether the theorem holds depends on the interaction between person 
and resource, the results of which cannot be predicted in advance. This final corollary 
explains the importance of evaluating a resource once it is in steady use in a user’s authentic 
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work environment. While it is important to understand a user’s needs and expectations, the 
resource itself, and how the user interacts with the resource in a controlled environment, it is just 
as important to study this interaction in situ. Further, it is necessary to revise the resource if it 
does not have a positive impact on user behavior and outcomes. We found this corollary to be 
especially true in this research, which we further elaborate upon in Aim 2 (see Section 5.2). 
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3.0  RESEARCH DESIGN 
We have collaborated with the Birmingham Free Clinic (BFC) in Pittsburgh, Pennsylvania to 
conduct this research. In this section, I discuss the characteristics of the study setting and the 
motivation behind this research. Further, I provide an overview of the individual studies that 
comprise this dissertation as guided by three specific aims.   
3.1 SETTING: BIRMINGHAM FREE CLINIC 
This research focuses on challenges associated with the medication management continuum as 
typified by the BFC, which is the only free, non-federally-funded, walk-in health clinic in 
Pittsburgh [24,101]. The BFC was founded in 1994 through the Program for Heath Care to 
Underserved Populations (PHCUP) with the goal of placing free, compassionate healthcare 
services within the Pittsburgh community to provide a safety net of care for homeless, uninsured, 
and medically indigent individuals. The PHCUP was developed under the auspices of the 
University of Pittsburgh Medical Center (UPMC) in response to medically vulnerable 
individuals being discharged from hospitals without proper follow-up care. The mission of the 
Program is “to facilitate, provide, and improve access to high-quality care for those in need, 
through community partnerships, volunteerism, service learning, and advocacy” [101].  
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The BFC is the PHCUP’s longest-running initiative and “envisions a community were 
every individual has access to high-quality, compassionate healthcare” [101]. They use of a 
community-campus partnership model to achieve this. The BFC receives support from the 
Salvation Army, generous donations, and the Division of Internal Medicine at UPMC [101]. 
Further, they leverage relationships with the University of Pittsburgh School of Pharmacy / 
School of Medicine to provide educational experiences for students. A mostly volunteer team of 
physicians, pharmacists, nurses, health professional students, and other allied-health 
professionals donates over 2,000 hours of clinical service annually. These services, in addition to 
medications, are provided for free to approximately 1,100 uninsured and medically underserved 
individuals annually. In addition to these volunteers, the BFC hosts AmeriCorps National 
Service members who act as patient advocates in the clinic. Amongst other duties, their primary 
responsibility is to manage the PAP application process.  
The BFC focuses on continuity, prevention, and education with the goal of forming and 
maintaining a positive, trusting relationship with their patients. Their services include primary 
and acute medical care, medication access, medical and social services, case management, and 
insurance navigation services. They utilize an interdisciplinary team-based approach to provide a 
wide range of clinical services, including the identification and prevention of disease, 
management of chronic conditions, as well as extensive health and social service referrals. The 
services that are offered vary depending on the day of the week. For example, clinical 
pharmacists conduct a smoking cessation clinic on Thursday mornings, while Saturday 
afternoons may be a student-run clinic for walk-in, pediatric patients. Likewise, the clinic offers 
more specialized services, such as dermatology or optometry, on certain Monday evenings. 
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An on-site medication dispensary enables access to essential medications for free during 
every clinic session. Volunteer clinical pharmacists work collaboratively with the medical team 
to provide in-depth MTM and disease state management for patients with chronic diseases. Most 
medications are donated by UPMC, purchased in bulk at significantly discounted rates, or 
acquired for specific patients through PAPs. Approximately 20% of the patient population at the 
BFC receive prescription medication through PAPs. A study done by BFC pharmacists in 2009 
reported an average savings of $243 USD per patient per month because of these programs [24]. 
Pharmacists assist patients in applying for PAPs, and receive and dispense the medication to 
patients on-site. 
3.2 MOTIVATION 
3.2.1 A paper-based workflow 
Like many medical practices before the introduction of health IT, the BFC utilized paper charts 
to document patient visits. They standardized use of paper forms by creating customized charts, 
intake forms, and medication labels that adhered to certain regulations. The workflow was 
straightforward and consistent; a paper chart would follow the patient from intake to the 
dispensary. Physicians would handwrite medication orders and personally deliver and discuss 
them with pharmacists before dispensation. Although paper charts and handwritten 
documentation tasks were inefficient, labor-intensive and prone to human error, they facilitated 
collaborative team-based care. Physicians would often consult the pharmacist to determine 
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treatment plans based on stock availability before placing medication orders, which standardized 
communication between the medical and pharmaceutical services. 
3.2.2 A hybrid EHR-paper workflow 
UPMC donated their outpatient EHR system, EpicCare, to the BFC with the goal of enhancing 
the continuity of care within their enterprise. The introduction of an EHR has improved the 
quality and efficiency of several clinical processes, such as the ability to electronically view 
patient laboratory results and order medications using CPOE. However, pharmacists report that it 
has not benefited their productivity as it is unable to accommodate their workflow. The EHR 
essentially automates the medical services while failing to fully support the pharmaceutical 
practice, particularly dispensing and inventory tracking.  
While pharmacists at the BFC are active users of the EHR, they continue to use a paper-
based system for dispensing, inventory tracking, and monitoring medication use. Pharmacists 
play a key role in many processes related to the EHR at the BFC such as medication 
reconciliation, CPOE, patient evaluation, and other documentation tasks. While they recognize 
the benefits that the EHR provides, this hybrid EHR-paper system has created a culture of 
redundancy in the dispensary that is both inefficient and prone to error. Rather than providing 
efficiencies and improved time management, the partial support of the EHR has exacerbated 
many of the inefficiencies that existed due to the use of paper charts [102].  
The challenges described here, which are further elaborated upon in Aim 1 (see Section 
4.0), were the motivation for this research. The BFC pharmacists could benefit from an 
automated dispensary management information system that improves the efficiency of their 
dispensing workflow. This system should provide workflow efficiencies, safer and more 
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standardized dispensing, and strengthened supply chain integrity. Further, to avoid continued 
redundancy, this system should integrate with the EHR to receive electronic prescription data 
entered via CPOE [102].  
3.3 APPROACH 
The goal of this doctoral research is to understand challenging aspects of the pharmaceutical 
workflow at the BFC, design and deploy a system that directly alleviates these challenges, and 
iteratively evaluate the system (both in the field and the laboratory) to ensure that it does. That 
system is RxMAGIC.  
This research involved a combination of studies guided by Friedman and Wyatt’s 
evaluation framework, from needs assessment to problem impact. We have used a variety of 
methods including qualitative and quantitative data analyses, information system design and 
implementation, user-centered design, and multiple evaluation techniques. We began by 
qualitatively understanding the pharmaceutical workflow at the BFC and the specific challenges 
that pharmacists encounter. Having identified a set of workflow challenge themes, we quantified 
their impact on pharmacist time utilization to help prioritize intervention design. We used these 
data to design a novel dispensary management information system with functional components 
that could be directly linked to the challenges they are to alleviate. We employed a prototype-
and-test approach to ensure completeness and feasibility. After testing this prototype with 
potential users, we supervised development and iteratively evaluated the system for usability. We 
deployed RxMAGIC at the BFC, trained users, and observed initial use to diagnose and resolve 
functional and organizational challenges. Finally, after steady use, we evaluated the impact of 
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RxMAGIC on pharmacist time utilization and satisfaction, and inferred its effect on quality of 
care and cost. 
This process is described in several studies that are guided by the following research 
questions, and associated study types as described by Friedman and Wyatt [17]: 
1. NEEDS ASSESSMENT: What are the information needs and workflow challenges 
pharmacists encounter at the BFC, and what can we design to alleviate them? 
2. STRUCTURE VALIDATION / USABILITY: Does this information system design 
have the potential to meet those needs, and how can it be improved?  
3. FIELD-USER EFFECT: How do pharmacists interact with RxMAGIC once 
deployed, and how can we resolve problems related to system functionality and 
workflow organization? 
4. PROBLEM IMPACT: How does RxMAGIC impact pharmacist time utilization and 
satisfaction?  
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3.3.1 Dissertation overview 
 
Figure 3: Dissertation overview. 
 
Figure 3 provides an overview of this dissertation research that consists of three specific aims 
that are associated with the research questions defined above:  
AIM 1: To design a production version of RxMAGIC and evaluate it in a laboratory setting. 
Aim 1.i: Understand workflow challenges at the BFC and propose the initial framework 
for RxMAGIC. 
Aim 1.ii: Develop a prototype version of RxMAGIC and test it with potential users to 
guide the design of a production system. 
Aim 1.iii: Use results from Aim 1.ii to design a production system and evaluate its 




User story development; 
Prototype development;
Usability testing
User story modification and 
implementation; 
Usability testing
Aim 1.i: Mixed-methods 
needs assessment
Aim 1.ii: Structural 
validation and usability 
testing
Aim 1.iii: Development 
and usability testing
RxMAGIC
A medication management 











Aim 3: Problem impact study
(i-ii) Time-motion study; 
(ii) Usability evaluation survey;
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AIM 2: To identify and resolve post-deployment implications related to system design and 
workflow organization. 
Aim 2.i: Deploy components of RxMAGIC in two locations and train all users through a 
tutorial video and on-site instruction. 
Aim 2.ii: Conduct passive observations and a focus group with primary users to identify, 
understand and resolve post-deployment challenges.   
AIM 3: To evaluate the impact of RxMAGIC in the clinic within the framework of the lean 
value diamond. 
 Aim 3.i: Measure changes in pharmacist time utilization. 
 Aim 3.ii: Utilize results from Aim 3.i to infer changes in the quality of services provided. 
Aim 3.iii: Measure users’ perceptions about the usability of RxMAGIC.  
Aim 3.iv: Assess the cost-effectiveness of RxMAGIC as a prospective new intervention 
being considered for implementation by a free clinic. 
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4.0  AIM 1: DESIGN RXMAGIC AND CONDUCT USABILITY TESTING 
Aim 1 focuses on the user-centered design process employed to develop RxMAGIC. Identifying 
the need for an information resource before it is developed is an important precursor to any 
developmental effort. Thus, we began this research by conducting two needs assessment studies 
at the BFC to identify problems that may be amenable to a solution (Aim 1.i; see Section 4.1-
4.2). Both needs assessment studies are published separately in BMC Health Services Research 
[102,103]. Keeping with the user-centered design process, we developed a proof-of-principle 
prototype that captured enough functional aspects of the desired system to support user research 
and structure validation (Aim 1.ii; see Section 4.3). Results from the prototype usability 
evaluation guided the design and development of a production version of the system, which we 
iteratively tested for usability in a laboratory environment (Aim 1.iii; see Section 4.4). 
4.1 QUALITATIVE NEEDS ASSESSMENT 
We conducted a qualitative investigation utilizing contextual inquiry to document the dispensary 
workflow and identify processes that may benefit from introduction of an informatics 
intervention. Holtzblatt et al. designed contextual inquiry as a user-centered, social method 
aimed to identify and understand users’ needs and unarticulated knowledge about work processes 
[104]. This methodology users direct work observation, informal interviews, and four graphical 
 50 
models to describe all aspects of workflow and provide highly detailed data about the structure 
of work practice. Contextual inquiry differs from other qualitative methods, such as interviews 
and focus groups, because it does not just rely on the user’s ability to clearly articulate his/her 
needs, which can be a difficult task for any user [104,105].  
4.1.1 Methods 
We performed three contextual inquiry sessions at the BFC dispensary during clinical care 
according to the guidelines suggested by Holtzblatt et al. [104]. Each session lasted 
approximately four hours and included direct work observation and unstructured questions about 
work tasks. We observed a wide range of pharmaceutical tasks including pharmacist-physician 
consultation, prescription preparation and dispensation, and patient counseling and education. 
The University of Pittsburgh Institution Review Board approved this study as exempt 
(PRO15010330). This research was published in BMC Health Services Research in February 
2016 [102]. 
Notes representing user-provided data such as key user needs, information sources and 
flow, physical artifacts, activities, and regulatory tasks were captured during contextual inquires. 
We also identified ‘breakdowns’ in the workflow, which are defined as anything or anyone that 
interrupts the pharmacist during task completion. As part of the contextual inquiry process, we 
used these data to create four graphical models (physical, artifact, sequence, and cultural) to 
facilitate data visualization and interpretation. The physical model captured the actual layout of 
the BFC to portray different components of the environment that may support or hinder 
pharmacist’s work. The artifact model documented and described any physical objects (i.e. 
documents or forms) that are necessary to understand the workflow. The sequence model 
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illustrated the main steps pharmacists take to perform certain work tasks, and described how 
workflow strategies may differ between users. The cultural model illustrated the expectations, 
goals, values, and general policies that may influence how the pharmacists accomplish their 
work and coordinate information flow with co-workers. The models were validated for accuracy 
and completion during a member-checking discussion with the pharmacists. The discussion 
lasted one hour and was audio-recorded.  
We used a pattern coding approach to categorize the qualitative data and develop a set of 
themes summarizing the primary workflow challenges encountered by the pharmacists. Pattern 
coding is used to identify trends and repetitive patterns in a dataset. It allows the use of the same 
codes, which may describe themes or categories, to be used repeatedly throughout a qualitative 
dataset. To focus the design of an intervention on problems most amenable to a technological 
solution, we asked the pharmacists to rank the themes by level of importance. We used a 
weighted ranking technique by assigning scores to each ranked item, where the highest-ranked 
item received the greatest score (equivalent to the total number of ranked items) and the lowest-
ranked item received the lowest score (i.e. a score of 1). The scores for each ranked item were 
added across the datasets and ranked in descending order to produce a new, harmonized set of 
themes. We then proposed informatics interventions to address the five highest-ranking 
workflow challenges that received the greatest aggregate scores during the ranking process. 
Figure 4 provides an overview of the methodology employed in this study; this figure is adapted 




Three pharmacists participated in this study, all with varying levels of experience volunteering at 
the BFC. Figure 5, the physical model, is an approximated floor plan of the BFC to provide some 
context as to the physical location of the on-site dispensary. The cultural model (Figure 6) shows 
the degree to which different organizations, general policies, values, and relationships within the 
clinic influence the pharmacists primary goal of medication management. For example, this 
model shows that providers have limited knowledge of the available formulary which may lead 
to errors in CPOE and negatively impact the pharmacist’s ability to efficiently dispense 

























Figure 4: Overview of methodology used in the qualitative inquiry. Adapted from Turner et al. [106]. 
 53 
 
Figure 5: Birmingham Free Clinic floor plan (physical model). WS = workstation, A = PAP medication cabinet, 
B = general stock medication cabinet. 
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Figure 6: Cultural model. The size of the circle indicates the degree of influence, and the text in italics 
describes the primary concerns of each influencing factor. 
 
We used the sequence model (Appendix A) in conjunction with the qualitative data to identify 12 
themes that describe workflow challenges in the BFC dispensary. Table 4 lists these themes in 
order of importance as ranked by the pharmacists. The five highest-ranking workflow challenges, 
which are indicated in bold in Table 4, include handwritten medication labeling, insufficient 
process notification, redundant documentation, challenges related to CPOE, and knowledge of 
the medication formulary. We recognized that the latter two themes were symptomatic 
challenges related to the same root problem: poor inventory control. Thus, these themes were 
















































workflow, I describe these four themes in detail and the interventions we proposed to address 
them below:  
Table 4: Workflow challenges uncovered in the qualitative inquiry. The items in bold indicate the five highest-








The EMR has an inefficient method of alerting the pharmacist that a patient 
is ready for dispensary services due its reliance on the clinician’s memory. 
Triple 
Documentation 
The pharmacists currently document patient prescription/dispensation 
information in three separate documentation forms (i.e., medication labels, 
Pharmacy Activity Sheet, and the EMR).  
Challenges with 
CPOE 
Frequent errors in clinician ordering due to confusion around available 
inventory and patients’ financial capabilities.  
Knowledge of 
formulary 
Clinicians have no visibility into the available medication stock at the BFC 
dispensary. 
Dispensing The EMR is only capable of supporting the prescribing process at the BFC and does not provide a similar structure for dispensing practices. 
Patient Validation The dispensary lacks an explicit method to validate that the right medication is being dispensed to the right patient. 
Inventory 
Maintenance 
The dispensary is unable to use prescription information in EMR to track 
medication inventory and dispensing history in real-time. 
Drug-Drug 
Interactions 
The dispensary lacks an explicit method for checking potential DDI’s at the 
counseling site due to the inability to readily access past dispensation records. 
EMR 
Accessibility 
Pharmacists cannot readily access the EMR at relevant locations, such as the 
patient counseling location. 
EMR Complexity 
Volunteer pharmacists and clinicians are not familiar with the specific protocol 
when ordering medications to the BFC dispensary in the EMR which leads to 
incorrect EMR order entries. 
PAP Application 
Process 
The PAP application process is challenging and time consuming due to the large 
amount of paperwork involved and the wide variation in application format and 
patient requirements. 
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Insufficient process notification 
After a physician places a medication order in the EHR using CPOE, he must change the patient 
status to ‘ready for dispensary services’ on the EHR dashboard. This notifies the pharmacist that 
he may begin preparing the prescription; however, the pharmacist must be continually checking 
the dashboard to notice this update. Changing the patient status following CPOE may be an 
unfamiliar step to many volunteering clinicians as it is not part of their workflow at their typical 
medical practice. Thus, in conjunction with a high patient burden, this step is easily overlooked, 
which may result in unnecessary patient delays and limited time for the pharmacist to counsel the 
patient on appropriate medication usage. 
➢ Intervention proposal: Implement a dashboard that displays pending prescriptions in 
order of their receipt via CPOE.  
Poor inventory control 
Once an order is placed in the EHR, the pharmacist may determine that the medication is 
currently unavailable or that the BFC typically does not carry this medication. The clinician was 
likely unaware of this because, as an infrequent volunteer, he is not familiar with the limited 
formulary at the BFC and how it differs from a typical retail community pharmacy formulary. 
Further, the clinician lacks visibility into this unique inventory from his prescribing location, 
which results in incorrect medication orders and extra work for the pharmacists to correct this 
mistake. The underlying cause of these challenges is a lack of automated inventory control, 
which can lead to unreliable monitoring of medication utilization, uninformed CPOE, and drug 
stockouts. 
➢ Intervention proposal: Use electronic dispensing to establish a system of automated 
inventory reduction that will update inventory counts in real-time. Using past 
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consumption data and expiry information, we can alert pharmacists of low-inventory 
items and medications approaching expiry. This will remind pharmacists to reorder high-
usage medications and dispense expiring medications first, which will help keep critical 
drugs on the shelves and may reduce wastage of low-usage drugs due to expiry. The 
inventory will be visible to clinicians by a web-browser that they can view on the same 
computer as the EHR, resulting in a more informed patient-provider conversation during 
the patient visit. 
Handwritten medication labeling 
The pharmacist begins to prepare the prescription by handwriting medication labels for all 
medications the patient is receiving that day. These labels contain similar information to those on 
prescription bottles from a typical community pharmacy (i.e. medication name, strength, 
directions for consumption, prescriber). The artifact model in Appendix B describes this label in 
more detail. This handwritten process is labor intensive, prone to human error, and lacks 
scalability if patients are receiving multiple medications that day. 
➢ Intervention proposal: Use computer-generated barcode labels to streamline and 
standardize the dispensing process. Each laptop in the BFC dispensary will receive a 
barcode scanner and thermal label printer to produce patient medication labels upon 
dispensation. This scalable method will maintain dispensation records for each BFC 
patient, and will replace the paper-based filing system used at the clinic. 
Triple documentation 
After patient care has ended, the pharmacist handwrites information summarizing each 
dispensation that day (i.e. the same information written on the patient labels) on another 
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document, the activity sheet, that is delivered to the PHCUP office. The artifact model in 
Appendix B describes the activity sheet in greater detail. Any low-inventory medication items 
must also be written on this document so that they can be replenished. Use of the activity sheet 
represents this notion of redundant work. 
➢ Intervention proposal: Generate automated reports based on the information previously 
used to produce computer-generated dispensing labels. Low-inventory items can be 
automatically added to electronic reports when they fall below a certain threshold, so that 
the pharmacist does not have to recall low-inventory items at the end of the day.  
4.1.3 Discussion 
To our knowledge, limited research exists on the challenges pharmacists encounter in free clinic 
settings. While the BFC workflow has undergone many refinements since its inception, we noted 
much inefficiency and redundancy in the dispensing process. It was obvious that inefficiency 
was at the core of many workflow breakdowns. We identified five main challenges that may be 
amenable to a technological solution: insufficient process notification, challenges related to 
CPOE, knowledge of formulary, handwritten medication labeling, and triple (redundant) 
documentation.  
In proposing individual interventions designed to address these challenges, we 
recognized that many of the problems shared the same root cause, and thus their interventions 
would be dependent on one another. For example, electronic dispensation and automated 
inventory control are somewhat synergistic; they can certainly exist on their own, but they would 
be more successful if working together. It was necessary to consider these dependencies so that 
we could design a ‘systems thinking’ solution that would act as an umbrella under which 
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multiple performance improvements to occur. This solution evolved into a framework for a 
dispensary management information system, RxMAGIC, that was grounded in these individual 
interventions. 
4.1.4 Limitations 
We recognize that contextual inquires by a single researcher is a limitation of this study. 
However, the pharmacists were actively involved in model development and theme validation. 
We believe this level of user engagement is critical to sustain innovation, although we still 
wanted to validate these results with quantitative data. We planned to conduct a time-motion 
study to measure pharmacist time utilization and understand the magnitude of these workflow 
inefficiencies. This would help to prioritize the design of RxMAGIC to focus on the tasks that 
were most inefficient tasks and amenable to improvement. Further, as efficiency is the outcome 
for which RxMAGIC is intended to improve, it was necessary that we acquire a baseline 
measurement to eventually ensure that it does.  
4.2 QUANTITATIVE NEEDS ASSESSMENT 
The qualitative investigation provided a somewhat broad understanding of the workflow 
inefficiencies that may be alleviated through introduction of an informatics intervention. 
However, it did not provide any insight into the relative impact of relevant inefficiencies in the 
current workflow. A more quantitative understanding of pharmacist time allocation was 
necessary to determine where to focus RxMAGIC so that it maximizes value for its users. We 
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conducted a continuous observation time-motion study informed by lean principles to quantify 
pharmacists’ time expenditures on defined tasks. The goal of this study was to quantify time 
invested in non-value-added tasks, or tasks pharmacists thought were amenable to efficiency 
improvements, and to focus RxMAGIC on reducing redundancy in these areas.  
Time-motion studies are business efficiency techniques that have been adopted in the 
biomedical domain to evaluate the adoption of health IT systems and how they impact the 
quality, efficiency, and cost of healthcare [107]. Using time-motion observations to quantify 
healthcare workers’ time expenditures on different clinical activities can provide valuable insight 
into system specifications and workflow redesign. Improving process efficiency may benefit 
staff productivity and other related organizational challenges such as communication and process 
transparency.  
4.2.1 Methods 
Two researchers conducted time-motion observations in the BFC dispensary on tasks that 
comprise the pharmaceutical workflow. The University of Pittsburgh Institutional Review Board 
reviewed this study and approved it as exempt (PRO14020120). This research was published in 
BMC Health Services Research in September 2016 [103]. 
Codebook development and pilot studies 
We developed an initial set of ten task subcategories, or codes, describing pharmacist activities 
based on data from the qualitative investigation. We conducted a pilot study to test these codes 
for completeness and calculated Cohen’s kappa to determine inter-rater reliability. Both 
researchers observed the same pharmacist for the duration of the data collection session and 
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documented the amount of time he/she took to complete tasks; these data were not analyzed. 
Questions about the appropriateness of certain categorizations following the pilot study resulted 
in several modifications in the codebook. We also clustered related subcategories into higher-
level workflow categories to assist with broader analysis. Due to these changes, we conducted a 
second pilot study to measure inter-rater reliability with the new coding system.  
Data collection and analyses 
Each researcher observed a different pharmacist during a three-hour shift, which began 
approximately 30 minutes before the first patient appointment. This allowed the researchers to 
document pre-work tasks, such as pending medication orders in the EHR. Data collection 
continued through general care hours until onsite care was completed. Each session lasted 
roughly three hours. 
We collected data using the Time Motion Study application by Graphite Inc. 
(www.graphiteinc.com) for Android devices. This software allowed the observer to create a list 
of motions, i.e. task subcategories, to track pharmacist activity. Timing began as soon as the task 
was selected and ended upon selection of a new task. Data was recorded in comma separated 
value files where each row summarized the duration of a single task selection. We used RStudio 
0.98 (RStudio Inc., www.rstudio.com) and R 3.1 to analyze the accumulated time invested in 
each subcategory, and hence each major category, over the entire dataset. We created bar charts 
to help visualize these data. 
Value stream mapping 
The core idea of lean is to maximize value for the customer while minimizing waste, or simply, 
to create more value for customers with fewer resources. To do this, we must first identify value 
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as perceived by the customer and then distinguish non-value-added tasks from value-added tasks; 
in lean language, this is the value stream mapping phase [78]. While we recognize that there are 
many customers affected by the therapeutics value stream, and that the patient represents our 
final customer, it is the pharmacist who is immediately involved in the processes described here. 
Thus, we identified BFC pharmacists as the internal customer in this study, and they specified 
efficiency as the value they desired. Efficiency is defined as the ability to accomplish a task with 
the minimum expenditure of time and effort. Pharmacists classified the tasks described in this 
study as non-value-added and value-added, thereby indicating non-value-added tasks as potential 
areas for efficiency improvements through waste reduction. 
We used these value categorizations to calculate the value quotient for each dataset. The 
value quotient is a metric for determining the efficiency of a workflow; it calculates the 
percentage of value-added time over the total time [108]. This metric provides insight into the 
amount of time pharmacist spend completing tasks they consider to be non-value-added, time 
that can be redirected to focus on more patient-centered tasks. Our goal is to increase the value 
quotient by decreasing the amount of time invested in non-value-added tasks. The value quotient 
formula is shown below: 
Value Quotient: (value-added-time / total time) 
The numerator was calculated by summing the total time spent performing value-added-tasks for 
the entire dataset. The denominator represents the total time collected. 
4.2.2 Results 
Time-motion data was collected during three independent clinic sessions between September and 
November 2014 for a total of approximately 16.5 hours. These sessions occurred on a Friday; the 
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clinic sees a mix of general walk-in patients and scheduled MTM patients on Fridays. Two 
pharmacists were observed during each session, which is the total number of working 
pharmacists at any given time. Cohen’s kappa for the first pilot session was found to be κ = 
0.806, indicating strong agreement between raters. We made several changes to the coding 
system after the first pilot session: two subcategories were added for completeness (consulting 
clinician and traveling); the definition of dispensing medication was broadened to accommodate 
a multiple-step process; and strict initiation and termination times were defined for each 
subcategory. The final codebook and value categorizations are shown in Table 5 and a complete 
list of the subcategories, definitions, and their intuition/termination protocols is in Appendix C. 
After modifying and finalizing the codebook, we recalculated Cohen’s kappa to be κ = 0.808 for 
the second pilot session. This coefficient further indicates strong agreement between raters. 
Table 5: Final codebook for the pre-deployment time-motion study. Items in bold indicate changes made to the 
codebook after the first pilot study. NVA = non-value-added, VA = value-added. 
Major task category Minor task subcategory Value categorization 
Prescription (Rx) Preparation 
Hunting for medication NVA 
Traveling NVA 
Dispensing medication NVA 
Labeling medication bottles NVA 
Duplicate documenting NVA 
Clinician Interaction 
Consulting clinician VA 
Teaching VA 
Patient Interaction 
Counseling patients VA 
PAP [application] initiation VA 
PAP [application] discussion VA 
EMR Operations EMR Operations NVA / VA 
Other Other NVA 
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  We compare pharmacist time investment between the five main categories described in 
Table 5 above: Prescription (Rx) preparation, clinician interaction, patient interaction, EMR 
operations, and other tasks. Figure 7 shows pharmacist time utilization by each major workflow 
category, which are deconstructed into their associated subcategories for the entire dataset (16.5 
hours). These data are further explained below.  
 
Figure 7: Percent total time investment by major workflow categories and their associated subcategories. 
Prescription preparation 
Pharmacists invest 39.8% of their time into preparing prescriptions for dispensation. This 
category includes five subcategories: traveling (2.4%), duplicate documenting (3.6%), hunting 
for medication in the stock cabinets (4.8%), dispensing medication (7.3%), and handwriting 
medication labels (21.8%). The pharmacists identified these tasks as non-value-added because 
they are inefficient and amenable to improvement, potentially via automation. It was difficult to 














what to dispense based on what was ordered via CPOE could be more efficient if the orders were 
presented to them in a single view. For example, using a dashboard that is updated in real-time to 
display all pending prescriptions. Similarly, while these documentation tasks are necessary steps 
in the prescription preparation process at the BFC, they consume an unnecessary amount of 
pharmacist time and resources, in addition to underutilizing their clinical expertise.  
EMR operations 
Our results indicate that pharmacists spend 14.8% of their time using the EMR. These activities 
include reviewing relevant patient information, pending medication orders, and modifying 
incorrect orders entered by physicians via CPOE. The CPOE process is somewhat different at 
Birmingham and may be unfamiliar to volunteer physicians. For example, the clinic does not 
allow medication refills and will only dispense a month’s worth of medication during a given 
patient visit. These reasons, in addition to prescribing a drug that is out of stock, may lead to 
incorrect order entry. The pharmacists report that this correction process can be cumbersome and 
hinders their productivity. While they recognize that the EMR is both necessary and beneficial 
for clinical care, it often creates redundant work when combined with their paper-based 
processes. 
It was difficult for the observers to differentiate productive versus nonproductive use of 
the EHR without interrupting the pharmacist. For this reason, the value quotient was calculated 
twice for each dataset, once with this task considered to be value-added, and once with it 
classified as non-value-added. 
Clinician interaction 
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Clinician interaction consumes more than a fifth (21.5%) of pharmacist time. This includes 
clinician consultation (8%) and teaching students and/or volunteers (13.5%). Due to the limited 
formulary at the BFC, physicians often utilize the pharmacist’s expertise to determine an 
appropriate and affordable treatment plan. This clinician consultation also provides a teaching 
opportunity for students, which is a valuable component of the clinic’s community-campus 
model. The pharmacists consider both tasks in this category to be value-added. 
Patient interaction 
Pharmacists spend 18.7% of their total time interacting with patients, which includes direct 
pharmacist-patient counseling (16.7%) and initiation and discussion of PAP applications (1.8% 
and 0.2%, respectively). Initiation of a PAP application occurs when a patient needs a 
prescription medication and lacks insurance/drug coverage. This process typically beings with 
the pharmacist or AmeriCorps worker filling out sections of the paper application. The 
application is discussed with the patient during counseling, as personal financial information 
must be obtained from the patient. The pharmacists identified all tasks related to patient 
interaction as value-added, as they are integral to patient education and chronic disease state 
management.   
Other 
Tasks unrelated to any aspect of the pharmacist’s job, such as casual conversation or using the 
restroom, consume 5.2% of pharmacist time. These tasks were considered as non-value-added in 
the value quotient calculation.  
Value quotient 
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Based on the value categorizations made by the pharmacists, the value quotient range for the 
entire dataset is 40.3% - 54.8% (Table 6). The lower bound represents the value quotient when 
the EHR was considered a non-value-added task, whereas the higher value includes EHR 
operations as a value-added component.  
Table 6: Value quotients for each dataset. Each figure is calculated when EMR=NVA and EMR=VA. 
Session Value Quotient (%) [EMR = non-value-added] 
Value Quotient (%) 
[EMR = value-added] 
1 39.3 56.5 
2 43.6 51.4 
3 38.0 56.5 
Overall 40.3 54.8 
4.2.3 Discussion 
The pharmacists at the BFC are in expanded clinical roles of direct patient care that extend 
beyond dispensing medication. While documentation and other administrative activities are 
necessary, it is important these tasks are completed efficiently so the pharmacists can contribute 
fully to individual patient care. Our results indicate that pharmacists at the BFC allocate roughly 
40% of their time to prescription preparation, most notably the handwritten labeling of 
medication bottles and related documentation tasks, which is not an optimal utilization of 
pharmacist time and expertise. The value quotient further supports the conclusion that 
pharmacists devote more than half of their time to tasks they consider to be inefficient.  
The results from this time-motion study act as a data validation component to the results 
from the qualitative inquiry. Handwritten medication labeling, redundant documenting, and poor 
inventory tracking were among the most significant workflow challenges uncovered in the 
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qualitative study. The time-motion data clearly capture the magnitude of this inefficiency for 
tasks like handwritten labeling and redundant documentation, and identify them as potential 
areas for improvement through automation. Although perhaps not explicitly, the time-motion 
data also support claims describing poor inventory tracking as a potential area for improvement. 
While it was difficult to quantify the challenging aspects of inventory control, we know it 
contributes to the time invested in hunting for medications and the non-productive use of the 
EHR (i.e. correcting order entries), which are both symptomatic problems of poor inventory 
control.  
The non-value-added tasks comprising the prescription preparation category in this study 
represent the main drivers of inefficiency in the BFC. Focusing an informatics intervention on 
alleviating these challenges, such as computer generated labeling and automated inventory 
control, may reduce the amount of time pharmacists invest in their completion. Decreasing time 
invested in non-value-added tasks should produce time savings for the pharmacists. While we 
cannot be certain how pharmacists will utilize this extra time, we believe their behavior will 
evolve to focus on more patient-centered tasks, thereby improving the value quotient.  
4.2.4 Limitations 
It is difficult to assess the generalizability of these findings. The pharmacists observed in this 
study each have more than seven years of experience at the BFC and understand how the EHR 
has changed their workflow. These pharmacists often used workarounds, or temporary solutions 
to bypass a recognized problem, to optimize the amount of time spent on different tasks, thereby 
minimizing their time investment on non-value-added tasks. We recognize that introducing new 
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volunteers into the workflow is common practice for free clinics, and that these volunteers may 
take longer to complete the same tasks due to a learning curve.  
Measuring the variability between pharmacists could be a useful study, yet this would be 
difficult at the BFC because the pharmacists do not evenly divide the task load (i.e. one 
pharmacist will do all the medication labeling, while the other focuses on counseling). These 
data maintain consistency across clinic sessions and measures time investment of the most 
experienced BFC volunteer pharmacists. Thus, the calculated value quotients may be an 
overestimate, because less experience pharmacists are likely to spend more time on non-value-
added tasks due to not having the opportunity to develop efficiency workarounds. To address 
this, it is necessary to engage pharmacists with varying levels of BFC experience during the user-
centered design process.  
4.3 PROTOTYPE AND TEST 
The mixed-methods needs assessment studies provided us with a greater understanding of the 
interactions and synergies of the dispensary workflow. At this stage of the research, we 
understood the specific problems pharmacists encounter at the BFC, proposed problem-driven 
interventions to address them, and articulated the outcome for which we were optimizing: 
efficiency. The individual interventions we proposed as part of the qualitative investigation 
would provide the foundation for a dispensary management information system, or RxMAGIC.  
We proposed a framework for RxMAGIC that was grounded in the interventions 
described above. The goal was to deliver a pharmacist-facing tool that would improve their 
ability to efficiently deliver medication services at the BFC. At a high-level, we intended for 
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RxMAGIC to standardize the dispensing practice, strengthen supply chain integrity, and enhance 
process efficiency and transparency between the pharmaceutical and clinical services at the BFC. 
We recognized that RxMAGIC would be most effective if it could receive e-prescription data 
from the EHR, which would require the use of health data standards and vocabularies. Lastly, to 
maintain the low-cost, potentially generalizable model of implementation, we proposed the 
application as an open-source, web-based system that would be flexible, cheap, and amenable to 
customization. 
Before considering the more technical aspects of the implementation (i.e. health 
information exchange and an open-source framework), we wanted to ensure that it was feasible 
to deploy a system like RxMAGIC at the clinic, and that the proposed functional requirements 
were complete from the perspective of the users. Continuing with the contextual user-centered 
design process, we involved users early in the development process. We built a proof-of-concept 
prototype that captured enough of the proposed system functionality to support user testing. This 
allowed us to iteratively refine system design, acquire an even greater technical understanding of 
the problem, and understand the utility of the system for different users.   
In this section, I discuss the creation and validation of system requirements which took 
the form of user stories. User stories are high level statements that describe desired software 
features and their benefits from an end-user perspective [109]. We chose a subset of the user 
stories to build the RxMAGIC prototype, which we showed to potential users in laboratory 
environment. I discuss the results of this usability test and how they guided incremental 
expansion of the prototype system.  
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4.3.1 Methods 
4.3.1.1 User story development and prioritization 
We transformed data from the needs assessment studies into user stories that describe software 
features from the perspective of three user roles at the clinic. User stories are an agile approach 
to facilitate system planning, prioritize functional components, and most importantly, integrate 
the end user’s perspective into the development plan at the earliest stages [109]. We used the 
following template to format the user stories: 
“As a <role>, I want <desired feature> so that <benefit>.” 
We wrote 44 user stories for three different roles: pharmacists (28), physicians (6), and clerical 
staff (10). These are the three primary user groups at the clinic who are involved in patient care; 
all three groups have access to the EHR. We asked a representative user from each group to 
modify and approve the user stories. This validation process ensured that the proposed system 
design was complete and in line with users’ expectations.  
We selected a subset of the user stories to develop a proof-of-concept prototype to ensure 
RxMAGIC was technically feasible. As user-centered approaches suggest, we planned to 
implement the remaining user stories and any additional functionality after prototype 
development and testing. We focused on the pharmacists’ user stories as they are the primary 
users of RxMAGIC, and thus all other user stories depend on their successful implementation. 
We chose 13 of the 28 pharmacist user stories to implement as part of prototype development 
which are shown in Table 7. These user stories were selected because they capture the minimum 
set of requirements for RxMAGIC, which include inventory tracking, computer generated labels 
(i.e. electronic dispensation) and some basic PAP functionality.  
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Table 7: User stories selected for prototype implementation. 
As a pharmacist (goal)… …so that (benefit) 
I want to know when a clinician has prescribed 
a medication for a new BFC patient… 
…so that I can ensure that this drug is in 
stock prior to end of patient/clinician visit. 
I want to have visibility into the current 
medication inventory… 
…so that I can inform AmeriCorps staff of 
low medication stock levels. 
I want to have visibility into the current 
medication inventory… 
…so that I don’t physically waste time 
looking for medications that we do not have. 
I want to have visibility into the current 
medication inventory… 
…so that I can efficiently aid clinicians in 
determining what medication and dosage we 
are currently able to dispense to patients.  
I want to have visibility into the distinct 
inventories maintained by the dispensary (i.e. 
PAP and general stock) … 
…so that, when a drug is in stock, I know 
whether to look in the PAP cabinet or general 
stock cabinet. 
I want to attach preprinted adhesive labels to 
dispensed medications… 
…so that my documentation tasks become 
more efficient. 
I want to attach legible labels to dispensed 
medications… 
…so that the patient clearly understands how 
much medication to take and when 
throughout the duration of the prescription. 
I want to attach detailed labels to dispensed 
medications… 
…so that all labels are complete with the 
necessary information required for adherence 
to dispensing standards.   
I want to know the expiration date of all 
medications… 
…so that I can prioritize dispensation of near-
expiry drugs to reduce medication wastage. 
I want to know the lot number of all 
medication in stock… 
…so that I can quickly respond to medication 
recalls by identifying patients who have 
received medications from a specific batch. 
I want to view past medication dispensation 
from the BFC, by patient… 
…so that I can more easily identify potential 
drug-drug interactions and be reminded of 
any differences between what was prescribed 
and dispensed. 
I want electronic dispensation to update drug 
inventory in real-time… 
…so that I am informed of low stock levels in 
the timeliest fashion. 
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I want to be able to identify patients who are 
currently enrolled in a PAP program… 
…so that I can efficiently locate that 
particular medication by patient name in the 
PAP inventory. 
 
We created a logical data model for RxMAGIC with a graphical schema utilizing an 
entity-relationship (ER) model that was generated in MySQL Workbench. The prototype was 
developed using a relational database model and SQL; phpMyAdmin, a free software tool 
written in PHP, was used to handle administration of MySQL over the web. We used HTML and 
PHP to build a functional web interface, and a 1D barcode scanner and Eltron Programming 
Language (EPL) compatible printer to produce medication labels. The prototype did not include 
the desired health data standards to achieve interoperability (i.e. RxNorm and HL7 messaging); 
we manually curated a representative medication list to support user testing.  
4.3.1.2 Prototype functionality   
The primary objective behind building the RxMAGIC prototype was to elicit reactions from 
potential users regarding certain functional components of the desired system. Thus, 
functionality was limited and the interface was not optimized for usability. I describe basic 
elements of the prototype below and show some screenshots to provide more context.   
Automated inventory control 
RxMAGIC maintains two separate inventories for the general and PAP medications to reflect the 
physical layout of the dispensary. Users can enter inventory items into the general stock by 
selecting a medication name from the dropdown list and completing the fields for medication lot 
number, expiration date, and received quantity. Once the entry is saved, a label is printed with a 
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barcode that encodes a unique inventory identification number for each unit of medication in the 
inventory.  
Figure 8: Inventory entry screen for PAP medications. 
Entering items into the PAP inventory has a slightly different workflow because each 
medication is tightly coupled to a patient name. Users are first prompted to search for the 
appropriate patient who is enrolled in a PAP2 before entering the medication details displayed 
above (Figure 8). In addition to these fields, users are also required to enter a ‘date to reorder’ the 
medication. Currently, the AmeriCorps member writes this date on each medication item with a 
marker. While not implemented in the prototype, this field will eventually be used to remind the 
pharmacists to reorder this PAP medication.  
Electronic dispensing 
The prototype includes a ‘prescription dashboard’ that lists pending prescriptions to be filled by 
the pharmacists (Figure 9A); this is a simulation of the desired functionality. Eventually, this 
2 At the BFC, pharmacists refer to PAPs as PMAPs, which is why PMAP is used within 
the RxMAGIC application as shown in the screenshots. 
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dashboard will be populated with e-prescriptions that are sent from the EHR. Once a prescription 
is selected, the user is prompted to scan the barcode on the label of the medication from which 
she is dispensing and enter the appropriate quantity to dispense (Figure 9B). The user selects 
‘print label’ to print the prescription label once complete.   
Patient management  
The prototype also includes some basic patient management functions such as patient registration 
and search capabilities. We also implemented a function that allowed users to identify patients in 
PAP applications and update application status within RxMAGIC, although these features were 
not intended to replace the actual paper process of PAP applications. These functions were 
implemented to help us understand how best RxMAGIC could support the PAP process, if at all, 
as this was not sufficiently capture this in the needs assessment studies.  
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Figure 9: Electronic dispensing screens in prototype. A) Prescription dashboard with queue of prescriptions. 
Selection of patient name brings user to (B) patient-specific dispensing screen. User completes fields to print 
prescription label. 
4.3.1.3 Usability testing 
To verify that RxMAGIC has the potential to effectively meet pharmacists’ needs and 
expectations, we conducted a laboratory-based usability evaluation with potential users. We 
recruited four pharmacy students and one resident pharmacist to participate in the usability study. 
All participants were affiliated with the University of Pittsburgh School of Pharmacy with an 
emphasis in underserved care and global health, and had experience volunteering at the BFC or a 




as they frequently rotate at the clinic, thus their feedback would provide insight into the potential 
learnability of the system for new users. The University of Pittsburgh Institution Review Board 
approved this study as exempt (PRO15010330).  
We conducted a think-aloud study in which participants were asked to complete five 
tasks within the system while discussing their perceptions of different features. These tasks 
included patient registration, inventory entry (general and PAP), medication dispensing, and PAP 
application initiation. For example, participants were given a bottle of Ibuprofen 200 mg oral 
tablets and asked to enter that item into the medication inventory. To complete this and print an 
inventory label, they had to enter the lot number, expiration date, and quantity into RxMAGIC. 
Additional details of these tasks are in Appendix D. We conducted the study in an office 
environment (Department of Biomedical Informatics) outside of the clinic, and used fake patient 
data to facilitate task completion. We passively observed each participant during the study and 
captured qualitative data in the form of participant comments. These data were used to identify 
positive and negative features of the system as described by the participants. 
4.3.2 Results  
Participants completed all five tasks without any failures or observed/reported confusion. They 
provided mostly positive feedback regarding the feasibility of the system at the BFC and the 
potential impact it would have on improving inefficient aspects of their workflow. Three of the 
four users praised the “clean interface” design and its lack of unnecessary clicking, screens, and 
dialogue boxes. These comments were often supplemented with comparisons to the cumbersome 
EHR interface. Further, they emphasized the importance of maintaining two separate inventories 
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for the general and PAP medications, as they consider these to be distinct inventories in the 
clinic.   
A commonly reported interface suggestion was the inconsistent method by which dates 
were entered within the application. There were three different instances where users were 
required to enter a date: expiration date, date to reorder PAP items, and patient birthdate. We 
only used a standard date-picker widget for the latter because we were unsure how best to 
represent the other two fields. As expiration dates are typically listed as MM/YYYY on most 
medication bottles, we just required the user to select a month from a dropdown menu and 
manually enter a year (Figure 8). However, the date to reorder field did not specify how the date 
should be entered which confused all participants (Figure 8). We recognized that all date fields 
should be consistent in the application and with the user’s mental model. Most users indicated 
that they prefer the use of a standard date-picker widget (i.e. selecting a date from a calendar) 
when interacting with date fields. We have incorporated these preferences in the production 
version of the application.  
Some other commonly reported suggestions included the ability to print medication 
directions in Spanish and save patient language preferences within the application. Further, 
participants found it difficult to locate low-inventory items within RxMAGIC. Most participants 
suggested this idea of an alert feed that would tell them when a medication item fell below a 
certain threshold, indicating that item should be reordered. They noted that other alerts could be 
present on this hypothetical alert feed as well, such as medication items approaching expiry and 
new prescription alerts. Lastly, many participants suggested the use of colors or icons to increase 
the visual appeal of the RxMAGIC interface, as other applications leverage certain colors to 
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indicate meaning. For example, participants suggested the use of green buttons to indicate the 
printing function and red font to indicate low inventory items.  
Although limited functionality was implemented in the prototype to support the PAP 
application process (i.e. initializing an application), we realized that it would not be feasible to 
address all aspects of the PAP application process. Most participants claimed that the PAP 
functionality in the prototype would likely create redundant work for them without making these 
tasks easier or more efficient. Therefore, we decided to not incorporate significant PAP 
functionality because it may decrease the perceived usefulness of RxMAGIC from the 
perspective of the AmeriCorps. However, results from the usability study did provide insight as 
to how RxMAGIC can assist pharmacists and AmeriCorps with this process. Participants 
suggested that a report summarizing PAP medications to be reordered would be useful, which 
will be addressed in the production version. User stories regarding the PAP process will be 
modified to reflect these results.  
4.3.3 Discussion 
The results from the ‘prototype and test’ phase of this research demonstrate the feasibility of 
deploying RxMAGIC at the BFC, while also providing a greater technical understanding of the 
problems at the clinic. The participants’ suggestions about desired interface components and the 
burdensome PAP functionality inform continued development of RxMAGIC, and user stories 
were modified to reflect these changes. Specifically, the use of an alert feed to update users of 
poor inventory levels, expired medications, and PAP reorders will be a significant component in 
the development of the production version of RxMAGIC.  
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The prototype included a subset of the desired functionality to facilitate inventory 
tracking and dispensing. Although the results were generally positive, there were still some 
important problems that needed to be addressed before implementation. In addition to the 
remaining user stories, these included, but are not limited to, improving the user interface, 
implementing reporting features, addressing Spanish-speaking needs, and incorporating data 
standards. Use of data standards are necessary to operationalize RxMAGIC so that it is 
interoperable with the existing EHR. In addition to achieving interoperability, implementing the 
‘alert feed’ that would update in real-time required significant changes to the schema and 
potentially additional data collection. For example, to generate alerts for low inventory items, we 
needed to understand the minimum amount of inventory that should be on the shelves for high-
usage medication items. This required access to data that summarizes medication consumption 
patterns at the BFC. 
While the prototype was developed in PHP, discussions with colleagues demonstrated the 
importance of using a potentially superior framework to develop web applications. Thus, in 
addition to the functional changes described above, we planned for the final application to be 
developed using Ruby on Rails. I further elaborate upon this in Section 4.4 below.  
4.4 EVALUATE USABILITY OF THE PRODUCTION VERSION 
To improve aspects of the prototype, we conducted additional contextual inquiry sessions in the 
BFC dispensary to update our understanding of certain processes. We directly observed two 
pharmacists in the dispensary over the course of five three-hour sessions. Both pharmacists that 
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were observed participated in the prototype usability study and provided feedback during the 
observations to inform continued development.  
Results from the prototype usability evaluation, in addition to these observations, 
uncovered more technical challenges that were not addressed in the prototype system such as the 
ability to dispense medication from multiple bottles. In addition to some of the functional 
modifications previously described (i.e. interoperability, the real-time alert feed, and an 
optimized user interface), we chose to develop the production version in Ruby on Rails rather 
than PHP. While PHP provided a quick and easy entry point for a prototype system, the 
RxMAGIC development team was most familiar with Ruby on Rails. To reduce the learning 
curve for the primary software developer, we developed the production version of RxMAGIC 
using Ruby on Rails, using the prototype as a skeletal starting point. We loosely adopted an agile 
methodology to facilitate development, thus most of the terms and artifacts I use in this section 
are taken from agile practices. 
In this section, I discuss the artifacts used for the development of RxMAGIC, which was 
implemented with Ruby (v 2.2.3) on Rails (v 4.2.0), MySQL, bootstrap, and jQuery. I also 
describe the use of health data standards to achieve interoperability. As a fully functional 
application is the result of user story implementation, I discuss features of the RxMAGIC 
application in the results component of this study. Lastly, I discuss the laboratory-based usability 
evaluation we conducted with pharmacists from the BFC to understand and resolve potential 
interaction challenges.  
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4.4.1 Methods 
4.4.1.1 Modifying product requirements 
We significantly modified the user stories to reflect a deeper understanding of the challenges at 
the clinic and the intended RxMAGIC functionality. This process resulted in a new set of 47 user 
stories that spanned all three user roles: pharmacists (34), physicians (5), AmeriCorps (8). We 
grouped related user stories into distinct epics, which, in agile methodologies, are used to define 
larger feature requirements. Epics are used to describe a specific scope of work and typically are 
comprised of 5-10 user stories [109]. Eight epics were implemented that include: 1) View and 
maintain inventory through a web-based browser, 2) Use electronic dispensation to update drug 
counts in real time, 3) Produce computer generated labels upon dispensation, 4) Automatically 
alert pharmacists of new medication orders after CPOE, 5) Provide soft stop3 alert feed 
functionality that is updated in real time (five different alert types), 6) Automatically generate the 
activity sheet and enable PDF creation, 7) Provide medication reordering support for the PAP 
application process, and 8) Establish a user management framework. Table 8 shows an example 
of an epic in this context and its related user stories; a complete list of the epics and user stories 
is in Appendix E. 
Table 8: Eight epics used to describe large feature requirements. 
Epics used in RxMAGIC development 
Epic 01: View and maintain inventory through a web-based browser 
Epic 02: Use electronic dispensation to update drug counts in real time 
                                                
3 A soft stop alert requires minimal or no action/acknowledgement of the alert on the part 
of the user to proceed within the system.  
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Epic 03: Produce computer generated labels upon dispensation 
Epic 04: Automatically alert pharmacists of new medication orders after CPOE 
Epic 05: Provide soft-stop alert feed functionality that is updated in real-time (five types) 
Epic 06: Automatically generate the activity sheet and enable PDF creation 
Epic 07: Provide medication reordering support for the PAP application process 
Epic 08: Establish a user management framework 
 
Table 9: Example of an epic and its associated user stories from the pharmacist perspective. 
Epic 05: Provide soft-stop alert feed functionality that is updated in real time (five alert 
types) 
User Story 01: 
As a pharmacist, I want to know the approaching expiration date of all 
medications so that I can prioritize dispensation of near-expiry drugs to 
reduce wastage. 
User Story 02: 
As a pharmacist, I want to know when medications are expired so that I can 
keep patients safe by deleting them from the inventory. 
User Story 03: 
As a pharmacist, I want to know the lot number of all medications so that I 
can quickly respond to medication recalls and keep patients safe. 
User Story 04: 
As a pharmacist, I want to customize par levels (i.e. medication thresholds) 
so that I am in control of low inventory alerts. 
User Story 05: 
As a pharmacist, I want to know when a medication item has fallen below a 
par level so that I can add the item to the activity sheet and avoid stock outs. 
User Story 06: 
As a pharmacist, I want to know when a PAP patient hasn’t returned to the 
clinic in six months so that I can decide if I should transfer the medication 
item to the general stock. 
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We prioritized the user stories within each epic so that the pharmacist user stories would 
be implemented first; we also prioritized implementation of individual epics. We created 
wireframes using Mockingbird (https://gomockingbird.com/home) to supplement certain user 
stories and guide initial interface design. We then developed acceptance criteria or additional 
specifications for most user stories that were not implemented in the prototype version. 
Acceptance criteria provide a more detailed scope of the requirement and act as a checklist of 
parameters to ensure the user story is completed and working [109]. We recognize that this 
approach of developing acceptance criteria was somewhat non-traditional and that they acted 
more as a list of defined specifications. This was partly due to the previous development of a 
functioning prototype. These criteria included a step-by-step description of end-to-end user flow, 
the impact of user stories on other features, the output of artifacts after completion of a user 
story, and any potential negative scenarios of the functionality. Table 10 shows an example of 
the acceptance criteria we defined for User Story 05 from Table 9. 
Table 10: Acceptance criteria for User Story 5 for E5. 
Epic 05: Provide soft-stop alert feed functionality that is updated in real time (five alert 
types) 
 
User Story 05: As a pharmacist, I want to know when a medication item has fallen below a 
given par level so that I can promptly add the item to the activity sheet and avoid stock outs. 
Acceptance Criteria:   
- Alert should be generated when the drug count is < = the defined threshold (thresholds 
defined in separate document).  
- Alert should be generated at two time points in the day as requested by pharmacists. 
- Alert should use identical icon as general inventory and be titled General: Low 
Inventory. 
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- Alert should read ‘[Medication Item] stock below par level.’  
- Alert should have two options: 1) dismiss and 2) add to activity sheet.  
o Dismiss: Alert should be removed from the alert feed but reappear the next day. 
o Add to activity sheet: When user selects this option, the medication item should 
be automatically added to the ‘stock meds to be replenished’ section of the 
activity sheet. Upon selecting this option, a validation message should appear 
that reads ‘[Medication item] has been successfully added to the activity sheet.’ 
- The alert should not reappear if the user has added it to the activity sheet.  
o User will have alternate route of adding items to activity sheet should they need 
to repeat this process. 
 
 
The epics, user stories, acceptance criteria and wireframes comprised a product 
requirements document that constantly evolved throughout the duration of the development 
process. In addition to these items, we created several user scenarios to ensure RxMAGIC would 
meet varying user expectations and requirements once deployed. Further, we reproduced the 
physical artifacts from the qualitative study, i.e. inventory/dispensation labels and the activity 
sheet, to illustrate their new representation within RxMAGIC.  
Health data standards 
As the BFC is within the UPMC network, all components of the RxMAGIC application (e.g. 
database server, application server) must be within the UPMC network and adhere to all 
necessary privacy and security requirements. Thus, as part of the development process, we 
worked with several teams (i.e. UPMC and EpicCare) to ensure that all necessary steps were 
taken in order to meet these requirements. One of the first requirements for deployment was that 
RxMAGIC authenticates users using UPMC’s active directory services. To this end, RxMAGIC 
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supports a lightweight directory access protocol (LDAP) that allows users to access the 
application using their UPMC credentials. All RxMAGIC users have valid UPMC accounts.  
RxMAGIC leverages HL7 (v 2.3) messaging and RxNorm to achieve functional and 
semantic interoperability with the EHR. HL7 messaging was chosen because there was already 
an outgoing HL7 framework in place at the clinic, and these messages included all the 
information RxMAGIC needed to facilitate dispensation. We use Mirth, a cross-platform HL7 
interface engine, to receive HL7 messages and transform them into a standard format that is 
written to the RxMAGIC database. While Mirth allows bi-directional communication of HL7 
messages, RxMAGIC does not send HL7 messages back to the EHR because the EHR is not 
technically “listening.” Thus, this connection is unidirectional. RxMAGIC uses RxNorm as its 
drug nomenclature to achieve semantic interoperability with the EHR, which uses the vendor’s 
proprietary NDC nomenclature. The NDC of a drug product in an HL7 message is mapped to the 
appropriate concept in RxNorm. Drugs must exist in RxNorm to be inventoried in RxMAGIC.  
 
Figure 10: Network diagram of the RxMAGIC implementation. 















The network diagram in Figure 10 illustrates the various components of the RxMAGIC 
application. All machines are located within the UPMC network. The RxMAGIC application 
itself is hosted on a web server that is physically located in the BFC, whereas the database is 
hosted on a virtual server in a UPMC data center. This was done to adhere to certain security 
requirements within the UPMC enterprise, however, other configurations are possible depending 
on the security requirements of the organization.   
4.4.1.2 Usability testing 
We iteratively tested the production system throughout the development process, typically after 
implementation of an entire epic, to ensure user stories functioned as designed. To complete 
functional testing for each epic, we identified functions that RxMAGIC was expected to perform 
and created fake input data based on the function’s specifications (i.e. Table 10). We defined 
specific steps for completion of each function, which we referred to as ‘test tasks.’ After 
execution of each test task, we compared the actual output to the expected results that should be 
achieved upon completion of the test task. This allowed us to check whether the application 
works as per the original design specification. Any discrepancies between the actual and 
expected results were investigated and the specifications were modified as necessary. For 
example, we tested the first specification in Table 10 that states “alert should be generated when 
the drug count is < = the defined threshold” by creating an inventory entry with a stock count 
that is lower than the threshold for that item. The expected result of this test task is an alert that 
notifies pharmacists to reorder this specific item. If the alert was not generated, then this 
specification was not implemented properly.  
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Upon implementation of all user stories, and multiple rounds of functional testing, we 
conducted a second laboratory-based usability evaluation with pharmacists who were actively 
volunteering at the BFC. Our goal was to diagnose potential interaction problems and ensure 
RxMAGIC performed the functions for which it was designed. Identifying these challenges 
before deployment would allow us adequate time to resolve them through careful redesign.  
Similar to the preliminary usability evaluation, we conducted a think-aloud protocol to 
gain a realistic understanding of how pharmacists navigate the system without any training on 
how to do so. We recruited pharmacists and AmeriCorps from the BFC via email to participate 
in the study, which took place in an office (Department of Biomedical Informatics) location 
outside of the clinic. During the study, we asked each participant to complete 11 tasks that were 
slightly tailored to their user role, as views and functionality in the application vary depending on 
the user role. Participants rated each task on a five-point scale to indicate its ease of completion, 
where 1 = “very difficult” and 5 = “very easy.” We calculated an average score for each task at 
the completion of the study.  
We used Kazaam Screencaster for Ubuntu (https://launchpad.net/kazam) to record on-
screen action and audio into a video file. Each file was annotated using ChonoViz [110] to 
identify commonalities amongst participant responses describing positive and negative features 
of the system, potential interaction problems, and suggestions for improvement. We used these 
data to compile a report of modifications to be implemented before deployment, which were 
prioritized using the MoSCoW method [111]. This is a technique used to prioritize requirements 
into four categories: Must have, Should have, Could have, Won’t have. Requirements labeled as 
must have are both important and required changes before deployment; requirements labeled as 
should have are important but not vital (i.e. the solution is still viable without them); 
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requirements labeled as could have are desirable but not necessary in the first release. We did not 
use the won’t have category in this analysis.  
4.4.2 Results 
RxMAGIC is a web-based dispensary management information system that is designed to focus 
on processes associated with medication management in a free clinic setting. The application 
supports these processes with four high-level features, including: automated inventory tracking 
and reduction, electronic dispensing and labeling, automated reporting and alerting, and support 
for the PAP reordering process. RxMAGIC is a freely available application; the source code can 
be downloaded from GitHub (https://github.com/amf022/RxMAGIC). Once implemented, the 
application can be accessed through any web browser. RxMAGIC has minimal requirements in 
terms of additional hardware, which are in the form of an EPL compatible printer and 1D 
barcode scanner. At the BFC, there are two workstations in the dispensary, both of which are 
used to access RxMAGIC (Figure 5). Thus, each workstation has a barcode scanner and printer. 
4.4.2.1 Production functionality 
I describe how these four features support aspects of the medication management process at the 
BFC. These stages include inventory tracking, order communication and interoperability, 
dispensing, and alerting and reporting. Not all possible screens of the application are illustrated 
in the following screenshots.   
Inventory tracking 
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RxMAGIC provides automated inventory control and visibility by tightly coupling each 
medication item to a unique barcode. The inventory features of the production version are similar 
to the prototype, however they are optimized for usability and interoperability (i.e. validation 
messages, colored buttons, use of RxNorm). When new ‘general stock’ medications arrive, 
pharmacists or AmeriCorps log their receipt by entering medication details (i.e. name, expiration 
date, lot number, and received quantity) in RxMAGIC. For PAP medications, users must first 
navigate to the patient profile screen before entering the medication item into the distinct PAP 
inventory (Figure11). In addition to the details described above, users also enter a ‘date to 
reorder’ the medication and an appropriate pharmaceutical company. This entry creates a unique 
barcode label that is affixed to the medication item and used to identify that item during 
dispensation. Users can view details of all stock items and are able to edit stock quantities, 
reprint inventory labels, or delete items from the inventory.  
The inventory screen also includes a stock summary panel that provides a high-level view 
of low-inventory items, well-stocked items, items approaching expiry, and expired items; this is 
a new feature of the production version (Figure 12). When selected, these features provide a 
more detailed understanding of the inventory to facilitate efficient and accurate management. 
Stock availability is determined by comparing the current drug count to a pre-determined par 
level. Par levels indicate the minimum amount of stock that should be on the shelves at any time. 
We calculated par levels for fast-moving drugs based on pharmacist expertise and a year’s worth 
of consumption data from the BFC (i.e. activity sheets). These levels are customizable and can 
be created for new medication items within the application 
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Figure 11: Patient profile screen. Users can add new PAP items by locating a patient and selecting either 'add PMAP 
item' or the blue plus sign next to an existing application. 
 
Figure 12: General inventory screen. Users can add new items to this inventory by selecting ‘add item.’ 
Order communication and interoperability  
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RxMAGIC does not have a direct impact on the medication ordering process; physicians 
continue to see patients and prescribe medication in the EHR using CPOE. However, like 
pharmacists, physicians can also view the available inventory within RxMAGIC at the point of 
prescribing (Figure 12).  
When a medication order is entered in the EHR, it is packaged as an HL7 message, 
electronically transmitted and transformed by Mirth into a format that is accepted by RxMAGIC, 
and loaded into the RxMAGIC database. The patient demographic information in the HL7 
message is used to create a patient record within RxMAGIC, if one does not already exist, and 
records the associated prescriptions. These prescriptions are stored in the RxMAGIC patient 
profile so that pharmacists can view a patient’s dispensation history at the BFC (Figure 11). 
Incoming prescriptions are added to a dashboard screen within the application and 
prioritized based on their receipt which initiates the dispensing process (Figure 14). In addition 
to this screen, a 19.5-inch dashboard that runs on a Raspberry Pi mini-computer is mounted in 
between the two pharmacist workstations to display pending prescriptions (Figure 13). This 
dashboard was implemented to alleviate challenges with insufficient process notification in 
EpicCare.  
 
Figure 13: Information displayed on the 19.5-inch dashboard screen. Users cannot interact with this dashboard. 
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Figure 14: Prescription dashboard within the RxMAGIC application. Users select a prescription to fill by selecting 
the pill icon in the ‘action’ column. 
Dispensing 
Pharmacists electronically dispense medications by selecting a prescription from the prescription 
dashboard (Figure 14). Selection of a prescription brings them to the patient-specific dispensing 
screen (Figure 15). Here, pharmacists can review the prescription and select the preferred patient 
language (English or Spanish) which will determine how the medication directions are printed. 
Currently, if Spanish is the selected language, the medication directions will not print on the 
label so that the pharmacist can manually translate them.  
The dispensing screen also provides inventory suggestions based on expiration date and 
inventory type (i.e. PAP or general). Items closest to expiry will appear at the top of the list to 
encourage pharmacists to dispense medications that may be wasted due to expiry. The 
pharmacist scans the barcode label of the stock medication and enters the dispensed quantity; if 
the dispensed quantity does not equal the prescribed quantity, RxMAGIC assumes the 
pharmacist is dispensing medication from a second bottle. Once these two values are equal, a 
label is automatically printed and the stock counts are adjusted appropriately within RxMAGIC.  
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Figure 15: Patient-specific dispensing screen. Users are brought here after selecting a prescription in Figure 14. 
Alerting and reporting 
As suggested in the preliminary usability study, an alert feed was implemented on the home 
screen of the application that initially included five different alert types (Figure 16). These are 
soft-stop alerts in that they don’t interrupt and prohibit the user from completing a task; however, 
they are actionable. Pharmacists are alerted of new prescriptions, items approaching expiry, 
expired items, low-inventory items (PAP and General), and underutilized PAP items. Alerts for 
underutilized PAP items are generated when a PAP-receiving patient has not returned to the 
clinic in six months. This is intended to encourage the pharmacist to contact the patient or 
transfer the item to general stock so that it can be used for another patient. 
Alerts for low-inventory items are generated using the same query that creates the stock 
summary panel. However, the alert provides instant access to information that allows the 
pharmacist to efficiently determine a course of action at the point of care (i.e. add the item to the 
activity sheet). The activity sheet is automatically populated with each dispensation and can be 
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accessed at any point during clinical care (Figure 17). This document can be exported as a PDF 
or saved within the application. All historical activity sheets are stored in the application and able 
to be viewed at any time. In addition to the activity sheet, RxMAGIC creates a report for the 
AmeriCorps member to facilitate the PAP reordering process. Users can select an appropriate 
date range within the application to understand which PAP medications are due for reordering.  
 
Figure 16: RxMAGIC home screen. Users can act on alerts as they appear in the feed on the right side of the screen 




Figure 17: Example of the pharmacy activity sheet. (Fake patient data is used). 
4.4.2.2 Usability testing 
Six participants completed the usability evaluation, which is a representative sample of the total 
volunteer population at the clinic. These participants included four BFC volunteer pharmacists 
and two AmeriCorps representatives. We also asked two non-users (i.e. colleagues recruited as a 
convenience sample) to complete the evaluation prior to the beginning of the study to pilot the 
protocol and data collection tools; their data was not included in the analysis. The study took 
place in May 2016. At the time of this usability evaluation, RxMAGIC was not receiving 
prescription data from the EHR; thus, the database was populated with simulated patient data to 
support user testing.  
Overall, five of the six participants completed each task without any failures in the 
software. Of the 11 tasks, all of them averaged a score of four or five on the ease of completion 
scale. Tasks three and five had the greatest standard deviation, 1.67 and 1.26, respectively. One 
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participant was unable to complete task three due to a complication with the printer which was 
resolved immediately (i.e. a printer jam). Two participants struggled to complete task five, which 
asked the user to dispense medication without receipt of an order (i.e. it did not appear on the 
prescription dashboard), because they were unable to quickly locate this function in the software. 
A complete list of the tasks and their mean scores and standard deviations are in Appendix F.  
The participants supplemented these ratings with mostly positive feedback regarding the 
simplicity of the system, its high learnability, and the potential benefit it will have on their 
productivity at the clinic. They all expressed satisfaction with their user experience and 
articulated specific benefits and efficiencies the system would provide. I show some direct user 
quotes that support these claims.  
“It’s [RxMAGIC] really modern, it’s very easy to use, like it reminds me of my 
Gmail inbox [application], it’s very intuitive, just with the look of how it is. I 
know what to expect with each click.” 
“Honestly, all of this was really easy, it’s very simple, I think somebody new 
would have no problem, actually, I don’t know if you’d even need to train new 
people, you can pretty much just figure it out [laughter].” 
“Wow, this would’ve saved a lot of time last week! Not only that, it just makes 
me feel safer, I don’t know, like I’m doing a better job.” 
In addition to the positive feedback, there were several commonly reported suggestions to 
improve interface design. I discuss these results in the context of the MoSCoW prioritization 
technique.  
Must have 
While participants liked the idea of the alert feed, they all commented that some alerts were 
irrelevant and that they may overshadow more important alerts. Specifically, participants did not 
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think it was necessary to include a low-inventory alert for PAP items as the AmeriCorps are 
alerted of this in other places within the application. They also thought it was unnecessary to 
alert them that an item is approaching expiry, as they can look in the stock summary panel within 
the inventory to view medications approaching expiry. Further, some participants thought the 
‘new prescription’ alert would be redundant once the system is interoperable, as the dashboard 
will display new prescriptions. The participants were most interested in alerts for low-inventory 
items (general stock), expired items, and underutilized PAP items.  
There were several required additions to be made on the labels produced during 
dispensation. These included the phone number of the BFC, the date of the dispensation, the 
manufacturer of the dispensed item, and some type of unique identifying number (i.e. Rx #) so 
that they could link dispensed items to the automated activity sheet. To this end, changes to the 
activity sheet were also required. In addition to adding a unique Rx #, the activity sheet was not 
scrollable, so users were unable to view low-inventory items listed at the bottom of the sheet. 
Participants also wanted the ability to export the activity sheet to a word document in addition to 
a PDF, so that they can type comments if necessary.  
Participants also made suggestions to improve interface design in several places. They 
specifically noted that the word ‘cancel’ had several different meanings in the application, and 
that that could be confusing for a new user. Sometimes, the ‘cancel’ button terminated the 
current activity and redirected the user to the home screen, while in certain dialogue boxes, the 
word ‘cancel’ simply closed the dialogue box. Participants suggested the term ‘close’ be used 
instead of ‘cancel’ in the latter scenario. Further, participants thought some of the validation 
messages, i.e. ‘Metformin 500 mg has successfully been added to the inventory’, could be more 
specific to include the lot number of the medication. Lastly, in screens where icons are used to 
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indicate actions such as edit and print (Figure 12), participants tried to hover over the icon before 
selecting it to understand its meaning. They noted inconsistency in the application as some icons 
had clear definitions when they hovered, whereas others did not.  
Should have 
Participants made several suggestions that we categorized as should haves as they were not as 
critical or time-sensitive to the deployment deadline. First, participants were confused when they 
attempted to sort medication names by expiration date in the general inventory view. When 
selecting the expiration date column, the application sorted dates by the letter of the month, not 
the date itself. All six participants were expecting this feature to sort by date, where the first item 
on the list was the one closest to expiry.  
Participants also seemed confused when selecting the appropriate medication name from 
the filtered dropdown menu populated by RxNorm. RxNorm utilizes a certain capitalization 
pattern that confused the participants, as they were expecting to see words listed in title case. 
Lastly, participants consistently searched the screen for some type of feature that would allow 
them to toggle between different views within the application. Most features within the 
application can only be accessed from the home screen; participants found this frustrating when 
they wanted to quickly toggle between different views in the inventory. 
Could have 
There were few suggestions we classified as could haves, and these items would likely be 
implemented after the first release of the system. Participants suggested that, rather than alerting 
users of underutilized PAP items, this information could be included in the stock summary panel 
on the PAP inventory screen. This way, they could select this item in the stock summary panel 
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and have a more high-level view of all underutilized PAP items. Further, some participants 
recognized the importance and quality of the dispensation data that RxMAGIC would produce 
once deployed. They suggested some type of reporting framework within the application that 
would allow them to easily understand prescribing and dispensing patterns over a long period. 
4.4.3 Discussion 
Results from this round of usability testing demonstrated the importance of having real users 
interact with an application before deployment. The functional testing we conducted throughout 
development demonstrated that all user stories were implemented and functioning as designed. 
However, although the results were generally positive, we recognized several design flaws that 
did not align with users’ expectations. For example, the definition of the word ‘cancel’ in 
different places in an application and how items should be sorted in various fields. Resolving 
these somewhat minor flaws in the application would improve the utility and satisfaction with 
the system once deployed, and that would only facilitate system adoption and continued use. 
Using the MoSCoW technique to prioritize requirements facilitated results reporting and 
continued development. As the method suggests, items in the must have and should have 
category should be implemented prior to deployment, these categories just prioritize 
implementation so that items that are more complex are implemented first (must have). Thus, all 
items listed as must have and should have were implemented prior to deployment. These 
included the reorganization and elimination of some alerts (i.e. new prescription, item 
approaching expiry, low PAP inventory), changes to the labels and activity sheet, more specific 
validation messages, sorting based on expiration date, harmonizing ‘cancel’ and ‘close,’ defining 
hovering actions, a menu feature to easily toggle between screens, and utilizing title case in 
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RxNorm. Further, the suggestion to incorporate the underutilized PAP items in the stock 
summary panel was also implemented. We continued to conduct functional testing as changes in 
the application were made.  
4.4.4 Limitations 
The results from the laboratory-based usability evaluation were promising, however, as this 
study was done in a controlled environment, we knew that user interaction would likely change 
once the system was in use at the clinic. This is particularly true as the interoperability 
component was not tested in the laboratory setting, and this would likely create new challenges 
that had not been considered during development. Thus, understanding how users interact with 
RxMAGIC once deployed, and this level of interaction, would be critical to ensure a seamless 
integration with the BFC workflow. 
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5.0  AIM 2: IDENTIFY AND RESOLVE POST-DEPLOYMENT CHALLENGES 
Aim 2 focuses on the deployment of RxMAGIC. Although some hardware components were 
deployed previously (i.e. the dashboard in June 2016), system deployment started in October 
2016. We were prepared to deploy RxMAGIC in June 2016, however, challenges with achieving 
interoperability continued to delay this timeline. These challenges were more bureaucratic than 
technical due to our collaborations with several groups within UPMC that were working on other 
high-priority projects. For example, it took several months to establish a virtual server in a 
UPMC data center due to procedural delays.  
In Aim 2 I discuss the several stages of system deployment, including user training and 
materials, and the identification of challenges regarding the impact of RxMAGIC on user 
behavior and vice versa. We used the sociotechnical model proposed by Sittig and Singh to 
inform the categorization of different challenges [89]. For the purposes of reporting the results in 
Aim 2, I discuss these challenges as either functional or organizational, where functional 
challenges refer to actual system design and use and organizational challenges describe 
implications on workflow and behavior. 
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5.1 SYSTEM DEPLOYMENT 
5.1.1 Delays 
We experienced delays in deploying RxMAGIC due to several reasons. First, the laptops at the 
BFC used Internet Explorer as their web browser; RxMAGIC did not function properly in 
Internet Explorer due to challenges with communicating to an EPL compatible printer. As 
Internet Explorer was not an option, UPMC required that the RxMAGIC application be accessed 
through Google Chrome for security reasons. As RxMAGIC was developed and tested in 
Firefox, ensuring the application functioned properly in Google Chrome caused delays. We then 
needed to install Google Chrome on the BFC laptops, which took a significant amount of time 
because application installation requires administrative privileges on devices within the UPMC 
network. Thus, the BFC clinic director had to submit several requests to UPMC before Google 
Chrome was successfully installed. A similar process was required to install the thermal label 
printers at the BFC, as printer installation also required administrative privileges. Together, these 
installations delayed the deployment timeline. 
In addition to these delays, we also experienced challenges with establishing 
interoperability. There were several different steps to ensure the RxMAGIC server was receiving 
HL7 messages from the EHR at the clinic. While these steps are not technically complex, they 
depend on successful communication between different groups within UPMC that are all 
managing multiple projects; RxMAGIC was not necessarily a top priority for many of these 
teams. Once functional interoperability was established with the EHR, we experienced a final 
delay in receiving access to a service account that supports LDAP within RxMAGIC. As UPMC 
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required that users must have UPMC credentials to access RxMAGIC, deployment was delayed 
until access was granted and the user management framework was established.  
5.1.2 Phased deployment 
All hardware was installed during the summer of 2016 (i.e. dashboard, server, printers, 
scanners); interoperability and LDAP access were successfully achieved in September 2016. 
RxMAGIC was deployed in October 2016, which happened in three consecutive stages: 1) PAP 
inventory component (PHCUP office), 2) stock counts and data entry, and 3) electronic 
dispensing. Conceptually, all medication items in the BFC inventory cabinets had to be 
physically counted and electronically entered into the RxMAGIC inventory before the electronic 
dispensing component could be deployed. It was important that these stages occurred 
consecutively, so that the physical counts were accurate in RxMAGIC when electronic 
dispensation was deployed. I describe these stages below:  
Stage 1: PAP inventory component [October 12, 2016; ~2 hours] 
We first installed a thermal label printer at the PHCUP office in UPMC Montefiore where the 
AmeriCorps staff receives all PAP medications; most general stock medications also come 
through the PHCUP office before being delivered to the BFC. This was done to ensure that all 
medications are entered into the RxMAGIC inventory and labeled at the PHCUP office before 
being delivered to the BFC so that they are prepared for dispensation. AmeriCorps users have 
limited privileges in RxMAGIC so that they can only enter and view inventory information; they 
do not have access to the dispensing component.  
Stage 2: Stock counts and data entry [October 13 –15, 2016; ~10 hours]  
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Two pharmacy students at the BFC were tasked with physically counting all medication items in 
the BFC inventory. We scheduled data entry to occur during the longest break in time between 
two clinic sessions (Thursday AM – Saturday AM). All medication items were counted during a 
Thursday morning smoking cessation clinic; the dispensary does not typically dispense 
medication during this clinic. Data entry began after patient care ended Thursday morning and 
lasted until Friday evening, before patient care began Saturday morning, which was the planned 
deployment date for the dispensing component. The large volume of medications to be entered 
coupled with poor query optimization in RxMAGIC caused the application to slow down 
tremendously, and data entry was not completed before Saturday morning. Thus, data entry was 
prioritized so that all high-usage medications were entered before Saturday morning. The 
pharmacists continued to enter the remaining medications as needed, which was much easier 
once the query bottleneck in RxMAGIC was alleviated.  
Stage 3: Electronic dispensing [October 15, 2016; ~8 hours] 
The electronic dispensing component went live on Saturday, October 15, 2016. The clinic did 
not limit the number of patients they accepted, so the patient volume was comparable to any 
other Saturday walk-in clinic. Pharmacists used RxMAGIC to dispense medications to nine 
patients; 37 total prescriptions were dispensed. RxMAGIC was used throughout the duration of 
onsite patient care. While there were some initial challenges during deployment that I will 
discuss in Section 5.2, there were no significant challenges that caused us to turn off the system 
and resort back to the paper dispensing process. RxMAGIC has been used for every clinic 
session since its deployment on October 15. At the time of this writing, RxMAGIC has been in 
use for 9 months and has 15 active users. 
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5.1.3 User training and materials 
Although many pharmacist users had interacted with RxMAGIC during usability testing, some 
training was required. We conducted one-on-one training sessions at the BFC before onsite 
patient care began; sessions typically lasted between 10 and 20 minutes per user. I trained ten 
users during the first two months of system use. Approximately five new users that volunteered 
in the dispensary after the first two months of system use were trained by their colleagues. A 
small number of pharmacist users who had been involved with RxMAGIC development from the 
early stages quickly became proficient in system use. We identified one of these users as a 
‘champion’ of the system, and she continues to train new pharmacy students and volunteers that 
rotate through the dispensary.  
In addition to the one-on-one onsite training, we prepared a tutorial video that 
demonstrates and explains system use (RxMAGIC Tutorial Video). We published this video on 
YouTube and the link was distributed to all BFC volunteers. The video link is also posted in the 
‘About’ section within the RxMAGIC application. As some users were not able to watch the 
video during patient care, we also created a Frequently Asked Questions (FAQ) document based 
on questions we received during the first few weeks of system use. The FAQ document is 
hanging in the BFC dispensary and all questions are listed under ‘FAQ’ within the RxMAGIC 
application. This document includes relevant YouTube links that demonstrate how to properly 
refill the printer labels and ribbons.  
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5.1.4 Physician use of RxMAGIC 
We consider the pharmacists and AmeriCorps to be the primary users of RxMAGIC, which is 
evident in the description of the deployment process. While we wrote five user stories from the 
perspective of the BFC physicians, we consider them to be secondary users of the system. Their 
user privileges are comparable to the AmeriCorps in that they can just view the inventory (i.e. 
they do not have access to the dispensing functionality). Although they were included in system 
design, they were not trained on how to access RxMAGIC from their computers. This was 
discussed and agreed upon with the pharmacists. Our goal was to ensure that the pharmacists and 
AmeriCorps were confident using the system before demonstrating its use to the physicians. 
Once RxMAGIC was being used routinely, we planned to show the physicians how to access the 
inventory from the computers in the exam rooms. I further elaborate upon physician use of 
RxMAGIC in Section 5.2.2.2.  
5.2 FIELD-USER EFFECT STUDY 
While we consider the deployment of RxMAGIC to be successful, there were some initial 
challenges encountered during the first week of system use. These challenges demonstrated that 
it is difficult to predict how users will interact with a system once deployed, which is the third 
corollary to the fundamental theorem of biomedical informatics. In addition to evolving user 
requirements, this can be attributed to a variety of factors. For example, during the evaluation 
studies, users did not have to address interruptions, manage actual patients and prescriptions, or 
use the system for extended periods of time. Further, we were unable to effectively test the 
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interoperability component of RxMAGIC before deployment. We knew that RxMAGIC was 
receiving HL7 messages successfully, but it was difficult to assess their completeness and 
accuracy outside of the clinic setting. For these reasons, we conducted a field-user effect study to 
understand post-deployment implications. 
Field-user effect studies focus on the behaviors and actions of users, and not the 
consequences of these actions on patient outcomes. These studies provide an opportunity to 
understand if and how a system is being used, if this usage is appropriate, if users retrieve correct 
information from a system, and if the system is causing any problems. The questions asked and 
methods employed in a field-user effect study can vary depending on the scenario. In this study, 
the evaluation questions emerged during the deployment process and evolved in the days 
following. Our goal was to determine how the pharmacists and AmeriCorps were using 
RxMAGIC and when physician usage would be appropriate. Further, we planned to identify and 
resolve any challenges associated with RxMAGIC.  
We used the sociotechnical model developed by Sittig and Singh to facilitate the 
identification of challenges in the different dimensions of health IT use [89]. This model is 
grounded in the idea that these different dimensions are inherently related and significantly 
influence one another. As such, many of the challenges we uncovered could be classified into 
several dimensions in the model. Thus, I discuss these challenges in two primary categories: 
functional and organizational. Functional challenges are more technical and relate to hardware 
and software, clinical content, and the design of the system interface. I group these challenges 
together as they are more tightly coupled and their solutions are dependent on one another. 
Organizational challenges, however, focus on the more social end of the socio-technical 
spectrum. These challenges relate to system users, workflow and communication, and 
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organizational policies. While I discuss these challenges separately, it is important to note that 
many social components exert strong influences on technical components.   
In this section I discuss the subjectivist approach we used to understand post-deployment 
challenges. This included passive observations, member-checking discussions, and a structured 
debriefing with primary users to validate our findings. We used these qualitative data to 
understand specific challenges related to RxMAGIC, which we classified as either functional 
(i.e. software, clinical content, human computer interface) or organizational (i.e. user behavior, 
workflow, communication). Most functional challenges were resolved immediately, specifically 
if they were caused by bugs in the application. However, some functional challenges were a 
product of previously unarticulated user requirements, and these solutions were not as urgent. As 
organizational challenges were not as straightforward, because they required changes in people 
and workflow, we used lean healthcare principles that empowered users to develop “standard 
work” to accommodate RxMAGIC.  
5.2.1 Methods 
Continuing with the contextual inquiry process, we passively observed pharmacist users during 
patient care at the BFC and AmeriCorps users at the PHCUP office. Most of the BFC inventory 
is entered into RxMAGIC at the PHCUP office, so it was important that we also document any 
challenges with this interaction. To understand the immediate impact of RxMAGIC on the 
dispensary workflow, we observed users on the first clinic session following deployment. We 
attended every clinic session for an entire week; each session lasted approximately four hours. In 
addition to data collection, these observations allowed us to train new users as they rotated in the 
dispensary during the first week of system use.  
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Open-ended discussions with users were frequent during these observations. These 
discussions often focused on specific challenges users were encountering, most of which were 
considered bugs in the application. As the week progressed and users became more comfortable 
with RxMAGIC, they often suggested new features (functional challenges) or workflows 
(organizational challenges) that would further improve their medication services. Suggestions 
that were not complex or time intensive were implemented immediately so that they could be 
tested and refined through member-checking sessions. These incremental improvements in 
system design and workflow organization facilitated the development of “standard work,” which 
is a core principle of lean healthcare.  
After the observations, we categorized the qualitative data into functional or 
organizational challenges. Solutions to functional challenges were prioritized and implemented 
as soon as possible, particularly those related to interoperability. We conducted a focused 
debriefing with five primary users who were actively involved in system development. This 
semi-structured debriefing allowed the users to discuss their experience using RxMAGIC, both 
positives and negatives, and provide suggestions for improvement. Additionally, we 
demonstrated new features within RxMAGIC that resulted from the observation sessions. 
Together, we discussed organizational challenges and how they could be alleviated through 
standard work and solutions were communicated appropriately to other BFC volunteers.  
5.2.2 Results 
We observed users at the BFC for approximately 25 hours in the week following deployment. 
During this time, we trained and observed six RxMAGIC users. Data from these observations 
informed the development of functional and organizational challenges, which were discussed in 
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a one-hour audio recorded focused debriefing with three pharmacists and two AmeriCorps users. 
These results are explained in detail below as they pertain to functional or organizational 
challenges. I also attempted to classify them as they pertain to the individual dimensions of the 
sociotechnical model in Table 11, however, it is important to note that there is significant overlap 
between challenges and dimensions (i.e. some challenges could be classified into multiple 
dimensions). Further, two dimensions were not addressed in this study: external rules, 
regulations, and pressures, and system measurement and monitoring. We studied system 
measurement and monitoring in Aim 3 of this research. 
Table 11: Results classified by the different dimensions of the sociotechnical model. Challenges of the first three 
dimensions are discussed as functional challenges and the latter three are organizational. 
Sociotechnical 
model dimension Challenge Description 
Hardware and 
software 
1) NDC-to-RxNorm mappings 
2) Duplicate HL7 messages 
Some NDCs used in the EHR could not be 
mapped to related concepts in RxNorm.  
Two HL7 messages were generated for one 
order (discontinuation and new order). 
Clinical content 1) Scope of RxNorm 2) Mismatched par levels 
Some items were out-of-scope of RxNorm 
(vitamins, non-medication items). 
The term types used to match par levels to 




1) Delete/reprint labels 
2) Dispensing less than what is 
prescribed 
The process whereby users delete/reprint 
items was unnecessarily complex. 
Users were unable to efficiently dispense 
less than the prescribed quantity. 
People Implications of inaccurate stock counts 
Users did not trust the automated inventory 




1) Pre-work activities and 
impacts on prescribing 
2) Inventory management 
Pharmacists needed physicians to enter 
medication orders before they could 
dispense. 
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Variation in data entry regarding confusion 




Assigning new responsibilities  
New tasks were not being completed 
appropriately due to confusion around who 
was responsible.  
 
5.2.2.1 Functional challenges 
Several functional challenges were uncovered and resolved during deployment; bugs in the 
software were fixed before new features were implemented. For example, some medication 
names were so long that they disrupted the barcode on the inventory label, which made it 
unreadable by the barcode scanner. This was a bug that was fixed immediately. New features 
were implemented once a use case was observed, such as the ability to void dispensed items and 
reprint labels. While new feature requests were important, we focused on challenges with 
interoperability (i.e. RxNorm and HL7) as these were the most critical to the field of informatics.    
Scope of RxNorm  
We encountered several problems with the completeness of RxNorm once RxMAGIC was 
deployed. RxNorm includes all prescription medications that are approved for human use in the 
US; it does not include non-prescriptions, non-drug items such as supplies and equipment, and 
multivitamins, which are partially represented [69]. The RxNorm documentation states that OTC 
medications will be added to the vocabulary when reliable information about the medication can 
be found [70]. The BFC dispenses many of these out-of-scope items, so we recognized that 
RxNorm might not be complete for their purposes. Also, RxNorm is designed to be used in 
electronic prescribing applications, and its use in electronic dispensing has not been adequately 
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studied. We discussed this with the pharmacists prior to deployment and decided that RxNorm 
was the most suitable vocabulary to ensure semantic interoperability with the EHR.  
As expected, there were several items not included in the RxNorm vocabulary (mostly 
vitamin and dermatological products), and the pharmacists did not know how to inventory them. 
Several solutions were considered, like a specified medication list for OTC items, however this 
did not seem sustainable. The pharmacists identified certain active ingredients in OTC products 
that were included in RxNorm (i.e. partial representation). This was not a perfect solution, but it 
became the new standard for entering these products. Further, we concluded that non-medication 
items would not be inventoried and dispensed with RxMAGIC, as they are often not prescribed 
by the physician via CPOE. While this may not be ideal, the benefits of using a standard 
vocabulary such as RxNorm significantly outweighed these negatives. Although initially 
frustrating, the pharmacists realized that a customized medication list would not facilitate 
interoperability, sustainability, or generalizability, which are all critical to RxMAGIC’s success.  
NDC-to-RxNorm mappings 
Challenges with OTC medications were not limited to inventorying. We realized that the HL7 
messages for some e-prescriptions were not successfully transferring to RxMAGIC. This was 
confusing because the physician could prescribe these medications in the EHR, which meant the 
HL7 message included a NDC for that prescribed item. A thorough investigation of this specific 
interoperability failure proved that some NDC codes used in the EHR were unable to be mapped 
to a prescribable concept in RxNorm. For example, RxMAGIC was not displaying e-
prescriptions for Aspirin 81 mg tablets, although this concept is included in RxNorm. We found 
that the NDC used in the HL7 message is not the same NDC used in RxNorm for this item. As 
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RxMAGIC matches the NDC identifier in the HL7 message to one in a RxNorm concept, it was 
unable to transform and write this prescription to the RxMAGIC database.  
This challenge can be attributed to RxNorm’s process of retiring CUIs [69]. We assume 
that the NDC used for Aspirin 81 mg in the HL7 message is no longer used in the most current 
RxNorm concept for that item. Although this was initially problematic, pharmacists were still 
able to electronically dispense OTC medications in RxMAGIC because it has a feature that 
allows users to dispense medication to patients without a prescription from the EHR. This feature 
was implemented for two reasons: 1) in the case that we encountered challenges with 
interoperability, and 2) to ensure aspects of RxMAGIC could be generalizable to clinics without 
an ordering system.  
While this workaround was helpful at the time, it could be problematic as the pharmacists 
become more reliant on RxMAGIC to display all pending prescriptions. We implemented a 
specific solution to alleviate this problem. When RxMAGIC receives an HL7 message with an 
‘invalid’ NDC in RxNorm, it extracts the medication name of the prescribed item and matches it 
to a medication name in the RxMAGIC inventory. This suggested matching is displayed in the 
form of an alert that reads ‘missing drug reference.’ Users select this alert and validate the 
suggested matching, or suggest a new one that is more appropriate (Figure 18). Once the match 
is confirmed, the HL7 message is written to the RxMAGIC database and added to the queue of 
pending prescriptions as per usual. Users only have to do this once for a given medication, as this 




Figure 18: NDC-to-RxNorm mapping alert. Users select ‘Map to RxNorm’ from the alert shown in the above figure. 
Below, users can approve the suggested mappings or search for a more appropriate one. 
Duplicate HL7 messages 
While some HL7 messages were not appearing in RxMAGIC at all, others were appearing in 
duplicate. The same exact prescription would be listed in the queue twice. While the pharmacists 
recognized that the prescriptions were duplicates and reacted appropriately, they were frustrated 
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that the duplicate orders were cluttering the prescription dashboard. RxMAGIC is designed to 
update a prescription if it receives identical HL7 messages (same provider, same medication, 
same dose, etc.), which should have resolved a problem of this type. Therefore, there had to be 
something in the HL7 messages that was different between the duplicate prescriptions. We also 
noticed that the duplicate prescriptions were only appearing for patients who had been to the 
clinic previously, and that prescriptions placed for new patients were appearing appropriately. 
An investigation of the duplicate messages in Mirth revealed that the EHR sends two 
HL7 messages per one medication order. The first message is a discontinuation of the medication 
if it was prescribed previously, and the second is the initiation of the new medication order, 
although all aspects of the refill are the same. There is a field in each HL7 message that identifies 
it as a ‘discontinuation/historical order’ or a ‘new medication order.’ A filter was applied to all 
incoming HL7 messages so that only those encoding new medication orders are written to the 
RxMAGIC database, which immediately resolved the problem. 
Similarly, RxMAGIC would occasionally receive and display prescriptions to be filled at 
a community pharmacy. When a provider at the BFC orders a medication in the EHR, he/she is 
supposed to select a certain option (‘no printout’) that indicates the prescription is to be filled by 
the BFC dispensary. Medication orders that do not use ‘no printout’ are sent to the patient’s local 
pharmacy. This indication is encoded in the HL7 message. We applied a filter to all incoming 
HL7 messages so that only those identified as ‘no printout’ are displayed in RxMAGIC.   
Mismatched par levels  
RxMAGIC compares the aggregate stock quantity of an inventory item of the same name to its 
associated par level to determine its stock availability. For example, if the par level for 
Fluoxetine 10 mg oral tablets is 1000 and RxMAGIC lists three separate bottles of Fluoxetine 10 
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mg oral tablets each with quantities of 200 (total stock = 600), then this drug would be 
considered under-stocked (600 < 1000). The successful aggregation of similar inventory items 
and the matching of these items to their associated par level relies on their semantic 
representation in the RxMAGIC database, which depends on the term types (TTYs) and CUIs 
used in the RxNorm implementation. RxNorm uses TTYs to indicate generic and branded drug 
names at different levels of specificity (Table 12); different TTYs have different RXCUIs for the 
same drug product. When RxMAGIC was deployed, both the par level and inventory features 
used the prescribable name (PSN) and the semantic clinical drug (SCD). Further, par levels were 
matched to inventory items based on their RXAUI. While this worked during testing, it was not 
successful once RxMAGIC was in practice.   
Table 12: RxNorm TTYs that are relevant to this research. RxNorm describes 20 total TTYs. 
TTY Name Definition Example RXCUI 
PSN Prescribable Name 
Given for clarity and display 
purposes in prescribing applications. 
Only one PSN per concept 
Leena 28 Day Pack 749148 
SCD Semantic Clinical Drug Ingredient + Strength + Dose Form 
Fluoxetine 4 MG/ML 
Oral Solution 310386 
SBD Semantic Branded Drug 
Ingredient + Strength + Dose Form 
+ Brand Name 
Fluoxetine 4 MG/ML 

















During usability testing, we ensured that all medication items were represented similarly 
in RxMAGIC by specifically creating par levels based on medication names in the inventory (i.e. 
par level medication name = Fluoxetine 10 mg oral tablets, inventory medication name = 
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Fluoxetine 10 mg oral tablets). However, we realized that the logic used to match par levels to 
inventory items was too specific, and RxMAGIC was incorrectly classifying items as under-
stocked. For example, items were inventoried using their brand names (i.e. Prozac 10 mg oral 
tablets), or some other representation (i.e. Fluoxetine HCl 10 mg oral tablets), but par levels were 
created using generic names (i.e. Fluoxetine 10 mg oral tablets), different dose form (i.e. 
Fluoxetine 10 mg oral capsules) or some form of synonym. To improve the par level 
functionality, we needed to understand how pharmacists would use this information in practice 
and which TTYs would best meet these needs.  
We modified the TTYs used to create par levels to enable a broader mapping between 
different semantic representations of the same medication in the database. This took multiple 
attempts, but we found that the semantic clinical drug component (SCDC) and semantic branded 
drug component (SBDC) to be most successful for the par level feature. This means that par 
levels created for medication names just include the drug name and strength, but not the dose 
form (i.e. tablet, capsule, etc.). Also, rather than matching items based on their RXAUI, we 
match items by RXCUI to broaden the matching potential. Now, when users create a par level 
for Fluoxetine 10 mg, it is compared to items with the name Fluoxetine 10 mg oral tablets, 
Fluoxetine 10 mg oral capsules, Prozac 10 mg oral tablets, etc.  
Ability to delete/reprint labels 
The pharmacists typically received medication orders and prepared a patient’s prescription 
before bringing the patient into the dispensary for counseling. In some instances, the patient no 
longer needed or requested the medication that had been ordered and dispensed. Because the 
pharmacist had already completed this dispensation in RxMAGIC, the dispensed item was added 
to the activity sheet and the dispensed quantity was subtracted from the stock quantity. The 
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pharmacist was unable to delete this dispensation within RxMAGIC, so she would manually edit 
the stock quantity to add back the quantity she had dispensed. Further, there was no way to 
delete this dispensation from the patient’s record in RxMAGIC or the activity sheet.  
In addition to deleting dispensed items, pharmacists also wanted the ability to reprint 
dispensation labels. This would be useful in the case where the label ripped during the dispensing 
process or if the dispensed items were separated into different containers. To resolve these 
problems, we implemented a feature that allows users to delete a dispensed item which 
automatically replenishes the inventory within RxMAGIC. Deleting the dispensed item also 
removes it from the activity sheet and the patient’s record. Further, we updated the system to 
include a reprint feature so that users can print a second dispensation label. Both options appear 
as action icons next to each dispensation on the patient profile page.  
Dispensing less than is prescribed 
RxMAGIC allows users to dispense medication from multiple bottles to fill a prescription. When 
a user is dispensing, RxMAGIC does not print a label until the dispensed quantity matches the 
prescribed quantity. This was done to ensure the prescription is filled completely. While this was 
a necessary system requirement uncovered in the usability testing, there were some instances 
where the pharmacist did not want to dispense the total prescribed quantity (i.e. they had 
insufficient stock). We noticed that the pharmacists created a workaround to achieve this by 
dispensing the necessary quantity to print a label, and then retrospectively editing the stock 
counts to reflect what they dispensed. This was not only extra work for the pharmacists, but it 
would likely contribute to inaccurate stock counts and information regarding past dispensations. 
The pharmacists wanted to be able to edit the prescribed quantity in RxMAGIC so that 
the dispensation records were accurate and complete. After much discussion with the 
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pharmacists about their reasoning for this feature, we implemented the ability to edit the 
prescribed quantity on the patient-specific dispensing screen (Figure 15). Users select the edit 
icon to update this value and then proceed with dispensation as usual.  
5.2.2.2 Organizational challenges 
We expected RxMAGIC to change the medication management services. However, managing 
the people dimension of this technological change is critical to health IT adoption. Although we 
had our own vision of how RxMAGIC would be used in practice, it was important that the 
pharmacists and AmeriCorps felt empowered to optimize their own workflow to use RxMAGIC. 
We relied on their judgement to facilitate incremental changes in their workflow that realized the 
full potential of RxMAGIC.  
Inventory management  
It was important that the pharmacists managed data entry so that medication items were 
represented in a way that made sense to them and their practice as they would be responsible for 
entering all medications moving forward. Several different pharmacy students entered most of 
the medication items into the inventory during deployment and there was much variability in the 
way these items were entered. Some of this variability was resolved by modifying the RxNorm 
TTYs described above (i.e. brand name versus generic name), however there were questions on 
how best to enter items such as inhalers, topical ointments, and insulin. For example, should the 
stock quantity of an inhaler indicate the number of doses (or puffs) in the inhaler? Or should 
each inhaler be entered as a quantity of one? Likewise, for topical ointments, do we enter the 
stock quantity as the volume of the tube (i.e. 28 g)? It was obvious that some form of standard 
work was necessary to ensure consistency and accuracy in the inventory.  
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Physician prescribing patterns ultimately determined this standard. Nearly all medications 
are prescribed in their generic form, so the pharmacists made a group decision that all inventory 
items should be entered in the same way to maintain consistency. For inhalers, it was decided 
that the number of doses should be included in the drug name, i.e. 200 ACTUAT Albuterol 0.09 
MG metered dose inhaler, and that each inhaler should be entered as a quantity of one. 
Developing a standard for topical ointments, though, was a bit more complex. These items are 
typically prescribed by volume (i.e. grams), so they could not be inventoried as a quantity of one 
because RxMAGIC would assume there is insufficient quantity to dispense. The pharmacists 
decided that all topical creams/ointments/gels be inventoried by volume, and that the volume 
should be rounded up to the nearest ten (i.e. 28.2 g = 30 g). Insulin pens were also inventoried by 
volume (ml).  
The original philosophy of RxMAGIC was that each medication item would be barcoded 
with a unique inventory ID, and this barcode would be utilized for electronic dispensing. This 
would ensure that all dispensable units are tightly coupled to a single entity in the inventory that 
can be defined by its drug name, lot number, and expiration date. This is the process by which 
items were inventoried when RxMAGIC was initially deployed. However, the pharmacists 
ultimately chose to group similar medication items together by lot number and expiration date, 
and enter all of these items into the inventory under one unique inventory ID. For example, there 
were 15 inhalers of the same type (200 ACTUAT Albuterol 0.09 MG metered dose inhaler) with 
the same lot number and expiration date. Rather than enter each item individually as a quantity 
of one, the pharmacists chose to enter all 15 inhalers in one transaction, so that the total stock 
quantity was 15. While this was not how we intended the system to be used, the pharmacists 
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considered this to be the most efficient means of inventory tracking, which made it the new 
standard method for data entry.  
Pre-work activities and impacts on the prescribing process (CPOE) 
Before RxMAGIC was deployed, some pharmacists would prepare medications to dispense 
before the physician entered any orders in the EHR. This was mainly done for patients with 
chronic conditions who were coming to the clinic monthly. The pharmacists reported that these 
pre-work tasks were necessary because the labeling process was so time-intensive. Once 
RxMAGIC was deployed, the pharmacists were frustrated that they could not begin preparing 
medication labels until the physician placed the order in the EHR. Previously, the ordering and 
dispensing processes were completely decoupled. With RxMAGIC, however, the physician must 
sign and enter the medication order in the EHR to initiate the dispensing process, which was an 
organizational change in the dispensary.  
Over time, the pharmacists realized that these pre-work activities were not as necessary 
with RxMAGIC, as the actual dispensing process was much more efficient. However, this notion 
of needing the physician to enter medication orders in the EHR to initiate electronic dispensing 
was still a frustration. The pharmacists at the BFC often enter and sign medication orders in the 
EHR as a time-saving tactic, amongst other reasons, which is a practice they encourage. The 
EHR only allows one user to be in the patient order screen at a given time. While this was not a 
new problem, it was amplified now that the pharmacists needed medication orders to be entered 
to initiate electronic dispensing in RxMAGIC. Previously, they could dispense items and enter 
them in the EHR later.    
During our observations, the pharmacists frequently had to find the physician and ask 
him/her to exit the patient’s order entry screen so that they enter orders and proceed with 
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dispensation. Because the physicians were not involved with the RxMAGIC deployment, they 
did not understand what had changed and that this was suddenly a problem. We realized that it 
was necessary to include all volunteer personnel of this organizational change, so the physicians 
were given a brief orientation on RxMAGIC and how it may impact the prescribing workflow. 
Specifically, they were instructed to enter medication orders as soon as possible, or exit the order 
screen in the patient’s EHR. This demonstrated the importance of all clinicians working 
cohesively in an organization to accomplish patient care. 
Implications of inaccurate stock counts 
There are many factors that caused inaccurate stock counts during the first weeks of deployment. 
First, due to the magnitude of medication items to be entered, there were opportunities for error 
in the data entry process (i.e. counting, transcription). Second, given the nature of a free clinic, it 
is not uncommon for pharmacists to dispense a few tablets of Ibuprofen, for example, to a patient 
who has a headache. Prior to RxMAGIC, these trivial dispensations had no major implications 
on inventory control. However, pharmacists learned the importance of accountability and 
recording all stock movement in RxMAGIC, which was a new aspect of their workflow. In 
addition to these challenges, some first-time users did not use RxMAGIC for every dispensation. 
For example, one pharmacist became overwhelmed during his/her first time using RxMAGIC 
and decided to dispense medications by hand and used RxMAGIC retrospectively once on-site 
care had ended.  
For these reasons, some stock quantities were incorrect in RxMAGIC, which caused 
users to distrust the automated inventory. In addition to this distrust, inaccurate stock quantities 
led to other challenges, such as the inability to electronically dispense from a bottle that has 
insufficient inventory. This is particularly frustrating when the pharmacist knows the that there is 
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physically enough inventory to dispense, but the stock quantity is incorrect in RxMAGIC. Thus, 
harmonizing physical stock counts with their automated representation continues to be a 
necessary component of the medication management process. While automation may have made 
the inventory more transparent, its benefits will not be fully realized if it is poorly maintained 
and inaccurate.  
Distrust in the automated inventory was evident as the pharmacists rarely utilized 
RxMAGIC when consulted by physicians to determine what is in stock. Initially, this lack of 
utilization was likely due to the novelty of RxMAGIC and its potential to inform discussions 
about stock availability. However, remarks made by the pharmacists during the focused 
debriefing uncovered that they do not feel comfortable relying on the automated inventory 
because it has been inaccurate in the past. As a result, they specifically requested that we do not 
show physicians how to access the inventory in RxMAGIC as originally planned. They were 
concerned that this access would hinder clinician communication and cause confusion around 
stock availability at the point of CPOE, potentially causing more incorrect medication orders. 
Further, the pharmacists stated that the physicians would likely prefer a higher-level overview of 
the medication inventory rather than an itemized description of each medication unit. It is 
possible that these concerns would have been realized and addressed if we included the 
physicians in the earlier contextual inquiry studies. However, at the time of this writing, 
RxMAGIC continues to be a pharmacist-facing application, with no plans of expanding its use to 
the physicians at the BFC.   
Assigning new responsibilities  
The introduction of a new system brings new tasks and responsibilities that did not previously 
exist. There were two situations that demonstrated the importance of defining new work tasks 
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and user roles, the first being how to handle the activity sheet. Previously, pharmacists would 
complete the handwritten activity sheet and leave it in a bin on the patient registration desk. The 
sheet would eventually be transported to the offices at UPMC Montefiore. Now that the activity 
sheet is automated, the AmeriCorps can access it from their computer at UPMC Montefiore. 
Some pharmacists continued to print the automated sheet while others assumed the AmeriCorps 
would print it at UPMC Montefiore, which created confusion for pharmacists and AmeriCorps 
alike. In a group meeting, the pharmacists decided that the AmeriCorps would be responsible for 
printing the document unless the pharmacist needed to add something to it (i.e. a non-medication 
item). 
Responsibilities were similarly confused when it came to removing expired medications 
from the stock cabinets. Pharmacy students typically accessed RxMAGIC to see which 
medications were expired and would then physically remove them from the stock cabinets. 
However, they would often forget to electronically delete those removed items from RxMAGIC. 
This caused problems when pharmacists were looking for certain medications in the stock 
cabinet that were listed as ‘well-stocked’ in RxMAGIC. Clarifying the responsibility of the 
pharmacy student to ensure that items are both physically and electronically deleted alleviated 
confusion around this task.  
5.2.3 Discussion 
Observing user interaction after deploying RxMAGIC proved the third corollary following the 
“Fundamental Theorem” to be true: whether the theorem holds depends on an interaction 
between person and resource, results of which cannot be predicted in advance [100]. Although 
the results from the earlier usability studies were helpful in alleviating potential interaction 
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challenges before deployment, new and different challenges were realized once RxMAGIC was 
in practice. It is unlikely that these challenges could have been identified and resolved before 
deployment, particularly those related to health data standards and interoperability. Similarly, the 
social components of system use, which exert strong influences on the technical components, 
may not have been predicted before in situ interaction.   
The benefits of using a reliable, rigorously structured standard vocabulary like RxNorm 
significantly outweigh the challenges uncovered in this study, especially as vendor EHR systems 
like EpicCare intend to use RxNorm in the future [73]. However, there are still some areas in 
RxNorm that could benefit from further refinement to improve its completeness such as 
maintaining accurate and current NDC-to-RxNorm mappings. The results from this study 
demonstrate that there are inconsistencies between the prescribable concepts in RxNorm and a 
vendor’s proprietary nomenclature, which is an area of caution that has been documented in the 
literature [68,69]. Likewise, the challenges we encountered associated with mismatched par 
levels highlights cases of synonymy or ambiguity in RxNorm; eliminating nonspecific terms is 
another area for improvement. Maintaining the completeness of RxNorm in addition to accurate 
NDC-to-RxNorm mappings is critical as RxNorm continues to expand its vocabulary, which 
would improve its utility in a setting like the BFC. 
In addition to problems associated with the adoption of health data standards, the results 
from this study demonstrate the importance of managing organizational change, which has both 
emotional and situational components. Although several pharmacists were involved in the 
planning and evaluation of RxMAGIC, its specific impact on people and processes in the BFC 
were difficult to predict before deployment. It was most surprising to observe this user distrust in 
the automated inventory and how that negatively affected the physician’s potential use of 
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RxMAGIC. While this result was unexpected, we believe that new user behaviors will emerge to 
enable the realization of RxMAGIC's potential to be helpful. However, these findings 
demonstrate that, although RxMAGIC has the potential to improve efficiency and time 
utilization, a problem impact study is required to determine its effects once it is in steady use. 
This study is discussed in Chapter 6. 
5.2.4 Conclusions 
While there were no significant design flaws that prohibited pharmacists and AmeriCorps from 
using RxMAGIC, the deployment process emphasized this notion of evolving user requirements 
and multiple levels of evaluation. It was important to prioritize bugs in the application before 
new feature requests so that RxMAGIC was successful in supporting dispensing tasks in 
practice. However, it was also important that new features were continually implemented to 
sustain innovation, which did not end with the conclusion of this study. At the time of this 
writing, we continue to make changes to RxMAGIC to further accommodate user needs and 
provide a resource that brings maximum value to the medication management services at the 
BFC.  
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6.0  AIM 3: PROBLEM IMPACT STUDY 
The results from the field-user effect study demonstrated that, however promising the results 
from the previous levels of evaluation, an impact study is necessary to determine the ultimate 
effects of RxMAGIC once rolled out into routine practice. RxMAGIC was and continues to be 
iteratively updated following deployment to accommodate the evolving needs of the pharmacists 
and AmeriCorps. For example, as requested by the pharmacists, a new report was recently 
implemented that summarizes dispensation information at the level of the medication item for 
any period of time desired by the user (i.e. daily, weekly, monthly). This report is intended to 
help the pharmacists understand consumption, discrepancies in prescribed versus dispensed 
items, and inform medication ordering. 
The field-user effect study was instrumental in understanding how RxMAGIC impacts 
user behavior in addition to identifying and resolving facilitators and barriers of success 
regarding RxMAGIC adoption. However, we were now interested in studying whether 
RxMAGIC successfully addressed the original problems for which it was designed. This is a 
problem impact study. Problem impact studies are similar to field-user effect studies in many 
aspects, but differ significantly in what is being explored. The original need that motivated the 
design of RxMAGIC was improved efficiency, specifically during the prescription preparation 
process (i.e. labeling). Thus, understanding changes in pharmacist time utilization was a driving 
factor behind the problem impact study.  
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RxMAGIC was designed in the context of a lean intervention, and we used many lean 
principles throughout this research. Time utilization is one metric of the lean value diamond, 
which is used to understand the impact of interventions on four metrics: time, quality, 
satisfaction, and financials [79]. These four metrics are inherently related and each metric affects 
the others in some way. We are interested in exploring how changes in time utilization, as a 
result of RxMAGIC, may impact the other three metrics of the lean value diamond. Although 
measuring time utilization was perhaps the biggest component of the problem impact study, we 
also directly measured the impact of RxMAGIC on the financial health of the BFC in addition to 
pharmacist satisfaction. Further, we used results from these evaluation components to understand 
potential changes in the quality of patient-centered services provided by the pharmacists. I 
discuss each of these separate evaluation components, and how they relate to one another, in the 
following sections. 
6.1 TIME UTILIZATION 
In Section 4.2 we conducted a pre-deployment time-motion study as part of the needs assessment 
(November 2014) to quantify pharmacist time investment in 12 tasks that comprise the 
dispensing workflow in the BFC; these are the baseline results for comparison (see 4.2). To 
measure changes in time utilization after deployment of RxMAGIC, we performed a post-
deployment continuous observation time-motion study once the system was judged to be in a 
steady state of use (February 2017). At that time, RxMAGIC had 21 active users (i.e. 
pharmacists, AmeriCorps, and pharmacy students) and was used daily in the dispensary for all 
clinic sessions and dispensations with no major problems. 
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The objective for this study was to measure changes in pharmacist time utilization to 
understand if RxMAGIC alleviated the challenges for which it was designed. Further, if time 
invested in non-value-added tasks decreased, we were interested in understanding how this time 
was redirected. Ideally, pharmacists would spend more time completing patient-centered, value-
added tasks.    
6.1.1 Methods 
To ensure the most accurate pre-post comparison, we attempted to mimic the parameters from 
the pre-deployment study. However organizational changes in the clinic made it difficult to 
reproduce all aspects of the pre-deployment study. Most notably was the type of clinic that was 
observed during data collection sessions. In the pre-deployment study, we collected data during 
Friday sessions, which includes a mix of general walk-in and scheduled MTM patients. Since 
this study, the clinic has reduced the amount of Friday clinic sessions due to difficulties 
scheduling an attending physician for this day. Thus, in the post-deployment study, data was 
collected during Wednesday afternoons, which is a clinic only available to nonscheduled walk-in 
patients. I will later discuss how the difference in clinic sessions affects the results of this study.  
The same researcher that assisted with the pre-deployment study helped with data 
collection for this study. This allowed us to each observe an independent pharmacist during 
observations. The University of Pittsburgh Institutional Review Board reviewed this study and 
approved it as exempt (PRO14020120). 
Codebook development and pilot study  
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The 12 task subcategories, or codes, used in the pre-deployment study were restructured to 
accommodate a new workflow that had evolved due to RxMAGIC implementation. These 12 
subcategories are grouped into five major workflow categories (e.g. Rx Preparation, EMR 
Operations, Clinician Interaction, Patient Interaction, Other). To maintain consistency with the 
earlier study, the five major categories were not modified, although a new major category was 
introduced (Inventory). New subcategories were introduced under the major categories to 
account for new workflow tasks, or to facilitate a more granular analysis due to limitations 
realized during analysis of the pre-deployment study. Similarly, subcategories that were no 
longer relevant were removed.  
 We conducted a pilot study to test the restructured codes for completeness and to 
calculate Cohen’s kappa to determine inter-rater reliability. Both researchers observed the same 
pharmacist for the duration of the pilot study and documented the amount of the he/she took to 
complete the coded tasks; these data were not included in the final analysis. Questions about the 
appropriateness of certain categorizations following the pilot study resulted in very minor 
changes to definitions in the codebook (Table 13).  
Table 13: Final codebook for the post-deployment time-motion study. Items in bold indicate new 
categories/subcategories as compared to the pre-deployment codebook. NVA = non-value-added, VA = value-
added. 
Major task category Minor task subcategory Value categorization 
Prescription (Rx) Preparation 
Hunting NVA 
Traveling NVA 
Rx Management VA 
Dispensing NVA 
Labeling NVA 
Inventory Inventory VA 
Clinician interaction 





PAP initiation VA 
PAP discussion VA 
EMR operations 
Patient care VA 
Order correction NVA 
Other Other NVA 
 
Data collection and analyses 
Each researcher observed a different pharmacist during data collection, which began 
approximately 30 minutes before the first patient appointment. This allowed researchers to 
document any pre-work tasks that, such as reviewing patient information in the EHR. Data 
collection continued through general care hours until onsite care was completed. Each session 
lasted roughly three hours.  
Data was collected using the Time Motion Study application (Graphite Inc., 
www.graphiteinc.com) for Android devices, which was the same application used in the pre-
deployment study. With this software, we created a list of motions, i.e. subcategories, to track 
pharmacist activity. Timing began as soon as the task was selected and ended upon selection of a 
new task. Data was recorded in comma separated value (CSV) files where each row summarized 
the duration of a single motion selection. We used RStudio 0.98 (RStudio Inc., 
www.rstudio.com) and R 3.1 to analyze the total time invested in each subcategory, and hence 
each major category, over the entire dataset. Bar charts were created to help visualize these data. 
Additionally, like the pre-deployment study, we used these data to calculate the value quotient 
for each dataset. 
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6.1.2 Results 
Cohen’s kappa for the pilot session was found to be κ = 0.651, which indicates substantial 
agreement between raters. The codebook used in the pilot study was the same codebook used 
during data collection. Time-motion data was collected during three independent clinic sessions 
in February 2017 for a combined total of approximately 16.5 hours (not including the pilot study 
data). Two pharmacists were observed during two of the three clinic sessions. Due to scheduling 
changes, only one pharmacist was observed during the third data collection session in addition to 
a pharmacy student. Because their roles differ in the clinic (pharmacist and student), the data 
from the student observation is analyzed and reported separately. Thus, the overall dataset 
represents approximately 13.5 hours of observation, and the student dataset is approximately 3 
hours of observation.   
The final codebook (Table 13) for the post-deployment study includes 14 subcategories 
clustered into six major categories; the new category ‘Inventory’ does not include any 
subcategories. In addition to Inventory as a new major category, there are few differences 
between the pre/post codebook, which are indicated in Table 13. Two changes have been made 
to Rx Preparation: 1) the subcategory ‘duplicate documenting’ was removed as a result of 
automation; 2) ‘Rx Management’ was introduced as a subcategory, which describes the 
pharmacist’s use of RxMAGIC to dispense prescriptions. Further, the ‘EMR Operations’ 
category now includes two subcategories to allow for a more granular analysis. Previously, this 
category did not contain any subcategories, and it was difficult to distinguish value-added from 
non-value-added time regarding EMR usage. To address this, two subcategories were introduced 
(patient care and order correction) to categorize this distinction. Lastly, some subcategory 
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definitions were modified to accommodate the new workflow. The complete codebook, 
including definitions and initiation/termination protocols, is in Appendix G.  
 I describe the results as they compare to those from the pre-deployment time-motion 
study. Figure 19 shows the percent total time invested in each of the five main categories, which 
are deconstructed into their associated subcategories for the entire post-deployment dataset (13.5 
hours). Figure 20 compares the percent total time invested in the shared workflow categories as 
they pertain to the pre- and post-deployment studies. The category ‘Inventory’ that was 
introduced in the post-deployment study is not included in Figure 20. Changes in time utilization 
between the pre- and post-study are also shown in Table 14.   
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Figure 20: Comparing time investment by major task category between the pre- and post-deployment studies. 
 
Table 14: Comparing percent total time investment between the pre- and post-deployment studies. 
Subcategories followed by (+) are new to the post-study; subcategories followed by (-) have been 
eliminated in the post-study. 
Workflow categories Pre (% total time) Post (% total time) 
Rx Preparation 39.8 16.6 
Hunting 4.8 1.5 
Traveling 2.3 2.1 
Dispensing 7.3 2.3 
Labeling 21.8 3.8 
Rx management (+) -- 6.9 
Duplicate documenting (-) 3.6 -- 
EMR Operations 14.80 23.1 
Patient Care (+) -- 21.0 
Order Correction (+) -- 2.1 
Clinician Interaction 21.50 19.3 
Consulting 8.0 7.9 
Teaching 13.5 11.4 
Patient Interaction 18.70 5.5 


























PAP discussion 0.2 0.1 
Counseling 17.7 5.4 
Inventory (+) -- 16.4 
Other 5.2 19.2 
Prescription preparation 
Post-deployment, pharmacists invested 16.6% (SD = 6.3) of their time into preparing 
prescriptions for dispensation, which has decreased from 39.8%. This category includes five 
subcategories: traveling (2.1%), hunting for medication in stock cabinets (1.5%), dispensing 
medication (2.3%), automated labeling (3.8%), and Rx management (6.9%). Apart from Rx 
management, which is a new subcategory, the percent total time invested in each subcategory has 
decreased post-deployment. The most significant decrease was noted in the labeling task 
(previously 21.8%), which can be attributed to RxMAGIC use. Although ‘Rx management’ 
consumed the largest proportion of pharmacist time within prescription preparation, the 
pharmacists categorized it as a value-added task because of the impact it has had on all other 
tasks, particularly labeling. Further, this task essentially replaced ‘duplicate documenting,’ which 
consumed 3.6% of pharmacist time in the pre-deployment study. All other tasks in this category 
remain classified as non-value-added.  
EMR operations 
The results indicate that pharmacists spent 23.1% (SD = 4.9) of their time using the EMR 
compared to 14.8% pre-deployment. Difficulties in classifying EMR operations as value-added 
or non-value-added in the pre-deployment study required a more granular depiction of the tasks 
that comprise this category. As a result, EMR operations includes two subcategories: patient care 
(20.97%) and order correction (2.12%). Patient care included activities such as reviewing patient 
information and pending medication orders, which are tasks the pharmacists considered to be 
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value-added. Order correction, however, is a non-value-added task. This task is related to 
challenges with CPOE and occurred when the pharmacist had to correct a medication order in 
the EMR for a variety of reasons that may be unique to this setting (i.e. the physician indicated a 
refill).  
Inventory 
Pharmacists invested 16.4% (SD = 11.2) of their time managing the inventory within 
RxMAGIC, which is a category that did not exist in the pre-deployment study. This primarily 
included the entry and labeling of new medication items. Although components of this task may 
be non-value-added, like harmonizing automated stock quantities with physical counts, the 
pharmacists identified this task as value-added because it is necessary to utilize the dispensing 
component.  
Clinician interaction 
Clinician interaction consumed approximately a fifth (19.3%; SD = 11.4) of pharmacist time. 
This value is comparable to the pre-deployment study, which was 21.5%. Clinician interaction 
included clinician consultation (7.9%) and teaching students and/or other volunteers (11.4%). 
These tasks were both considered to be value-added.  
Patient interaction 
The amount of time pharmacists invest into patient interaction has decreased from 18.7% to 
5.5% (SD = 3.8) post-deployment of RxMAGIC, which is a value-added category. This category 
was primarily comprised of patient counseling, as the PAP initiation and discussion categories 
consume a trivial amount of time, 0.0009% and 0.1%, respectively. Thus, the reduction can be 
attributed to a decrease in the amount of time invested in patient counseling, which has fallen 
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from 17.7% to 5.4%. The pharmacy student observation data, collected during the third clinic 
session, can potentially describe this discrepancy. Figure 21 shows that the students invested a 
third of their active time (12.93%) counseling patients. These results demonstrate that, during 
walk-in clinics, the pharmacy students do most of the patient counseling, and may explain the 
decrease in the time pharmacists invested in this subcategory.  
 
Figure 21: Percent total time invested by pharmacy student. 
Other 
Pharmacists invested 19.15% (SD = 8.2) of their time in this category, which has increased from 
5.2%. In the pre-deployment study, tasks that were classified as ‘other’ included using the 
restroom or casual conversation. In the post-deployment study, however, in addition to using the 
restroom and casual conversation, new tasks were classified as ‘other’ that did not have a 
specific code because these behaviors were not noticed previously. For example, we noticed that 




















Although this is a value-added task, we classified this major category as non-value-added to 
maintain consistency with the pre-deployment study.  
Value quotient  
Based on the value categorizations made by the pharmacists, the value quotient for the entire 
dataset is 69.6% (Table 15). However, it is likely that this is a conservative calculation because 
other tasks, which comprised 19.2% of pharmacist time, were considered non-value-added. The 
overall value quotient may be greater if our analysis of ‘other’ tasks was more granular, as some 
of these tasks were value-added. These values have increased from the pre-deployment study, 
where the range was 40.3% - 54.8%, indicating that the amount of value-added time in the 
dispensary workflow has increased.  
Table 15: Value quotients for each dataset. 







This study evaluated how RxMAGIC use affected time utilization by pharmacists. We found that 
compared to the pre-deployment results, RxMAGIC reduced the amount of time pharmacists 
invest in non-value-added tasks, thereby making these tasks more efficient. Further justifying 
this claim, the results indicated that the pharmacists spend 70% of their time completing tasks 
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they consider to be value-added. Possibly having the largest impact on this value is the decrease 
in time invested in the prescription preparation category, which has decreased by more than half. 
This change can be attributed to the nearly tenfold decrease in the total time invested in the 
labeling process, as the differences in the other subcategories are trivial in comparison. The tasks 
in this category were the main drivers of inefficiency at the clinic [103], specifically the labeling 
process, and RxMAGIC was designed to reduce waste and maximize efficiency of these tasks. 
In an unstructured interview with the pharmacists following the study, they stated that the 
results met their expectations. They expected to see a significant decrease in labeling, and minor 
decreases in dispensing and hunting, as RxMAGIC has improved the efficiency by which they 
determine which medications they have in stock. However, although RxMAGIC provides a 
means for checking the stock quantity of a medication, the pharmacists reported that they will 
continue to physically check the inventory in addition to RxMAGIC. It is a typical pharmacy 
behavior to check both the physical and automated inventory. This behavior also encourages the 
pharmacists to continually harmonize physical counts with those in RxMAGIC.   
Although it is a value-added task, the amount of time that pharmacists invested in the 
inventory category is surprising. Apart from the initial data entry that was done when RxMAGIC 
was deployed, the AmeriCorps typically receive all medication (both PMAP and general stock) 
to their office at UPMC Montefiore. Medications are entered into the inventory and labeled at 
Montefiore before they are brought to the clinic, thus inventory entry is not a primary task for the 
pharmacist. The pharmacists also agreed that the proportion of time invested in inventory was 
unusual, and that they rarely enter medication items into the inventory. They explained that, 
during the first two clinic sessions, a large donation of dermatology samples had just been 
delivered to the clinic as opposed to Montefiore. Although this is not the typical workflow, the 
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pharmacists entered these medications into the inventory themselves, which explains the 16.4%. 
During the third data collection session, the pharmacist invested under 1% of his total time in 
this category, which further justifies the 16.4% as atypical behavior. This also justifies the value 
quotient being less for this clinic session compared to the others (63.5%).  
It is also important to note that entering items into the inventory is an asynchronous task. 
That is, it is a flexible task that can be completed independently of all other tasks; it is not time-
sensitive or necessary to dispense medication and counsel patients at the time of its completion. 
On the contrary, the activities described in Rx Preparation are synchronous tasks in that they 
must be completed before moving on to another task. These tasks are time-sensitive and many 
other activities are dependent on their timely completion such as patient counseling. It is likely 
more important to provide workflow efficiencies for synchronous tasks compared to 
asynchronous tasks, as efficient synchronous tasks will provide more flexibility in a workflow to 
complete other potentially asynchronous tasks.  
Time spent in direct patient care activities such as counseling patients decreased post-
RxMAGIC implementation, which is a disappointing result. However, conversations with the 
pharmacists justified this decrease as being unrelated to RxMAGIC use. The pre-deployment 
study was conducted during Friday afternoon clinic sessions. On these days, the clinic sees a mix 
of both MTM and nonscheduled walk-in patients. MTM patients are scheduled to see only the 
pharmacist and do not have a typical physician examination before receiving their medications. 
These patients receive extensive counseling on their disease state, lifestyle decisions, and other 
medication-related needs [5,31,112]. MTM patient encounters are different than walk-in patient 
encounters because the pharmacist is the only clinician the patient will see that day, thus they are 
inherently more time-intensive [31]. At the BFC, the attending pharmacist or resident will 
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counsel all MTM patients. For general walk-in patients, however, the pharmacy students do most 
of the counseling as it is more straightforward; this is a teaching opportunity for the pharmacists 
[113]. These patients have already met with the attending physician and understand what 
medications are being prescribed that day, so the patient interaction is expected to be less for 
walk-in patients. This was the case in the post-deployment study which was conducted on 
Wednesdays. Thus, differences in clinic type influence the level and type of pharmacist-patient 
interaction, which justifies the discrepancy in the pre/post results.  
The amount of time pharmacists spend doing ‘other’ tasks has increased, which was also 
discussed with the pharmacists following the study. Again, this difference can be partially 
attributed to the difference in clinic types. There are typically a wide variety of patient 
encounters during walk-in clinics. These patients may have never been to the clinic before, so 
pharmacists may take more time to investigate their disease state by consulting the literature. 
Pharmacists also make greater use of the EHR to understand patient history, a value-added task, 
which may explain the increase in EHR operations post-deployment. The observational data 
further supports this claim. This behavior was not noticed in the pre-deployment study, however, 
as MTM patients have been coming to the clinic for months and the pharmacists are familiar 
with their disease state; this time is instead spent counseling. While there were likely other 
unrelated job activities that were classified as ‘other’, researching a patient’s disease state and 
looking for inexpensive medication alternatives were prominent tasks. 
6.1.4 Limitations 
The difference in clinic days is an obvious limitation of this study. Amongst other organizational 
changes at the BFC (between 2014 and 2017), this made it difficult to statistically compare the 
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pre/post results. We were unable to conduct the time-motion observations during Friday clinics 
because the BFC does not always have a scheduled attending physician, which affects the 
volume of the patient population. Although observing MTM encounters would have made for a 
more accurate pre/post comparison, it was more important to observe how RxMAGIC use affects 
time utilization when there is a large volume of patients. We recognize that collecting data 
during MTM encounters may have increased the amount of pharmacist-patient interaction, which 
would have also improved the value quotient. The student data and further discussions with the 
pharmacists helped put the post-deployment results in perspective, particularly in regard to 
patient interaction and inventory entry.  
It could be useful to understand changes in the amount of time invested per patient, 
however these data were not collected previously. This would allow for greater comparisons 
across the pre/post results, although the difference in clinic days observed would have also 
affected these data and their implications. The effect of continued experience is also not 
explicitly evaluated in this study. RxMAGIC may affect time differently depending on the level 
of experience with the system. However, of the two pharmacists observed, one had been using 
RxMAGIC since its deployment and the second was a new resident. Although the variability 
between these two pharmacists was not measured, the observational data confirmed that both 
pharmacists easily navigated the system, and that differences in experience did not affect time 
utilization.  
6.1.5 Conclusions 
This component of the problem impact study focused on how RxMAGIC use affects pharmacist 
time utilization. We conclude that, compared to the pre-deployment results, RxMAGIC has 
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decreased the amount of time pharmacists invest in tasks they consider to be non-value-added. 
RxMAGIC has addressed the problems for which it was designed (i.e. reducing waste in 
labeling, documentation, etc.) and improved the value quotient, which indicates improvement in 
workflow efficiency. This study demonstrates that RxMAGIC introduces value-added hours into 
the dispensary workflow, which is a claim further justified by the pharmacist. While the results 
do not describe how the pharmacists redirect this additional time, the observational data 
confirmed that new patient-centered behaviors have evolved. Further studies are needed to 
understand these new behaviors and how RxMAGIC affects other aspects of the lean value 
diamond. 
6.2 QUALITY 
The results from the time-motion study demonstrate that RxMAGIC has had a positive impact on 
pharmacist time utilization. As a result, it is possible that pharmacists redirect additional time 
toward other activities, specifically those that are patient-centered. Many of these benefits are not 
quantifiable in the context of the time-motion study, nor are they in the scope of this research. 
For example, reduced wastage of medication due to expiry, as RxMAGIC prioritizes 
dispensation of medications closest to expiry. However, the literature strongly supports that 
improved time management and the elimination of tasks that have little or no financial value can 
enhance the quality of services provided [112,114–116], which is why ‘quality’ is included in the 
lean value diamond. Quality is defined as the degree to which healthcare services increase the 
likelihood of desired health outcomes [117]. Thus, although we did not directly measure changes 
in health outcomes, the improvement of pharmacist time utilization may correlate with improved 
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outcomes. Data from the time-motion study in addition to unstructured interviews with 
pharmacists following the study informed potential changes in the quality of services provided. 
In free clinic settings, patient counseling and MTM services have been correlated with 
improved medication adherence and patient outcomes [5,31,118,119]. Study results indicate that 
enhanced patient-pharmacist interactions can increase adherence from 37% to 81% for 
respiratory therapies and from 67% to 92% for cardiovascular therapies, as well as reduce first-
fill abandonment by 90% [120]. First-fill abandonment occurs when a patient receiving a chronic 
medication fails to fill his/her prescription after the first month’s supply. This may be due to 
financial limitations, a lack of understanding of the chronic condition, or limited availability of 
healthcare services. Similarly, the National Association of Boards of Pharmacy reports that 
counseling by pharmacists increased the adherence rate of elderly patients taking three or more 
medications by 43% and of patients suffering from heart failure by 46% [121]. These improved 
adherence rates are of obvious benefit to patients in regard to better medical outcomes and fewer 
trips to the hospital, which could result in cost savings for patients and providers alike [122]. 
Although the results of the time-motion study may not reflect enhanced pharmacist-patient 
interaction, the pharmacists report that the dispensing process is safer and more standardized. 
Further, due to efficiency gains during the dispensing process, the pharmacists feel that patient 
counseling is no longer rushed, and that they have ample time to discuss proper medication use 
with patients. As new behaviors continue to evolve, the pharmacists may have additional time to 
dedicate to patient-centered tasks. 
Also contributing to this notion of ‘safer’ dispensing procedures is the use of computer-
generated prescription drug labels (as compared to the handwritten labels used previously). The 
Institute of Medicine (IOM) cited poor or illegible medication labeling as a central cause of 
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medication errors [123,124], as it may lead to miscommunication of medication information and 
poor patient outcomes. A study has shown that 33% of all medication errors are attributed to 
packaging and label confusion [125]. This is further exacerbated in a population with poor health 
literacy and multiple chronic conditions [5,7,8], as these patients may take more medications 
which can lead to increased mistakes and decreased medication recall [126,127]. Improving the 
legibility of drug labels (i.e. electronically-generated labels) can have the same effect on 
reducing medication errors and improving the quality of patient safety as e-prescribing has 
[123,124,128,129]. Further, the use of a standardized nomenclature to clearly and effectively 
communicate a drug product to patients via prescription labels is important [123]. The literature 
suggests that dispensing pharmacies utilize health IT that is integrated with the prescribing 
system to complete and print labeling components. This could reduce variability in formatting 
and the risk that medication directions become lost in conversion [124,126]. Thus, because of the 
reasons listed here, it is likely that RxMAGIC has improved the legibility and standardization of 
drug labels, which may improve medication adherence at the BFC.  
Observational data from the time-motion study also indicates potential improvements in 
the quality of services provided. As discussed previously, there was an increase in the amount of 
time pharmacists invest in completing ‘other’ tasks. The pharmacists reported that this is time 
they did not previously have, which makes this increase a representation of the time savings 
potentially created by RxMAGIC. Several behaviors were noticed during the time-motion study 
that were classified as ‘other.’ For example, pharmacists spent more time consulting the 
literature to understand a patient’s disease state. They often compared different medication 
therapies and researched less expensive alternatives for patients. The pharmacists also researched 
and discussed the importance of receiving the appropriate vaccinations before traveling abroad. 
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Further, one pharmacist, who was not observed in the time-motion study, reported that she now 
sits-in on the clinical encounter with the physician as time permits, which she was not able to do 
as frequently at the BFC pre-RxMAGIC implementation. While many of these behaviors cannot 
be directly attributed to RxMAGIC, it is likely that that its use has created additional time that 
can be redirected toward value-added tasks [112] such as patient interaction and inventory 
maintenance.  
In addition to changes in the quality of services provided, the pharmacists also report an 
improvement in their quality of work life. The pharmacists used to come to the clinic an hour 
before on-site care began to prepare medications for dispensation. Similarly, they used to leave 
nearly an hour after on-site care has ended (and the physicians have left) to finish counseling 
patients and complete any remaining paper documentation. Post-RxMAGIC implementation, the 
pharmacists reported that they no longer feel the need to complete pre-work tasks and that they 
are able to leave when on-site care has ended. Further, the BFC has noticed a decrease in their 
turnover rate of pharmacist volunteers. Previously, pharmacists were hesitant to volunteer 
because the dispensing process was labor-intensive and overwhelming. Post-RxMAGIC 
implementation, pharmacists are more eager to volunteer because the workflow is more efficient 
and less stressful. I further elaborate upon quality of work life in the next section.  
6.3 SATISFACTION 
The post-deployment time motion study quantified the impact of RxMAGIC on pharmacist time 
utilization, however it did not evaluate the pharmacists’ perceptions of the system and their new 
workflow. Although the results indicate that RxMAGIC has improved pharmacist efficiency, 
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they do not provide any insight on user experience or perceived utility. If RxMAGIC supports 
achievement of certain tasks, but fails to impact higher level expectations such as job 
satisfaction, user acceptance will be variable. Ensuring that the pharmacists find RxMAGIC 
useful and important are necessary to facilitate its continued adoption. It is important that the 
pharmacists find value in using RxMAGIC so that they want to use it to support their medication 
services.  
To measure the perceived usability of RMAGIC, we customized the previously validated 
Health Information Technology Usability Evaluation Scale (Health-ITUES) [130,131]. Health-
ITUES was developed as a customizable questionnaire to subjectively evaluate usability of 
informatics tools and various health IT characteristics. The questionnaire includes 20 items 
grouped into four question domains: quality of work life, perceived usefulness, perceived ease of 
use, and user control. We chose this questionnaire because it measures perceptions as they 
pertain to different levels of user expectation, all of which are included in Nielsen’s five facets of 
usability [93]. Quality of work life represents higher expectations of system impact, whereas 
perceived usefulness refers to the pharmacists’ perception of RxMAGIC’s ability to help them 
preform their job better [131,132]. Both user control and perceived ease of use capture user-
system interaction, the ease by which users can recover from errors and how difficult RxMAGIC 
is to learn in relation to its benefits, respectively [131,132].  
6.3.1 Methods 
We customized the Health-ITUES to address the type of tasks that pharmacists are expected to 
perform while using RxMAGIC. Each questionnaire item was motivated by a pharmacist user 
story so that they were tightly coupled to the functions and benefits originally desired by the 
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pharmacists (Table 16). The questions were randomly sorted so that they were not grouped 
together by the four domains described above. Pharmacists were asked to rank their agreement 
with each statement on a scale of 1 to 5 where 1= “Strongly Disagree” and 5= “Strongly Agree.” 
The survey was administered using Qualtrics, which is a Web-based service that allows you to 
create a survey, collect and store data securely, and analyze responses (Qualtrics Inc., 
http://www.qualtrics.com/). Mean scores and their standard deviations were calculated for each 
statement. The University of Pittsburgh Institution Review Board approved this study as exempt 
(PRO17020591). No personally identifiable information was collected as part of the 
questionnaire. 
Following completion of the time-motion study, the clinic director emailed the survey 
link to the core pharmacist distribution list. Recipients were instructed to only participate in the 
survey if they have used RxMAGIC at the clinic. The survey link was active for one month 
(March 30, 2017 – April 30, 2017). The AmeriCorps member was not invited to complete the 
survey as the statements focused on pharmacist use of RxMAGIC. We conducted an 
unstructured interview with the AmeriCorps staff member to understand her perceptions of 
RxMAGIC and how it has affected inventory management.  
6.3.2 Results 
The questionnaire was sent to pharmacist volunteers after the system was in steady use for five 
months. Of the 15 pharmacists on the core pharmacist distribution list, 11 pharmacists responded 
to the survey (73%), which represented the active users at that time. Overall, the pharmacists 
agreed/strongly agreed that RxMAGIC is both useful and easy to use, with mean scores of 4.47 
and 4.31, respectively. Further, pharmacists perceived that RxMAGIC has had a positive impact 
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on their quality of work life (4.79); all participants agree that RxMAGIC has been a positive 
addition to their medication management services. Pharmacists were more neutral in regard to 
user control (3.61). For the purposes of discussing these results, both ‘agree’ and ‘strongly agree’ 
indicate a positive response, and ‘disagree’ and ‘strongly disagree’ are negative.  
In regard to perceived usefulness, pharmacists were generally satisfied with RxMAGIC 
for making their workflow more efficient (10/11, 91%, Q.8). They found it particularly useful for 
efficiently producing complete and legible prescription labels (11/11, 100%, Q.12) and providing 
a more standardized process for dispensing medication (10/11, 91%, Q.7). Pharmacists were 
mostly in agreement with their increased ability to focus on patient-centered tasks (8/11, 73%, 
Q.5), with one participant disagreeing with this statement. The most variation in participant 
responses in this dimension was noted in statements related to improved inventory control, with 
Q.11 having the only mean score less than 4. Less than half of pharmacists perceived that 
RxMAGIC makes it more likely they ensure an uninterrupted drug supply (5/11, 46%, Q.11), 
with five pharmacists indicating neutral agreement and one pharmacist disagreeing with this 
statement. There was a similar distribution for Q.9. Most pharmacists were in agreement-to-
neutral that RxMAGIC clarifies current stock availability (10/11, 91%, Q.9); one pharmacist 
disagreed with this statement.  
Table 16: Summary of the Health-ITUES results. 
Statement Mean (SD) 
Quality of work life 4.79 (0.05) 
1. It has been a positive addition to the medication management services.  4.82 (0.39) 
2. It is an important part of our dispensary services.  4.73 (0.45) 
3. It has been a positive addition to the Birmingham Clinic. 4.82 (0.39) 
Perceived usefulness 4.47 (0.41) 
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4. It makes it easier to dispense medication and manage stock levels.  4.64 (0.48) 
5. It increases my ability to focus on patient-centered tasks.  4.00 (0.95) 
6. It enables me to produce labels during dispensation more quickly. 4.82 (0.39) 
7. It provides a more standardized process for dispensing. 4.64 (0.64) 
8. I am satisfied with it for making my workflow more efficient.  4.45 (0.66) 
9. It helps me understand current stock availability.  4.18 (1.03) 
10. I label dispensed medications in a timely manner. 4.82 (0.39) 
11. It makes it more likely that I ensure an uninterrupted drug supply.  3.73 (1.05) 
12. 
It is useful for efficiently producing complete and legible prescription 
labels.  
4.91 (0.29) 
Perceived ease of use 4.31 (0.23) 
13. It is easy for me to become skillful at using it.  4.64 (0.48) 
14. I can always remember how to log on and use it.  4.27 (0.96) 
15. I find it easy to use. 4.36 (0.64) 
16. I am comfortable with my ability to use it. 4.27 (0.62) 
17. Learning to use it has been easy for me. 4.00 (0.74) 
User control 3.61(0.73) 
18. It provides error messages that clearly tell me how to fix problems. 2.82 (0.83) 
19. I recover easily and quickly if I make a mistake using it.  3.73 (0.62) 
20. It provides clear information (i.e. stock counts, activity sheet).  4.27 (0.86) 
 
The pharmacists positively perceived the system’s ease of use. It was a bit more difficult 
to evaluate the pharmacists’ perception of system learnability. While all participants agreed that 
it is easy to become skillful at using RxMAGIC (11/11, 100%, Q.13), only 73% of pharmacists 
agreed that learning to use RXMAGIC was easy (8/11, 73%, Q.17). However, no participants 
disagreed with this statement. Only one participant disagreed with a statement in this dimension, 
that he/she can always remember how to log on and use RxMAGIC, with most pharmacists 
supporting system memorability (9/11, 82%, Q.14).  
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The statement receiving the lowest mean score was in the user control dimension. While 
most pharmacists were in neutral agreement (6/11), some pharmacists did not think RxMAGIC 
provides clear error messages that tell them how to fix problems (3/11, 27%, Q.18). However, 
most pharmacists agreed that they easily recover after making a mistake using RxMAGIC (7/11, 
64%, Q.19), with the remaining participants indicating neutral agreement.  
In addition to the questionnaire, we conducted an unstructured interview with the 
AmeriCorps to ensure all user perceptions were evaluated. The AmeriCorps does not have access 
to the dispensing functionality in RxMAGIC but is responsible for ensuring the clinic is 
sufficiently stocked with medications. The responses were overly positive in regard to how 
RxMAGIC has improved the medication ordering and restocking process, the PAP reordering 
process, and overall time management. The AmeriCorps claimed to use all stock features in 
RxMAGIC daily, especially the par level feature that allows users to identify medications that 
are understocked. Further, the report that summarizes which PAP medications need to be 
reordered each week is the most helpful. Previously, the AmeriCorps had to scan a several page 
excel spreadsheet to identify which medications were to be reordered. This process was 
incredibly time intensive and would sometimes consume a day’s work. Overall, the AmeriCorps 
perceptions of RxMAGIC were generally positive, which is supported by this direct quote: 
“I’m really quite fond of it [RxMAGIC], and I think it’s so useful. It makes my 
job easier and faster, I get things done more quickly and feel like I use it a lot, 
even if I don’t need to. I don’t know how we did things before it, honestly.” 
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6.3.3 Discussion 
The Health-ITUES subjectively evaluated pharmacists’ perceptions of RxMAGIC as they relate 
to different dimensions of usability: quality of work life, perceived usefulness, perceived ease of 
use, and user control. Analysis of the questionnaire shows that the pharmacists had a positive 
perception of three of the four dimensions, with user control being the only dimension receiving 
a mean score less than 4. Overall, these results indicate that pharmacists found RxMAGIC to be 
useful for improving their workflow efficiency, particularly tasks related to medication labeling, 
and providing a more standardized process for dispensing. Further, they perceived it to have had 
a positive addition to their dispensary services and are satisfied with its ease of use.  
The pharmacists’ perceptions of usefulness of RxMAGIC were slightly higher than their 
perceptions of ease of use, albeit not by much. The latter may be attributed to the turnover rate of 
volunteers at the BFC, especially in regard to remembering how to log on and use the system. Of 
the pharmacists who volunteer at the BFC and responded to this survey, most of them are 
frequent volunteers and use RxMAGIC several times a week. However, some volunteers are 
more infrequent, and may only have used RxMAGIC once or twice before completing this 
survey. Thus, the different levels of pharmacist experience with using RxMAGIC may have 
contributed to the variation in responses related to memorability and learnability. Regardless of 
varying levels of experience, the mean scores in this dimension indicate strong usability related 
to these two facets of usability. Moreover, a significant body of literature on technology 
acceptance suggests that perceived usefulness more strongly predicts intention to use and actual 
use of technology than perceived ease of use [132–134].   
While the results regarding perceived usefulness were generally positive, the variation of 
responses related to inventory management were surprising. It is clear that the pharmacists find 
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RxMAGIC to be most useful for producing complete and legible labels in a timely manner, 
however the potential benefits RxMAGIC could have on improving inventory control are not as 
realized. There are several factors that may contribute to this. First, managing inventory at the 
level of individual units of dispensation is a new task for the BFC pharmacists, and one that is 
still being learned and optimized after only five months of system use. Second, it is possible that 
some pharmacists, particularly those that don’t volunteer as frequently, find this task to be more 
burdensome than beneficial. As discussed in Aim 2, inaccurate stock counts in RxMAGIC 
prohibit the user from dispensing medication from that bottle, even if the bottle physically has 
sufficient stock. The frustrating task of harmonizing the physical and automated counts may 
hinder other inventory benefits provided by RxMAGIC. Lastly, as stock management is one of 
the AmeriCorps’s primary responsibilities, its benefits may not be realized by the pharmacists 
that responded to this survey. The qualitative feedback from the AmeriCorps supported this 
claim.  
It is difficult to assess the pharmacists’ perceptions of user control due to the variation in 
responses. User control concerns the ease by which a user can correct or navigate back from an 
error [135]. It is somewhat difficult to make an error that is realized by RxMAGIC. For example, 
a user can dispense a medication that does not match the name of the prescribed medication; 
RxMAGIC does not currently check to ensure the medication names match before dispensing. 
This was done intentionally and in agreement with the pharmacists. If the user does make this 
error, they can easily void the dispensation and correct the mistake (i.e. recover easily and 
quickly, Q. 19), however RxMAGIC does not provide an error message. RxMAGIC provides 
few error messages altogether, which may explain the number of neutral responses to this 
statement (6/11, 55%, Q.18). We recognize that the error messages RxMAGIC does provide are 
 155 
somewhat unclear, as they are the result of a bug in the application that has been difficult to 
understand. This has been discussed multiple time with pharmacists at the BFC. We continue to 
investigate this problem with the goal of alleviating incorrect error messages. 
6.3.4 Limitations 
It may be difficult to generalize these results to other settings as RxMAGIC was developed in 
collaboration with the BFC. However, we did not personally train all pharmacists that responded 
to this survey, and they may have little free clinic experience, yet the results indicate strong 
learnability and efficiency. The sample size may also limit the generalizability of the results, but 
it is a representative sample of the population of volunteer pharmacists.   
6.3.5 Conclusions 
The results of the usability questionnaire are generally positive and indicate that RxMAGIC 
addresses Nielsen’s five facets of usability (i.e. learnability, efficiency, memorability, errors, and 
satisfaction) [93]. Pharmacists claimed that learning to use RxMAGIC was easy, they found it to 
be useful for the tasks it was designed, they were satisfied with its ability to improve workflow 
efficiency, they remembered how to log on and use it, and they recovered quickly and easily 
from mistakes. Optimizing these usability factors early in the design process was important to 
ensure user acceptance, which has contributed to the overall success of RxMAGIC.  
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6.4 COST 
Reforming the US healthcare delivery system to improve the quality and value of care is 
essential to address increasing costs and the number of Americans without health insurance 
coverage. Although often debated, economic assessments are necessary components of 
evaluation because they can support decision makers in prioritizing interventions, allocating 
resources, and maximizing value [136]. Among the four metrics of the lean value diamond, 
demonstrating a decrease in costs associated with improved benefits may be the most difficult, as 
there are ethical issues regarding the monetization of health outcomes [136,137]. For example, 
critics of economic evaluations in healthcare believe that these methods hide assumptions about 
the goals of treatment, the selection of treatment, and the role of the patient [137]. These factors 
play an important role in healthcare delivery and should not be ignored even when providing 
patient care, regardless of the cost-benefit tradeoff.  
Moreover, many argue that willingness-to-pay methods, which determine the maximum 
amount an individual or healthcare organization is willing to sacrifice to accrue a desired benefit, 
is unethical as it assigns a value to human life. Many believe this value can be influenced by 
income level, age, or pre-existing conditions (i.e. should we assign greater value to a child’s life 
than an elderly adult?) [137]. In the unique case of a free clinic, it is even more difficult to assign 
costs to items that are donated, such as medication and clinician time. Thus, a cost-benefit 
analysis (CBA), which monetizes both the costs and benefits of an intervention, is often difficult 
to perform in healthcare; cost-effectiveness analysis (CEA) are more commonly used [138–140]. 
Both CBA and CEA assign monetary values to all project costs. However, a CEA is 
distinct from a CBA because the benefits are not monetized, but rather measured as a single 
unidimensional outcome such as illnesses prevented or years of life gained [141,142]. CEA 
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studies may be appropriate when there is only one type of physical outcome that is sought as a 
result of the intervention. The CEA is typically expressed in terms of a ratio where the 
denominator is a gain in health from a measure expressed in physical units and the numerator is 
the cost associated with that health gain. Because the numerator and denominator are 
incommensurable, they cannot be added or subtracted to obtain a single value. Therefore, CEA 
studies provide a source of unbiased information that offers insight into the tradeoffs and 
consequences of certain choices. CEA data is not, however, sufficient for making complex 
resource allocation decisions because it cannot incorporate all of the values that may be 
important (i.e. equity, feasibility, or overall budgetary impact) [143]. 
Many CEA studies compare the costs and health effects of prospective new interventions 
with current practice in that area. Evaluating the economic impact of open-source solutions is 
difficult because the costs incurred for development are one-time costs, while all subsequent 
adoptions of the solution can use the existing source code for free. The availability of free and 
ready-made components can significantly reduce or eliminate software development costs, 
depending on how future implementers utilize the source code. While development costs may be 
eliminated, it is likely that a second implementation site will incur greater costs for deployment 
and training as these tasks will not be tightly coupled to the development process. These costs 
may include downloading and customizing the source code for use in a particular setting. It is 
difficult to estimate these costs for a novel open-source solution that has yet to be implemented 
in a second site.  
To explore potential cost savings as a result of utilizing open-source software, we 
performed a CEA of implementing RxMAGIC in the BFC and from the perspective of a second 
free clinic. The costs used in the model describing the BFC implementation accurately depict the 
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costs incurred to develop and deploy RxMAGIC at the BFC. The second CEA model describes 
the cost-effectiveness of RxMAGIC as a prospective new innovation from the perspective of a 
second implementation site. We assumed that the second site utilizes the freely available source 
code, thereby eliminating the cost for development from this model. I describe the assumptions 
used in both models below.  
6.4.1 Methods 
We created two models to demonstrate the CEA of RxMAGIC usage: the first model is from the 
perspective of the BFC and the second is from the perspective of a subsequent implementation 
site. The primary outcome measure for both models was cost per additional hour of value-added 
time during a one-year period. A one-year time horizon was chosen because all expenditures and 
benefits are realized in the near-term. The models were framed from the perspective of the 
healthcare organization, and the reference strategy was their previous paper-based dispensing 
process.  
6.4.1.1 The BFC implementation 
Costs 
There are two categories of costs associated with RxMAGIC implementation: direct 
implementation costs and operational costs (Table 17). Direct implementation costs are those 
related to all means of production that are used to implement the system (i.e. hardware, software 
development, and deployment); indirect costs are not included in this model (i.e. administrative 
support). Operational costs are those related to the ongoing use and maintenance of the 
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intervention, such as materials and technology support. These figures accurately reflect the costs 
incurred to develop, deploy, and support RxMAGIC at the BFC and are based on receipts of 
purchase.  
Table 17: Costs of RxMAGIC used in BFC implementation model. 
Items Quantity Unit cost Base Value 




     Dashboard monitor 1 $             190.00 $                     190.00 
     Thermal label printer 2 $               53.14 $                     106.28 
     Barcode scanner 2 $               14.50 $                       29.00 
     Raspberry pi 1 $               30.00 $                       30.00 
     Server 1 $          1,210.00 $                  1,210.00 
Computer  0 $             350.00 $                         0.00 
Development  400 hours $               44.60 $                17,840.00 
Deployment 20 hours $               44.60 $                     892.00 





     Dispensed labels 9,100 $              0.008 $                       78.91 
     Inventory labels 1,040 $               0.008 $                         9.02 
Printer ribbon 7 $                 5.52 $                       38.23 
Power supply 
  
$                       30.00 
Training and support 15 hours $              44.60 $                     669.00 
Operational Costs $                     825.16 
Total Costs   $                21,112.44 
 
Hardware costs were calculated to be $1,565.28 for the implementation at BFC. We 
decomposed the hardware costs into their individual components for transparency. The hardware 
acquired for the BFC implementation included: one 19.5-inch dashboard monitor with a HDMI 
signal input, two Zebra TLP 2844 thermal label printers, two Symbol Motorola LS2208 barcode 
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scanners (with interface cable and stand), one Raspberry Pi 2 Model B, and an application server 
(custom core i5 Mini-ITX computer) to host RxMAGIC at the BFC.  
We purchased most hardware items ‘used’ and in bulk from eBay or Amazon, which 
significantly decreased the hardware costs overall. The BFC already had two laptop computers in 
the dispensary that were donated by UPMC during the EHR implementation, which is why the 
cost for a computer is listed as $0.00 in this model. We included this item as a direct 
implementation cost because we recognize that a clinic may need to purchase computers to 
utilize RxMAGIC. The pharmacists wanted to access RxMAGIC from both computers, thus we 
decided to set up two RxMAGIC workstations (i.e. two printers, two barcode scanners, etc.). 
Development costs, calculated to be $17,840.00, included the costs of developing 
RxMAGIC, establishing interoperability to the EHR, and periodic system upgrades. We did not 
keep a rigorous timetable of the hours invested to develop RxMAGIC; in addition to an estimate 
given by the actual RxMAGIC developer, we based this figure on the expert opinions of two 
open-source software developers with access to the RxMAGIC source code on GitHub. We 
concluded that development of RxMAGIC consumed 10 weeks of work (40 hours/week) at 
$44.60/hour, which was the actual hourly wage of the RxMAGIC developer. We used the same 
hourly rate to calculate the cost of deployment, which included installing hardware at the clinic 
and inventory data entry. This figure was based on the total time invested in the three-phase 
deployment process described in Aim 2.  
The cost of labels used per year was calculated to be $88.00, which includes both 
prescription labels and inventory labels. This figure was based on the average number of 
dispensations per day, which was obtained from RxMAGIC, and the average number of 
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inventory labels used per week. The cost of printer ribbons used per year was calculated to be 
$38 and based on the total number of labels used per year (i.e. one ribbon = 1464 labels).  
The cost for powering the new hardware was nominal at $30.00 and was calculated using 
the Appliance Energy Calculator at energy.gov (https://energy.gov/energysaver/maps/appliance-
energy-calculator). Training and support costs, calculated to be $669.00, included 15 hours of 
change management, user training, and ongoing maintenance and support. We assumed the same 
hourly rate for the calculation of this figure.  
Benefits 
The outcome measurement was additional hour of value-added time. This figure was calculated 
based on differences in the value quotient between the pre- and post-deployment time-motion 
studies. The value quotient describes the percentage of value-added time in a workflow. For the 
purposes of this calculation, we used the lower bound of the value quotient range for the pre-
deployment study (40.3%). The difference in value-added time between the pre- and post studies 
is 0.3 hour per hour of value-added time, or 18 minutes value-time gained per hour. Based on 
data from the BFC, we assumed that there are 364, 3 hour clinics per year. However, two 
pharmacists were independently observed during each clinic session in the time-motion studies. 
Each dataset per clinic observation was approximately 6 hours, thus we assumed each clinic is 6 
hours to reflect two working pharmacists. The benefits were calculated to be 728 additional 
value-added hours per year; this figure was used in both models. The calculation used to arrive at 














6.4.1.2 Subsequent implementations 
It is difficult to generalize the results described in the BFC implementation for several reasons. 
First, while the development costs were substantial in this model, they were a one-time cost and 
will not be incurred at this magnitude for a subsequent implementation because RxMAGIC is an 
open-source solution. Thus, assuming a second implementation site utilizes the freely available 
source code, development costs should not be a factor from the perspective of a new free clinic. 
Second, given the collaborative nature of this project, software development was tightly coupled 
to the deployment and training processes. Many of the pharmacist users were involved in the 
development of the system which may have reduced the amount of training needed during 
deployment. It is likely that the costs for deployment and training/support will be greater for 
subsequent implementations. This may include downloading and customizing the source code for 
a particular setting and establishing interoperability with existing systems. These costs will vary 
depending on the existing health IT infrastructure in a second implementation site. Third, the 
hardware costs used in the BFC model may not be generalizable because we purchased them in 
‘used’ condition and in bulk. This greatly reduced the cost for the thermal label printers and 
barcode scanners. Thus, the condition of the hardware purchased and the quantity of items 
needed may influence the CEA for a second site.  
We attempted to capture this variation in a second model that describes the cost-benefit 
tradeoff from the perspective of a second implementation site. In this model, we assumed that the 
site requires one unit of each piece of hardware, as if they are setting up one RxMAGIC 
workstation (i.e. one monitor, one printer, one barcode scanner, etc.). The base values for 
hardware items in this model represent the expected cost for purchasing each item in new 
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condition. We estimated these figures based on the current value of hardware items on Amazon 
and similar sites.  
  
Table 18: Costs of RxMAGIC used in subsequent implementations model. 
Items Quantity Unit cost Base Value Range 





     Dashboard monitor 1 $        190.00 $             190.00 $     0.00 – 249.00 
     Thermal label printer 1 $        389.99 $             389.99 $        0.00-780.00 
     Barcode scanner 1 $          89.00 $               89.00 $        0.00-178.00 
     Raspberry pi 1 $          30.00 $               30.00  
     Server 1 $     1,500.00 $          1,500.00 $     0.00-3,000.00 
Computer  0 $        350.00 $             350.00 $     0.00-1,000.00 
Deployment 40 hours $          44.60 $          1,784.00 $ 892.00-3,568.00 
Direct Implementation Costs 







$   43.97 – 175.86 
     Dispensed labels 9,100 $         0.008 $               78.91  
     Inventory labels 1,040 $          0.008 $                 9.02  
Printer ribbon 7 $            5.52 $               38.23 $        19.12-76.46 
Power supply 
  
$               30.00  
Training and support 30 hours $         44.60 $          1,338.00 $669.00–2,676.00 
Operational Costs $          1,493.93  
Total Costs   $          5,826.92  
 
Costs 
Hardware costs were calculated to be $2,198.99 for the model describing subsequent 
implementations. We assumed a quantity of one for all items in this model; the costs represent 
the hardware items in ‘new’ condition. Perhaps the greatest component of variation in these costs 
 164 
is the quantity of items an implementation site will need to utilize RxMAGIC. In the sensitivity 
analysis, the costs of items were varied to reflect changes in quantity, with a quantity of two 
being the most items needed for implementation. These values are in the last column of Table 18. 
The lower bound of all hardware items is $0.00 because it is possible that a clinic may already 
have the appropriate hardware, like the laptops at the BFC. This is particularly relevant for items 
such as the dashboard monitor, which is not a necessary item to utilize RxMAGIC.  
The upper bound for each hardware item in the sensitivity analysis was varied to 
represent a clinic needing a quantity of two of each item, which was 200% of the baseline cost. 
For the dashboard monitor, the upper bound represents a 23-inch screen as opposed to the 19.5-
inch screen, which is captured in the base value. A larger screen may be appropriate for a clinic 
that has a larger dispensary or more space between the workstations. For the server, we estimated 
the base value to be $1,500.00, however there is much variation in this cost depending on the 
sophistication of the server that is acquired. Further, if a clinic already has a dedicated server, or 
is able to use a virtual server for the entire application at no direct cost to them, then there may 
not need be a need for a server altogether. This is represented in the lower bound in the 
sensitivity analysis. Likewise, for computers, we estimated that one computer may cost a clinic 
$350.00. There is also much variation around this cost that depends on the current hardware in 
the clinic, the sophistication of the computer that is purchased, or the quantity needed. We 
attempted to demonstrate how this variation effects the CEA in the sensitivity analysis, however 
all upper bound values are estimates. 
The cost for development is not included in this model as those costs are not a factor for a 
second implementation site. However, because of the factors described above, we have doubled 
the cost for deployment in the second model ($1,784.00). This figure includes customization, 
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installing hardware, interfacing with other systems, and periodic system upgrades. Similarly, we 
have doubled the cost for training and support in the second model ($1,338.00). We expect that 
these costs will be greater for a second implementation site as they are not tightly coupled to the 
development process. As these values are estimates and not based on evidence, we varied these 
costs from 50% to 200% of the base value in the sensitivity analysis.  
 Apart from changes to training and support, all other operational costs remained the same 
in the second model. We varied the cost of labels and printer ribbons from 50% to 200% of the 
base value as these figures may change depending on the patient volume at a second 
implementation site.   
Sensitivity analysis  
To understand which parameters have the greatest influence on the outcome, we performed a 
one-way sensitivity analysis using the ranges shown in Table 18. This is a deterministic 
sensitivity analysis in which the input parameter is varied across the indicated range of values, 
while other input variables are held constant. The CEA ratio was calculated twice for each 
parameter using the minimum and maximum values in Table 18 as inputs. A tornado diagram is 
used to depict the results of the sensitivity analysis, where each bar depicts the overall effect on 
the CEA ratio.  
6.4.2 Results 
In the one-year CEA model for the BFC implementation, the cost per additional hour of value 
added time was $32.25. This ratio directly reflects the cost-benefit tradeoff experienced at the 
BFC. As expected, costs for development were the most significant in this model. The CEA ratio 
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for the second model was $8.90 for each additional hour of value-added time; this figure is more 
generalizable from the perspective of a second implementation site as development costs were 
eliminated. The model was most sensitive to variations in server costs, which ranged from $6.61 
to $11.19 (Table 19, Figure 22). Variations in deployment costs had the second largest effect on 
the CEA ratio ($7.53-$11.62). The model was least sensitive to variations in costs for printer 
ribbons and labels, in which the CEA ratio ranged from $8.87 to $8.95 and $8.83 to $9.03, 
respectively. Variations in most parameters did not have a large effect on the CEA ratio. We 
show the range of CEA ratios as they pertain to each cost included in the sensitivity analysis 
(Table 19).    
Table 19: CEA ratios for items varied in the sensitivity analysis.  
Item CEA Lower Bound CEA Upper Bound 
Printer ribbons $                       8.87 $                        8.95 
Labels $                       8.83 $                        9.03 
Barcode scanner(s) $                       8.76 $                        9.03 
Dashboard monitor $                       8.61 $                        8.99 
Thermal label printer(s) $                       8.30 $                        9.49 
Computer(s) $                       8.36 $                        9.89 
Training and support $                       7.88 $                      10.94 
Deployment $                       7.53 $                      11.62 




Figure 22: Tornado diagram showing the one-way sensitivity analysis of one-year CEA model. Each bar depicts the 
overall effect on the model as that input is varied across the indicated range of values, while other inputs are held 
constant. The vertical line indicates the base case ($8.90). 
6.4.3 Discussion 
This analysis demonstrates the potential cost savings of using open-source software, which is an 
important part of this research. While the CEA ratio for the BFC implementation is $32.25 per 
additional hour of value-added time, it is nearly $25 lower from the perspective of a second 
implementation site ($8.90). We report this value because it is more generalizable, as it assumes 
use of the freely available source code, which is an important component of this innovation. 
Further, the sensitivity analysis indicates that the CEA ratio is relatively stable across a wide 
range of assumptions. This is particularly important as it is difficult to estimate costs for 
hardware items, which may vary depending on the condition of the item or the quantity needed. 
This is evident in the model describing the BFC implementation, where the costs for printers and 











scanners are significantly reduced. Likewise, as RxMAGIC has not yet been utilized by a second 
free clinic, it is difficult to estimate customization, deployment, and training costs. The model is 
robust in that the CEA ratio does not deviate far from the base value when the upper bounds of 
the deployment and training costs were considered. We expect these costs to be the most variable 
for a second implementation site. 
The main objective of this CEA analysis is to provide unbiased information about an 
implementation scenario so that interested free clinics can reproduce this model and understand 
potential cost implications. The sensitivity analysis includes appropriate ranges for variations in 
cost of hardware components, however there could be even greater variation than what is 
represented in this model. For example, the BFC had two computer workstations in the 
dispensary thus requiring two printers and two barcode scanners. The amount of equipment 
needed to support RxMAGIC in a different setting can vary based on the quantity needed and the 
status of the purchased equipment (i.e. new or used). Purchasing used equipment may 
significantly reduce the amount of implementation costs, which is important in a low-resource 
setting.  
It is also important to note that many of the system costs included in this model are one-
time costs, meaning that they will only be incurred at the time of implementation. While we only 
developed the model for a one-year time horizon, it is likely that the CEA ratio would improve in 
consecutive years as the benefits will remain constant but the costs will decrease. Only 
operational costs will be relevant in consecutive years, which are trivial in this model, thus 
potentially overestimating the CEA ratio in both scenarios. Many models typically include the 
cost for replacing hardware every three years, in which case those costs would be incurred 
repeatedly over a longer time-horizon. Further, this model does not include costs for a potential 
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network installation or establishing a data feed from an EHR, which should be considered if this 
model is to be reproduced.  
Given the nature of a CEA, the benefits described in this model are unidimensional. It 
may be difficult to interpret what additional hours of value-added time means in this setting. The 
goal of RxMAGIC was to improve workflow efficiency so that pharmacists had increased time 
to focus on other tasks, particularly those that are more patient-centered. The results from these 
evaluations demonstrate significant time savings, however how that additional time is redirected 
is not as clear. There is a significant body of literature that discusses the importance of pharmacy 
involvement in direct-patient care to improve medical outcomes and decrease associated costs 
(i.e. hospitalizations and emergency department visits) [112,120–122], and particularly how 
effective, time-saving health IT can contribute to this goal [144]. Pharmacy staff can be 
redirected in a free clinic setting to serve more patients or just improve their existing interactions. 
Thus, there are many other potential areas of cost savings associated with implementing an 
intervention such as RxMAGIC that are not included in this model. These savings may include, 
but are not limited to, avoidable drug waste [145], transcription errors [146], and improved 
medication adherence [122]. 
Not all benefits of RxMAGIC are measurable in financial terms: other benefits include 
improved quality of work life and quality of care, reduced medical errors, and better access to 
information of good quality [147,148]. The latter has been found to improve decision-making 
and reduce physical and cognitive workload in a community pharmacy setting [42,148]. A CEA 
analysis is only one component of a complete evaluation of the effects of implementing 
RxMAGIC in this setting. These data alone are not sufficient for making complex allocation 
decisions as they do not consider all values that are likely important such as feasibility or overall 
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budgetary impact. Total budget impact tends to be of importance for technologies in general, but 
especially in a free clinic setting where resources are already limited. The majority of a free 
clinic’s budget is dedicated to procuring essential medicines for their patients, which is why a 
low-cost intervention that may result in savings can be beneficial.  
6.4.4 Limitations 
This CEA study has several limitations, most of which are covered in the context of the 
discussion. There may be other costs associated with implementation of RxMAGIC. For 
example, system integration costs (i.e. receiving electronic prescription data from an EHR) may 
be significant at other free clinics and are not included in this model. However, benefits can 
likely be realized even without this component. Likewise, the cots for deployment and training 
may be even greater than what is included in this model. It is difficult to estimate these costs as 
this is a novel open-source solution that has yet to be implemented in a second setting. 
Interpreting the results of a CEA can be difficult because there are many other factors that 
contribute to the decision-making process, such as budget impact, which may impact the 
generalizability of these results. Similarly, it is difficult to estimate an organization’s willingness 
to pay as it pertains to RxMAGIC, which is the maximum amount they are willing to sacrifice to 
accrue the benefits described.  
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6.5 CONCLUSIONS 
The results from Aim 3 describe the impact of RxMAGIC in situ as it pertains to the four metrics 
of the lean value diamond: time utilization, quality, satisfaction, and cost. Each component of 
this comprehensive problem impact study provides a different perspective on how RxMAGIC 
has effected the BFC. Together, these studies show that RxMAGIC has addressed the original 
problems that motivated its creation.  
The pre- and post-deployment time-motion study demonstrates a quantified improvement 
in pharmacist workflow efficiency, in which pharmacists spend less time completing non-value-
added tasks such as labeling and documenting. These results are further supported by the Health-
ITUES questionnaire results, that indicates pharmacists perceive RxMAGIC to be useful for the 
tasks it supports and an overall positive impact on their dispensary services. The implications of 
time savings are addressed in Section 6.2, which discuss potential improvements to the quality of 
services provided. Although we cannot explicitly claim that RxMAGIC has improved the 
pharmacist-patient relationship, it is possible that pharmacists will redirect time savings to focus 
on more patient-centered tasks, thereby resulting in improved medication outcomes. We attempt 
to compare the benefit of this additional value-added time with the cost of implementing 
RxMAGIC in Section 6.4. These benefits are described in the context of the BFC 
implementation in addition to the perspective of a second implementation site; the results from 
the latter are of greater interest as they are more generalizable for subsequent adoptions. While 
the study has several limitations, these results aim to provide information about a potential cost-
efficiency tradeoff because of RxMAGIC.  
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7.0  DISCUSSION AND FUTURE WORK 
This dissertation describes the process used to design, develop, and evaluate RxMAGIC, a 
dispensary management information system, as guided by Friedman and Wyatt’s evaluation 
framework [17]. We have used a combination of studies and methods to support the system 
development process, beginning with a needs assessment and ending with a problem impact 
study. While RxMAGIC is the obvious physical contribution of this research, the approach 
described in this research demonstrates the importance of user-centered design principles, health 
informatics standards, and multiple levels of evaluation. With this approach, we were able to 
achieve the three specific aims we set out to achieve in Section 3.3:  
 
AIM 1: To design a production version of RxMAGIC and evaluate it in a laboratory setting. 
• We proposed an initial framework for RxMAGIC based on a careful understanding of the 
specific workflow challenges encountered in the BFC. 
• We developed a prototype version of the system and tested its usability with potential 
users to guide its continued development. 
• We used these results to expand and improve the prototype version of RxMAGIC and, 
again, tested its usability with actual pharmacists from the BFC.  
AIM 2: To identify and resolve post-deployment implications related to system design and 
workflow organization.  
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• We deployed aspects of RxMAGIC in two locations (UPMC Montefiore and the BFC) 
and trained all users. 
• We performed a field-user effect study to understand how pharmacists interact with 
RxMAGIC in practice, and identified and resolved both functional and organizational 
challenges. 
AIM 3: To evaluate the impact of RxMAGIC in the clinic within the framework of the lean 
value diamond.  
• We performed a post-deployment time-motion study to measure changes in pharmacist 
time utilization. 
• We used these results to infer potential changes in the quality of care provided. 
• We administered the H-ITUES to understand pharmacists’ perceptions of the perceived 
usefulness and ease of use of RxMAGIC. 
• We assessed the cost-effectiveness of RxMAGIC in terms of additional hours of value-
added time as a prospective new intervention being considered for implementation by a 
free clinic.  
7.1 NEEDS ASSESSMENT AND USABILITY 
We began by qualitatively understanding the pharmaceutical workflow at the BFC and the 
specific challenges that pharmacists encounter in the dispensary. Having identified a set of 
workflow challenge themes, we quantified their impact on pharmacist time utilization to help 
prioritize intervention design and provide a baseline for post-deployment comparison. We used 
these data to map workflow challenges to individual interventions, which informed the initial 
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framework of a dispensary management information system, or RxMAGIC. We used a 
prototype-and-test approach to ensure the prototype had the potential to meet pharmacists’ needs, 
and used these results to modify the design and expand the prototype. The production version 
was evaluated for usability in a laboratory-based environment and these results continued to 
inform changes to the system before deployment.  
7.2 DEPLOYMENT AND FIELD-USER EFFECT 
To prepare for deployment, health data standards including RxNorm and HL7 messaging were 
implemented to achieve functional and semantic interoperability with the EHR at the clinic. 
RxMAGIC was deployed in the BFC dispensary in October 2016 and inventory components 
were deployed in UPMC Montefiore. At the time of this writing, RxMAGIC has 21 distinct users 
and is used daily at the BFC (approximately 5,000 dispensations to date). On average, 
pharmacists dispense 25 prescriptions per clinic and the inventory includes nearly 800 stock 
entries (approximately 300 distinct medications).  
In the week following deployment, we performed a field-user effect study to understand 
barriers to successful adoption. These challenges were classified as either functional or 
organizational. Functional challenges were related to the design and content of the system; these 
were mostly focused on problems with interoperability. Organizational challenges were those 
related to people, workflow organization and communication. While challenges were resolved in 
the context of this study, we continue to make changes to RxMAGIC so that it brings the most 
value to the dispensary services.  
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7.3 PROBLEM IMPACT 
Once RxMAGIC was in steady use, approximately four months after its deployment, we 
evaluated its impact on the four metrics of the lean value diamond: time utilization, quality, 
satisfaction, and cost. We used a combination of evaluation methods including a time-motion 
study, usability evaluation survey, and economic analysis. The results demonstrated that 
RxMAGIC has addressed the problems uncovered in the needs assessment studies. Specifically, 
it has improved workflow efficiency and the amount of time pharmacists invest in value-added 
tasks by streamlining the dispensing process. Per the H-ITUES results, pharmacists perceived 
RxMAGIC to be both useful and easy to use, having a positive impact on their dispensary 
services. We discussed how improvements in pharmacist time utilization can result in improved 
patient outcomes such as medication adherence. Lastly, we assessed the economic impact of 
RxMAGIC as an open-source solution as it relates to efficiency gains from the perspective of a 
free clinic. Together, these results proved that RxMAGIC has effectively met the pharmacists’ 
needs at the BFC, which can be attributed to the comprehensive process that was employed to 
create it.   
7.4 FUTURE WORK 
This research uncovers many potential areas of inquiry that future work could explore. Perhaps 
the most obvious direction for this research is to understand the generalizability of RxMAGIC in 
other free clinic settings. Although we do not intend to use the RxMAGIC source code for 
commercial purposes, we have filed an invention disclosure with the University of Pittsburgh 
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Innovation Institute. Our goal is to acquire an open source license that is approved by the Open 
Source Initiative (OSI). In brief, a license would allow our program to be freely used, modified, 
and shared; technically, we cannot call RxMAGIC “Open Source” if we do not have an approved 
license. At the time of this writing, we are still in the early phases of the licensing process. 
We have been exploring potential possibilities for implementation both domestically and 
internationally. Recently, as part of a collaboration with a non-profit, non-governmental 
organization called Shoulder to Shoulder, we have forked the original RxMAGIC code to create 
an independent and distinct application for a primary care clinic in rural Honduras. This version 
of the application runs on a touchscreen workstation and primarily utilizes dispensing and 
inventory features based on those in the original system. We were unable to use RxNorm in this 
implementation because it could not sufficiently support the medications used in this setting; this 
has proved to be challenging and further emphasizes the importance of health data standards and 
interoperability. In addition to the collaboration in Honduras, we have been contacted by a 
physician from Healthcare for the Homeless in Houston, Texas who is interested in using 
RxMAGIC in their pharmacy. We are currently in discussions with several people from this 
group as they attempt to establish interoperability with EpicCare in their clinic.   
There are several ways in which RxMAGIC can be improved and expanded. The process 
of therapeutic interchange has been shown to decrease drug expenditures and other related 
healthcare costs [149,150]. Therapeutic interchange is the practice of replacing, with the 
prescribing physician’s approval, a prescription medication originally prescribed with a 
chemically different medication [149]. RxMAGIC could accommodate this process by providing 
preferred medications as a guide for dispensing when alternative medication products are 
available to treat a patient’s condition. This could be particularly useful in a low-resource setting 
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that serves patients with poor medication adherence. The suggested alternative medication may 
be more convenient for patients to take. For example, the medication could be less expensive, 
cause less side effects, or only need to be taken twice a day rather than for times a day. 
Implementing this type of therapeutic substitution process could improve RxMAGIC’s 
generalizability and utility from the physician’s perspective. Likewise, RxMAGIC could 
incorporate a process that detects potential prescriptions errors in regard to drug-drug 
interactions (DDI) or drug dosing. Given the limited formulary in a free clinic setting, research is 
needed to understand what types of DDIs are most relevant in this setting.  
The implementation of RxNorm in this setting is another avenue of future research. Many 
studies have evaluated RxNorm in ambulatory electronic prescribing to understand its 
completeness [67,68]. Further, some studies have evaluated the content of prescribing errors 
from the perspective of the community pharmacist, however they may not focus on challenges 
with RxNorm [42,46,148]. To my knowledge, there is little research done on the use of RxNorm 
in a free clinic setting or in a pharmacy dispensing system. The implementation of RxNorm in 
RxMAGIC at the BFC can allow researchers to assess the completeness of the vocabulary, the 
success rate of NDC-to-CUI mappings, and its ability to effectively support pharmacists’ needs 
and intents in a dispensing system. This could be an interesting research area as RxNorm 
continues to be widely adopted by enterprise EHR systems, which may have implications on 
dispensing systems in community pharmacies. Further, as we were unable to use RxNorm in the 
Honduras application, establishing some form of standard terminology for use in international 
settings is certainly an area of interest from the perspective of global health informatics. 
Other potential research ideas can leverage the consumption data in RxMAGIC. After 
one year of use, RxMAGIC could provide a decent dataset summarizing dispensation patterns in 
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a medically vulnerable population. Although the BFC does not dispensed controlled substances, 
this type of data could be useful in understanding prescribing patterns and potentially 
investigating drug use and addiction if implemented in a setting that does dispense narcotics. 
Medication consumption data is also useful for inventory modeling, which can have a significant 
impact on reducing pharmaceutical expenditures. Effective pharmacy stock modeling is 
particularly important in developing countries where stockouts are frequently encountered and 
can have severe detrimental effects on patient care (i.e. poor outcomes and drug-resistance). 
Thus, as evidenced by the Honduras implementation, there is certainly a place for RxMAGIC in 
resource poor areas of the world.  
7.5 CONCLUSIONS 
This work has been motivated by challenges in the free clinic dispensing process, as articulated 
by the BFC pharmacists prior to the beginning of this work, by Friedman and Wyatt’s evaluation 
methods, and by the fundamental theorem of biomedical informatics. The obvious physical 
contribution of this research is RxMAGIC, an interoperable, web-based resource that is designed 
to streamline the dispensing process and improve inventory control in a low-resource dispensary.  
RxMAGIC is novel in that it was designed with user-centered principles to effectively 
meet the needs of pharmacist in these settings; it is comprised of problem-driven interventions 
that directly link to the challenges they are designed to alleviate; it is able to support multiple 
user groups including pharmacists, AmeriCorps, and physicians by providing visibility into the 
clinic’s formulary; it is an open-source program (pending licensing) that lends itself to 
customization; and it is capable of electronically receiving e-prescriptions from a vendor 
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enterprise EHR system. We believe that the process employed to create RxMAGIC has 
significantly contributed to its success at the BFC. Further, we think it holds high potential for 
improving processes associated with medication management in a free clinic setting that enable 
pharmacists to provide the best care possible.  
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APPENDIX A 
SEQUENCE MODEL FROM QUALITATIVE INQUIRY 
The sequence model decomposes all workflow activities into their individual tasks. The activity 
is described as having an intent (i.e. goal), trigger (i.e. what initiates the task), and an abstract 






Intent: Prepare ‘General’ 
prescription to be dispensed. 
 
Trigger: Clinician places a 
medication order (non-PAP). 
 
Abstract Strategy: To 
expedite the process, 
pharmacist prepares 
medication orders for patients 
with chronic conditions prior 
to clinician examination. 
T1. Scan EMR dashboard to see if 
patient status has changed. 
T2. Receives prescription 
information in EMR. 
T3. Scans stock cabinets for 
medication. 
B1. Clinician failed to update 
patient status after examination. 
B2. The dispensary does not 
have the prescribed medication. 
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Intent: Prepare PAP 
medications to be dispensed. 
 
Trigger: An PAP patient has 
checked in at the clinic and 
has met with the pharmacist. 
T1. If patient is a monthly 
scheduled patient, then pharmacist 
has a one-on-one counseling session 
with the patient in an exam room. 
T2. Medications are retrieved from 
PAP cabinet. 
T3. Medication labels are prepared 
and taped on top of previous labels. 
T4. Medications are dispensed 
immediately to patient (patient only 
requires clinician examination every 
three visits). 
B3. PAP medications have not 
been re-ordered. 
B4. Patient was due for an 
annual program re-enrollment 
but paperwork has not been 
processed. 
Intent: Discuss new 
medication plan with 
clinician. 
 
Trigger: Clinician prescribes 
a medication that the 
dispensary does not have. 
 
Abstract Strategy: 
Pharmacist feels comfortable 
determining a new treatment 
plan for the patient without 
consulting the clinician 
T1. Find clinician in the clinic 
during clinic session. 
T2. Consult clinician to discuss the 
problem. 
T3. Determine new treatment plan 
with clinician. 
T4. Scan medication cabinets for 
new medication. 
T5. Correct EMR entry to adjust for 
the new order. 
 
B5. Pharmacist must leave 
his/her workspace to interrupt a 
clinician while he/she is with a 
new patient. 
B6. Clinician does not 
remember all the details from a 
recent patient and must refer to 
EMR. 
B7. The prescribed medication 
is required and patient must buy 
the medication from 
community pharmacy. 
B8. EMR order correction 
process is cumbersome and 
time-consuming. 
Intent: Dispense medications. 
 
Trigger: Patient prescriptions 
are prepared and ready to be 
filled 
T1. All medication stock bottles are 
located and retrieved from cabinets. 
T2. New patient-medication bottles 
are retrieved from drawers. 
T3. Pharmacist counts the pills to 
be dispensed. 
T4. Pills are filtered into new 
medication bottles. 
T5. Medication labels are written 
and affixed to bottles. 
 
B9. There are not enough pills 
in the current stock bottle. 
B10. The pharmacist 
miscounted and needs to start 
over. 
B11. There is an error 
transcribed on the medication 
label and it must be re-written. 
B12. Wrong medication label is 
taped on the medication bottle 
 182 
Intent: PAP application 
initiation. 
 
Trigger: A patient qualifies 
for prescription medication 
from a pharmaceutical 
manufacturing company. 
T1. Pharmacist explains the PAP 
application process to the patient. 
T1. Pharmacist locates correct PAP 
application. 
T2. Patient fills out required fields. 
T3. Pharmacist and patient discuss 
what materials the patient must 
bring in to receive the medication 
(i.e. W2 form). 
T4. Application is placed in a bin to 
be processed. 
 
B13. There are no copies of the 
correct PAP application. 
B14. Patient is unable to 
provide income documents. 
Intent: Complete the 
Pharmacy Activity Sheet. 
 




Pharmacists complete the 
document throughout the 
clinic session. 
T1. Pharmacist retrieves new 
document from a binder. 
T2. Pharmacist transcribes 
dispensed medication information 
from that clinic session to the form. 
T3. Transcribes low inventory 
alerts to the proper section of the 
form. 
T4. Deposits form in specified 
outgoing bin located in the check-in 
room. 
B15. There are no copies of the 
Pharmacy Activity Sheet. 
B16. Pharmacist forgets to 
transcribe low-inventory 
medication. 
B17. There is insufficient time 





ARTIFACT MODELS FOR QUALITATIVE INQUIRY 
Two artifact models were created during the qualitative inquiry. The first is a replication of the 
handwritten prescription label pharmacists affix on patient bottles. These labels adhere to 
dispensing laws within the state of Pennsylvania. Each field is explained in the figure below. 
  
Medication Label 
Rx#: Prescription identifier 
number continually 
increments between clinic 
sessions. 
Lot #: This is used to identify 
dispensed prescriptions in the 
situation of a medication recall. 
Medication: The name and 
strength of the medication is 
listed here. 
3X Carbon Copies: One 
copy issued to patient on 
medication bottle, one 
copy saved in clinic for 
dispensation records. 
Directions: This field is used 
to describe how and when to 
take the medication. Some 
medications require patient to 
split capsules in half, which is 
specified here. 
Manufacturer: This field 
is only relevant if the 
patient is receiving a 
PMAP prescription.  
Clinic: Pharmacists write 
‘Birmingham Free Clinic’ 
on every label. 
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The second artifact is a copy of the activity sheet. This is completed at the end of each clinic 
session and describes each dispensation that day in addition to any low-stock medications that 
need to be replenished. Completion of this document adheres to certain regulations for free 
clinics in Pennsylvania. An example is shown on the first line of the sheet. All fields are 
described in the model below.  
 
 
Pharmacy Activity Sheet 
Stock meds.: This section of 
the document is to report low 
inventory for ‘General’ 
medications. However, 
pharmacists often list PMAP 
medications here, which 
causes confusion in the supply 
chain.  
Source of Today’s Meds: 
This field is used to specify if 
a patient received medications 
from the ‘General’ cabinet, 
PMAP medication, a sample 
brought in by a clinician, or a 
borrowed medication from 
another PMAP patient. This 
may occur if a patient’s 
medication hasn’t arrived yet 
and another patient has a 
larger stock remaining. 
PMAP Med Orders: 
Pharmacists specify if a 
PMAP medication needs to be 
re-ordered in this field. Also, 
pharmacists use these boxes to 
request a dose change or a new 
PMAP med. 
Comments: This box is used 
to communicate the status of a 
PMAP application to the 
offices at UPMC Montefiore.  
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APPENDIX C 
CODEBOOK FOR PRE-DEPLOYMENT TIME-MOTION STUDY 
Category Subcategory Definition Value definition 
Rx Prep Hunting for medication 
The physical search for stock medication in the 
cabinets.  
Begin: When pharmacist slides open cabinet 
door to initiate search.  
End: When pharmacist closes the door and/or 






The manual process of writing individual 
medication labels for patient bottles.  
Begin: When pharmacist starts writing on a 
label.  
End: When pharmacist finishes taping the label 






Explaining medication and administration 
instructions to patient during dispensation.  
Begin: When pharmacist calls patient into the 
dispensary.  
End: When patient exits the dispensary. 
VA 
EMR EMR operations 
Any time spent in the EMR (i.e. entering & 
correcting orders, retrieving patient information, 
managing patient status).  
Begin: When pharmacist turns to the computer 
and opens Epic. 




Rx Prep Duplicate documenting 
Filling out the Pharmacy Activity Sheet with 
dispensation information.  
Begin: When pharmacist starts writing patient 
information on PAS.  






Consulting physician to discuss patient treatment 
plans or answer questions regarding formulary.  
Begin: When physician physically enters the 
dispensary and/or when pharmacist talks to 
physician in exam room.  
End: When physician leaves dispensary and/or 




interaction PAP initiation 
Deciding to initiate a PMAP program with 
patient and beginning application process. 
Begin: When pharmacist starts filling out 
application.  




interaction PAP discussion 
Talking to patient about bringing in missing 
application materials.  
Begin: When pharmacist brings up PMAP 
during counseling. 








Teaching sessions with pharmacy students and 
new volunteers.  
Begin: When pharmacist initiates teaching 
session by asking questions of students.  
End: When the interaction ends.    
VA 
Rx Prep Dispensing medication 
Retrieving empty medication bottles, counting 
pills, and filtering medication into bottles. 
Begin: When pharmacist either begins counting 
pills or reaches for an empty medication bottles. 
End: When pills are filtered into bottle. 
NVA 
Rx Prep Traveling 
When pharmacist moves between locations in the 
entire clinic (i.e. walking to exam room) and in 
the dispensary alone.  
Begins: When pharmacist gets up from the desk. 
Ends: When pharmacist returns. 
NVA 
Other Other 
Any arbitrary tasks that are unrelated to work 





USABILITY TASKS FOR PROTOTYPE TESTING 
Participants were asked to complete the following tasks within the RxMAGIC prototype. All 
necessary information was provided to them to complete these tasks.  
(1) Register a patient. Please register the following patient: Jack Smith, DOB: 04/20/1956, 
Address: 332 Park Avenue, Pittsburgh, PA, 15232.  
(2) Enter medication into general inventory. Please enter Ibuprofen 200 MG Oral Tablets into 
the general inventory (quantity: 100, expiration date: Jul/2017, lot number: 78AD889) 
(3) Enter medication into PAP inventory. Please enter Depakote 250 MG Oral Tablets into the 
PAP inventory for Jack Smith. (expiration date: Sept/2018, lot number: AD113) 
(4) Dispense medication. Please select a prescription of your choice from the dashboard and 
dispense the appropriate medication. You may use any of the medication bottles you see in front 
of you. 
(5) Initiate a PAP application. Please enter a new PAP application for Jack Smith. Company: 
Abbott Pharmaceuticals; Medication: Depakote 250 MG Oral Tablets. 
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APPENDIX E 
EPICS AND USER STORIES 
Epic 01: View and maintain inventory through a web-based browser. (10) 
 
I want to have visibility into the medication inventory so that I can inform 
appropriate staff of insufficient inventory and facilitate reordering.  
I want to have visibility into the medication inventory so that I don’t waste time 
physically searching for medications in the cabinets that we don’t have in stock.  
I want to have visibility into the specific inventories maintained by the dispensary 
so that I know which cabinet to access when consulted about stock availability.  
I want to enter new medication items into the inventory so that I can attach a 
unique inventory ID barcode to all stock medications. 
I want to be able to edit drug counts in the inventory so that I can ensure they are 
accurate at all times. 
I want to be able to reprint inventory ID labels so that each medication item has a 
legible barcoded label (should one become detached). 
I want to be able to delete items from the inventory so that I can cleanse the 
inventory of expired medication.  
 I want to have visibility into the current formulary during patient visits so that I can 
have an informed discussion with the patient about their treatment plan without 
interrupting the pharmacist. 
I want to know if a patient is enrolled in a PAP program so that I know I can 
prescribe certain types of medications.  
AC I want to enter items into the inventory from my own office so that I can deliver them to the clinic labeled and reduce the pharmacist workload.  













 I want electronic dispensation to update drug counts in real time so that stock 
counts are updated accurately and immediately. 
 I want electronic dispensation to update drug counts in real time so that I am 
informed of low-inventory levels in the timeliest fashion. 
 I want to be able to electronically dispense medication without a medication order 
from the EHR so that I can maintain accurate drug counts for OTC medication too. 
 I want to know the history of a dispensation for a certain patient (medications 
patients are prescribed and taking) from the BFC so that I can avoid drug-drug 
interactions during dispensation. 
 I want to understand specific stock availability at the point of dispensation so that I 
ensure we prioritize dispensation of medications approaching expiry. 
Physician I want to know the history of dispensation for a certain patient from the BFC so that I can prevent an adverse drug event during ordering. 
Epic 03: Produce computer generated labels upon dispensation. (3) 
 I want to attach preprinted adhesive labels to dispensed medication so that my 
documentation tasks become more efficient.  
I want to attach preprinted adhesive labels to dispensed medication so that the 
patient clearly understands the medication directions throughout the duration of the 
prescription. 
I want to attach preprinted adhesive to prescription medication so that they are 
complete with all necessary information required for adherence to dispensing 
standards. 
Epic 04: Automatically alert pharmacists of new medication orders after CPOE. (6) 
 
I want to be alerted immediately when a physician has entered medication orders so 
that we can efficiently initiate the dispensing process and reduce patient wait times.   
I want to be alerted immediately when a physician has entered medication orders so 
that I can ensure that the drug is in stock prior to the end of the patent visit. 
I want to know when a physician is confused during CPOE so that we can resolve 
the problem and correctly update the order in EpicCare.  
I want incoming prescriptions to be automatically added to a list in order of their 
receipt so that I prioritize dispensation to the longest-waiting patients.  
I want incoming prescriptions to be automatically added to a visible dashboard so 
that I do not need to continually check the patient dashboard in EpicCare. 
Physician 
I want the pharmacist to be alerted immediately when I enter a medication via 
CPOE so that patients aren’t waiting for long periods of time if I forget to update 
their status. 





















I want to know the expiration date of all medications so that I can prioritize 
dispensation of near-expiry drugs to reduce wastage.  
I want to know when medications are expired so that I can keep patients safe by 
deleting them from the inventory. 
I want to know the lot number of all medications so that I can quickly respond to 
medication recalls and keep patients safe.  
I want to customize par levels so that I am in control of low inventory alerts.   
I want to be know when a medication item has fallen below a given threshold so 
that I can promptly add the item to the activity sheet to avoid stock outs. 
I want to know when a PAP patient hasn’t returned to the clinic in six months so 
that I can decide whether should transfer it to general stock to reduce waste. 
Epic 06: Automatically generate the activity sheet and enable PDF creation. (8) 
 
I want electronic dispensation to populate the activity sheet so that my 
documentation tasks are more efficient. 
I want to be able to search and view all old activity sheets within RxMAGIC so that 
I understand consumption patterns. 
I want to be able to print the activity sheet so that it gets to delivered to the 
PHCUP.  
I want to know when a patient has one month or less of a PMAP medication in 
stock so that I can indicate its due for reorder on the activity sheet.    
I want low inventory medications to be automatically added to the activity sheet so 
that I don’t have to remember low-stock items throughout the entire clinic session. 
 I want to view an automated copy of the activity sheet daily so that I know it is 
accurate, legible, and on time. 
I want to view an automated copy of the activity sheet so that I know which 
medications to reorder. 
I want to be able to export and print the activity sheet so that I can save it for my 
own records. 
Epic 07: Provide medication reordering support for the PAP application process. (5) 
Pharm 
I want to know the details of a patient’s PAP application so that I can ensure their 
medication is up-to-date and reordered. 
I want to ensure a patient is enrolled in a PAP application before adding their 
medication to the inventory. 
 I want to know the ‘date to reorder’ a patient’s medication so that I can ensure an 
uninterrupted supply of PAP medications. 
I want to view a report of all medications to be reordered in a certain time period so 




















I want to know the specific pharmaceutical company program in which a patient is 
enrolled so that I know who to contact for reordering. 
Epic 08: Establish a user management framework. (3) 




USABILITY TASKS FOR PRODUCTION TESTING 
Six participants completed the following tasks within RxMAGIC. Each participant rated the ease 
of completion of each task, where 1 = “very difficult” and 5 = “very easy.”  
 Task Mean (SD) 
1. A new shipment of medication just arrived at the clinic, and you want to 
enter an item into the general inventory (non PMAP) and give it a barcode 
label.   
Please enter the following medication: Ibuprofen 200 MG Oral Tablet, Lot 
No: 8BE1288, EXP: 12/17, QTY: 100) 
4 (0.63) 
2. Oops! You meant to enter 200 tablets rather than 100 for that last bottle of 
ibuprofen. Find your entry, edit the quantity, and print a new label.  5 (0) 
3. One of the clinicians just placed an order in Epic for 30 tablets of 
Amoxicillin 500 MG Oral Tablet for Fidelia Butler. Dispense medication to 
this patient.  
4 (1.67) 
4. Another order was just placed in Epic for 90 tablets of Naprosyn 500 mg 
oral tablets for Arlie Swain. Dispense medication to this patient, taking the 
expiry dates into consideration. You may dispense from multiple bottles if 
there is insufficient inventory in one bottle. 
4 (0.89) 
5. A patient is planning on purchasing her medication from Giant Eagle, but 
she can’t pick it up until Friday. You want to dispense medication to hold 
her over, although no prescription exists for this. Dispense 10 tablets of 
Ibuprofen 200 MG oral tablets to Theresa Starin (q6h prn).  
4 (1.26) 
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6. Can you tell me how many medications are about to expire in the General 
Inventory? Please name a few. 4.3 (0.82) 
7. How many medications are understocked in the general inventory? Select 
one and add it to the activity sheet. Check to make sure it added correctly. 
What else is on the activity sheet? 
4.8 (0.41) 
8. Let’s look up Theresa Starin and view her details. Can you tell me about 
her past dispensations? 4.8 (0.41) 
9. You realize that you have been dispensing a lot of Azithromycin 500 mg 
oral tablets lately and want to make sure you don’t run out in the future. Set 
a new par level for this medication so that you will receive low inventory 
alerts. Par level: 500 tablets. 
4.5 (0.84) 
10. Looking at the alert feed, what are some things you think you should do? 
Choose an alert of your choice and act on it. Please check on its outcome.  4.7 (0.52) 
11. Dominic Langdon receives Cardura 1 mg oral tabs through PMAP, but he 
hasn’t been to the clinic in over 6 months. Transfer this item to the general 





CODEBOOK FOR POST-DEPLOYMENT TIME-MOTION STUDY 
Category Subcategory Definition Value definition 
Rx Prep Hunting for medication 
The physical search for stock medication in the 
cabinets.  
Begin: When pharmacist slides open cabinet 
door to initiate search.  
End: When pharmacist closes the door and/or 






The process of printing and affixing adhesive 
label to bottle (includes reprinting).  
Begin: When pharmacist completes dispensation 
form in RxMAGIC.  
End: When pharmacist finishes affixing the label 






Explaining medication and administration 
instructions to patient during dispensation.  
Begin: When pharmacist calls patient into the 
dispensary.  
End: When patient exits the dispensary. 
VA 
EMR Patient Care 
Pharmacist interacts with EMR to assess patient 
history and/or enter medication orders. 
Begin: When pharmacist is actively using Epic 
to view patient info. 




EMR Order correction 
Pharmacist corrects CPOE (i.e. changes quantity, 
removes refill).  
Begin: When pharmacist opens a CPOE and 
modifies it.  






Consulting physician to discuss patient treatment 
plans or answer questions regarding formulary 
(also includes pharmacist interaction).  
Begin: When physician physically enters 
dispensary; when pharmacist goes to exam room; 
when two pharmacists discuss.  
End: When interaction is complete. 
VA 
Inventory Inventory 
Interacting with the inventory within RxMAGIC; 
adding items to the activity sheet; adjusting par 
levels; adding items to inventory. 
Begin: When pharmacist selects icon from home 
screen. 




interaction PAP initiation 
Deciding to initiate a PMAP program with 
patient and beginning application process. 
Begin: When pharmacist starts filling out 
application.  




interaction PAP discussion 
Talking to patient about application and/or 
missing materials.  
Begin: When pharmacist brings up PMAP 
during counseling. 
End: When they stop talking about the 
application. 
VA 
Rx Prep Rx Mgmt 
Using RxMAGIC dashboard to select and 
complete dispensation form; also includes 
manual entry of prescription info.  
Begin: When pharmacist selects a prescription 
from the dashboard. 







Teaching sessions with pharmacy students and 
new volunteers.  
Begin: When pharmacist initiates teaching 
session by asking questions of students.  
End: When the interaction ends.    
VA 
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Rx Prep Dispensing medication 
Retrieving empty medication bottles, counting 
pills, and filtering medication into bottles. 
Begin: When pharmacist either begins counting 
pills or reaches for an empty medication bottles. 
End: When pills are filtered into bottle. 
NVA 
Rx Prep Traveling 
When pharmacist moves throughout the clinic  
Begins: When pharmacist gets up from the desk. 
Ends: When pharmacist returns. 
NVA 
Other Other 
Any arbitrary tasks that are unrelated to work 
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